<SEC-DOCUMENT>0001193125-25-173098.txt : 20250805
<SEC-HEADER>0001193125-25-173098.hdr.sgml : 20250805
<ACCEPTANCE-DATETIME>20250805084219
ACCESSION NUMBER:		0001193125-25-173098
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20250805
DATE AS OF CHANGE:		20250805

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			STAAR SURGICAL CO
		CENTRAL INDEX KEY:			0000718937
		STANDARD INDUSTRIAL CLASSIFICATION:	OPHTHALMIC GOODS [3851]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				953797439
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1227

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-11634
		FILM NUMBER:		251182978

	BUSINESS ADDRESS:	
		STREET 1:		1911 WALKER AVE
		CITY:			MONROVIA
		STATE:			CA
		ZIP:			91016
		BUSINESS PHONE:		6263037902

	MAIL ADDRESS:	
		STREET 1:		1911 WALKER AVE
		CITY:			MONROVIA
		STATE:			CA
		ZIP:			91016

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	STAAR SURGICAL COMPANY
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>d30729ddefa14a.htm
<DESCRIPTION>DEFA14A
<TEXT>
<HTML><HEAD>
<TITLE>DEFA14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
<DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;
</DIV><DIV STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT STYLE="white-space:nowrap">8-K</FONT> </B></P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant
to Section&nbsp;13 or 15(d) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>of The Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported): August&nbsp;4, 2025 </B></P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>STAAR Surgical Company </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">0-11634</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">95-3797439</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(IRS Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification Number )</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="10"></TD>
<TD HEIGHT="10" COLSPAN="2"></TD>
<TD HEIGHT="10" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center"><B>25510 Commercentre Drive<BR>Lake Forest, California</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>92630</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>(Address of principal executive offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip Code)</B></TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">626-303-7902</FONT></FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Registrant&#146;s telephone number, including area code) </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Not Applicable </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Former
name or former address, if changed since last report) </B></P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <FONT STYLE="white-space:nowrap">8-K</FONT> filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions (see General Instruction A.2. below): </P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </P></TD></TR></TABLE>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Soliciting material pursuant to Rule <FONT STYLE="white-space:nowrap">14a-12</FONT> under the Exchange Act (17
CFR <FONT STYLE="white-space:nowrap">240.14a-12)</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to Rule <FONT
STYLE="white-space:nowrap">14d-2(b)</FONT> under the Exchange Act (17 CFR <FONT STYLE="white-space:nowrap">240.14d-2(b))</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to Rule <FONT
STYLE="white-space:nowrap">13e-4(c)</FONT> under the Exchange Act (17 CFR <FONT STYLE="white-space:nowrap">240.13e-4(c))</FONT> </P></TD></TR></TABLE>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&nbsp;12(b) of the Act: </P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Title of each class</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Trading<BR>Symbol(s)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Name of each exchange<BR>on which registered</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">Common</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">STAA</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">NASDAQ</TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of
1933 (&#167;230.405 of this chapter) or Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> of the Securities Exchange Act of 1934 <FONT STYLE="white-space:nowrap">(&#167;240.12b-2</FONT> of this chapter). </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#8194;&#9744; </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth
company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;13(a) of the Exchange Act.&#8194;&#9744;
</P>
<P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;
</DIV><DIV STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%" VALIGN="top" ALIGN="left"><B>Item&#8201;1.01</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Entry into a Material Definitive Agreement. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On August&nbsp;4, 2025, STAAR Surgical Company, a Delaware corporation (the &#147;Company&#148;), entered into an Agreement and Plan of Merger (the
&#147;Merger Agreement&#148;) with Alcon Research, LLC, a Delaware limited liability company (&#147;Alcon&#148;), and Rascasse Merger Sub, Inc., a Delaware corporation and a wholly owned direct subsidiary of Alcon (&#147;Merger Sub&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Merger Agreement provides, among other things, that subject to the satisfaction or waiver of the conditions set forth therein, Merger Sub will merge with
and into the Company (the &#147;Merger&#148;), with the Company surviving the Merger as a wholly owned subsidiary of Alcon. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The board of directors of the
Company (the &#147;Board&#148;) has unanimously (a) determined that the Merger Agreement and the transactions contemplated thereby are fair to, and in the best interests of, the Company and its stockholders (b) approved and declared advisable the
Merger Agreement and the transactions contemplated thereby and (c) resolved to recommend that the Company&#146;s stockholders adopt the Merger Agreement. The stockholders of the Company will be asked to vote on the adoption of the Merger Agreement
at a stockholder meeting that will be held on a date, and at a time and place, to be announced. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Merger Consideration </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the Merger Agreement, at the effective time of the Merger (the &#147;Effective Time&#148;), each share of common stock, par value $0.01 per share, of the
Company (&#147;Company Common Stock&#148;) issued and outstanding immediately prior to the Effective Time (other than certain excluded shares as described in the Merger Agreement) will be cancelled and converted into the right to receive $28.00 in
cash, without interest (the &#147;Merger Consideration&#148;). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Conditions to the Merger </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The respective obligations of the Company, on one hand, and Alcon and Merger Sub, on the other hand, to consummate the transactions contemplated by the Merger
Agreement are subject to the satisfaction or waiver of a number of conditions, including:&nbsp;(1) the adoption of the Merger Agreement by the Company&#146;s stockholders; (2)&nbsp;the absence of any law or order prohibiting consummation of the
Merger in specified jurisdictions in which the Company, Alcon or their respective subsidiaries have business operations; (3)&nbsp;the expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act
of 1976, as amended, and certain other specified regulatory approvals (the &#147;Requisite Regulatory Approvals&#148;); (4) the accuracy of the other party&#146;s representations and warranties, subject to certain materiality standards set forth in
the Merger Agreement; and (5)&nbsp;compliance by the other party in all material respects with such other party&#146;s obligations under the Merger Agreement. In addition, Alcon&#146;s and Merger Sub&#146;s obligation to consummate the transactions
contemplated by the Merger Agreement are subject to the satisfaction or waiver of a condition that there has not occurred a material adverse effect on the Company since the date of the Merger Agreement that is continuing. The availability of
financing is not a condition to the consummation of the Merger. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Representations and Warranties; Covenants </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Merger Agreement contains customary representations and warranties given by the Company, Alcon and Merger Sub.&nbsp;The Merger Agreement also contains
customary <FONT STYLE="white-space:nowrap">pre-closing</FONT> covenants, including covenants by the Company relating to the conduct of its business prior to the Effective Time.&nbsp;In addition, the parties have agreed to use their respective
reasonable best efforts to take all actions necessary, proper or advisable to complete the Merger and the other transactions contemplated by the Merger Agreement as promptly as practicable, including obtaining third-party approvals necessary to
complete the Merger and obtaining certain regulatory approvals. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Merger Agreement also provides that the Company is subject to certain restrictions on its ability to
solicit alternative acquisition proposals from third parties, to provide information to third parties and to engage in discussions with third parties regarding alternative acquisition proposals, subject to customary exceptions. In addition, the
Board is required to recommend that its respective stockholders vote in favor of the transaction, subject to exceptions for superior proposals and other situations where failure to effect a recommendation change would be inconsistent with the
Board&#146;s fiduciary duties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Merger Agreement provides that, following the Effective Time, the Company Common Stock will be delisted from NASDAQ
and deregistered under the Securities Exchange Act of 1934, as amended. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Termination and Termination Fees </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Either the Company or Alcon may terminate the Merger Agreement under certain circumstances, including if (1)&nbsp;the Merger is not completed by August&nbsp;4,
2026, subject to a three-month extension in certain circumstances in the event that the Requisite Regulatory Approvals have not been obtained or a legal restraint in certain specified jurisdictions prohibits consummation of the Merger (the &#147;End
Date&#148;), (2) the Company&#146;s stockholders fail to adopt the Merger Agreement, (3)&nbsp;a final and <FONT STYLE="white-space:nowrap">non-appealable</FONT> order or action in certain specified jurisdictions enjoins, prohibits or otherwise makes
illegal the Merger, or (4)&nbsp;the other party breaches its representations, warranties or covenants in the Merger Agreement in a way that would entitle the party seeking to terminate the Merger Agreement not to consummate the Merger, subject to
the right of the breaching party to cure the breach. Alcon may terminate the Merger Agreement if,&nbsp;prior to receiving Company stockholder approval, the Board has changed its recommendation in favor of the Merger. The Company may terminate the
Merger Agreement prior to receiving stockholder approval in order to enter into a definitive agreement with respect to a superior proposal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company
will be required to make a payment to Alcon equal to $43.4&nbsp;million if the Merger Agreement is terminated because (1)&nbsp;Alcon has terminated the Merger Agreement because the Board has changed its recommendation in favor of the Merger;
provided that the termination fee will be reduced to $14.5&nbsp;million if the change in recommendation occurs in response to a superior proposal received from a third party who provided an acquisition proposal during the <FONT
STYLE="white-space:nowrap">45-day</FONT> &#147;window shop&#148; period following the date of the Merger Agreement that constitutes or could reasonably be expected to lead to a superior proposal (a &#147;qualified bidder,&#148; provided that such
third party will cease to be a qualified bidder if its proposal expires or is withdrawn), (2)&nbsp;the Company has terminated the Merger Agreement in order to enter into an agreement providing for a superior proposal; provided that the termination
fee will be reduced to $14.5&nbsp;million if such termination occurs with respect to a superior proposal from a qualified bidder, or (3) (i)&nbsp;if the Company or Alcon terminates the Merger Agreement due to failure to obtain the Company
stockholder approval or because the End Date is reached prior to the Company obtaining stockholder approval, or Alcon terminates the Merger Agreement because of a material and uncured breach by the Company, (ii)&nbsp;an acquisition proposal is
announced and not withdrawn four business days prior to termination (or four business days before the stockholder meeting if terminated for a failure to obtain the stockholder approval or four business days before a material breach if terminated for
such a breach by the Company), and (iii)&nbsp;within 12 months of such termination, the Company enters into a definitive agreement for, or consummates a transaction for, a majority of its equity or assets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Alcon will be required to make a payment to the Company equal to $72.4&nbsp;million if the Merger Agreement is terminated by&nbsp;either the Company or Alcon
in certain circumstances related to the failure to receive certain required regulatory approvals. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Merger Agreement also provides that, in certain circumstances, the Company or Alcon may compel the other
to specifically perform its obligations under the Merger Agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Additional Information </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing description of the Merger and the Merger Agreement does not purport to be complete and is qualified in its entirety by reference to the full text
of the Merger Agreement, which is filed as Exhibit 2.1 to this report, and is incorporated herein by reference.&nbsp;A copy of the Merger Agreement has been included to provide investors with information regarding its terms and is not intended to
provide any factual information about the Company, Alcon or Merger Sub. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Merger Agreement contains representations, warranties, covenants and
agreements, which were made only for purposes of such agreement and as of specified dates.&nbsp;The representations and warranties in the Merger Agreement reflect negotiations between the parties to the Merger Agreement and are not intended as
statements of fact to be relied upon by the Company&#146;s stockholders or any other person.&nbsp;In particular, the representations, warranties, covenants and agreements in the Merger Agreement may be subject to limitations agreed by the parties,
including having been modified or qualified by certain confidential disclosures that were made between the parties in connection with the negotiation of the Merger Agreement, and having been made for purposes of allocating risk among the parties
rather than establishing matters of fact.&nbsp;In addition, the parties may apply standards of materiality in a way that is different from what may be viewed as material by investors.&nbsp;As such, the representations and warranties in the Merger
Agreement may not describe the actual state of affairs at the date they were made or at any other time and you should not rely on them as statements of fact.&nbsp;Moreover, information concerning the subject matter of the representations and
warranties may change after the date of the Merger Agreement, and unless required by applicable law, the Company undertakes no obligation to update such information. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%" VALIGN="top" ALIGN="left"><B>Item&#8201;8.01</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Other Events. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On August&nbsp;5, 2025, Alcon and the Company issued a joint press release announcing entry into the Merger Agreement. A copy of the joint press release is
attached as Exhibit 99.1 to this report and incorporated by reference. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%" VALIGN="top" ALIGN="left"><B>Item&#8201;9.01</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Financial Statements and Exhibits </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d)&nbsp;Exhibits </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="93%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>No.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Description of
Exhibit</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>2.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Agreement and Plan of Merger, dated as of August&nbsp;4, 2025, by and among STAAR Surgical Company, Alcon Research, LLC and Rascasse Merger Sub, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Joint press release of Alcon and the Company, dated August&nbsp;5, 2025</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>104</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">*&#8195;&#8195;&#8195;*&#8195;&#8195;&#8195;* </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Additional Information About the Merger and Where to Find It </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This report relates to the proposed transaction involving the Company. In connection with the proposed transaction, the Company will file relevant materials
with the U.S. Securities and Exchange Commission (the &#147;SEC&#148;), including the Company&#146;s proxy statement on Schedule 14A (the &#147;Proxy Statement&#148;). This report is not a substitute for the Proxy Statement or any other document
that the Company may file with the SEC or send to its stockholders in connection with the proposed transaction. BEFORE MAKING ANY VOTING DECISION, STOCKHOLDERS OF THE COMPANY ARE URGED TO READ ALL RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE
SEC, INCLUDING THE PROXY STATEMENT, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS THERETO, IN CONNECTION WITH THE PROPOSED TRANSACTION WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. Investors
and security holders will be able to obtain the documents (when available) free of charge at the SEC&#146;s website, www.sec.gov, or by visiting the Company&#146;s investor relations website, https://investors.staar.com. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>No Offer or Solicitation </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This report is for
informational purposes only and is not intended to and does not constitute, or form part of, an offer, invitation or the solicitation of an offer or invitation to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any
securities, or the solicitation of any vote or approval in any jurisdiction, pursuant to the proposed transaction or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Participants in the Solicitation </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under SEC
rules, the Company and certain of its directors, executive officers and other members of management and employees may be deemed to be participants in the solicitation of proxies from the holders of the Company&#146;s common stock in connection with
the proposed transaction. Information about the directors and executive officers of the Company and their ownership of the Company&#146;s common stock is set forth in the definitive proxy statement for the Company&#146;s 2025 Annual Meeting of
Stockholders (the &#147;Annual Proxy Statement&#148;), which was filed with the SEC on April&nbsp;24, 2025 (and which is available at https://www.sec.gov/ix?doc=/Archives/edgar/data/0000718937/000095017025058174/staa-20250424.htm), including the
sections captioned &#147;Compensation of Directors,&#148; &#147;Information Regarding Executive Officers&#148; and &#147;Security Ownership of Principal Shareholders and Management,&#148; or its Annual Report on Form
<FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;27, 2024, which was filed with the SEC on February&nbsp;21, 2025 (and which is available at
https://www.sec.gov/ix?doc=/Archives/edgar/data/0000718937/000095017025024813/staa-20241227.htm), and in other documents filed by the Company with the SEC. To the extent holdings of such participants in the Company&#146;s securities have changed
since the amounts described in the Annual Proxy Statement, such changes have been reflected on Initial Statements of Beneficial Ownership on Form 3 or Statements of Change in Ownership on Form 4 filed with the SEC by the Company&#146;s directors and
executive officers. These documents can be obtained free of charge from the sources indicated above. Additional information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security
holdings or otherwise, will be contained in the Proxy Statement and other relevant materials to be filed with the SEC in respect of the proposed transaction when they become available. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Forward-Looking Statements </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information
covered by this report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements often contain words such as &#147;anticipate,&#148; &#147;believe,&#148;
&#147;expect,&#148; &#147;plan,&#148; &#147;estimate,&#148; &#147;project,&#148; &#147;continue,&#148; &#147;will,&#148; &#147;should,&#148; &#147;may,&#148; and similar terms. All statements in this report that are not statements of historical fact
are forward-looking statements. These forward-looking statements are neither promises nor guarantees and involve known and unknown risks, uncertainties and other important factors that may cause actual results, performance or achievements to be
materially different from what is expressed or implied by the forward-looking statements, including, but not limited to: (1)&nbsp;the occurrence of any event, change or other circumstances that could give rise to the termination of the merger
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
agreement between the parties to the proposed transaction or extend the anticipated timetable for completion of the proposed transaction; (2)&nbsp;the failure to obtain approval of the proposed
transaction from the Company&#146;s stockholders; (3)&nbsp;the failure to obtain certain required regulatory approvals or the failure to satisfy any of the other closing conditions to the completion of the proposed transaction within the expected
timeframes or at all; (4)&nbsp;risks related to disruption of management&#146;s attention from the Company&#146;s ongoing business operations due to the proposed transaction; (5)&nbsp;the effect of the announcement of the proposed transaction on the
ability of the Company to retain and hire key personnel and maintain relationships with its customers, suppliers and others with whom it does business, or on its operating results and business generally; (6)&nbsp;the ability of the Company to meet
expectations regarding the timing and completion of the transaction; (7)&nbsp;the outcome of any legal proceedings that may be instituted against the Company related to the proposed transaction; (8)&nbsp;the possibility that the Company&#146;s stock
price may decline significantly if the proposed transaction is not consummated; and (9)&nbsp;other important factors set forth in the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended
December&nbsp;27, 2024 under the caption &#147;Risk Factors,&#148; as any such factors may be updated from time to time in the Company&#146;s other filings with the SEC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forward-looking statements speak only as of the date they are made and, except as may be required under applicable law, the Company undertakes no obligation
to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="44%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"><B>STAAR Surgical Company</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Date: August&nbsp;5, 2025</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Stephen C. Farrell</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Stephen C. Farrell</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Chief Executive Officer</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 2.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Execution Version </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT AND PLAN OF MERGER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">by and among </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STAAR SURGICAL
COMPANY, </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">a Delaware corporation, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ALCON RESEARCH, LLC, </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">a
Delaware limited liability company, and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RASCASSE MERGER SUB, INC., </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">a Delaware corporation </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Dated as
of August&nbsp;4, 2025 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Table of Contents </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>Page</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>SECTION&nbsp;1 </B> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE MERGER</B></P></TD>
<TD VALIGN="bottom"><B>&nbsp;</B> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"><B>&nbsp;</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">1.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>The Closing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">1.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>The Merger</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">1.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Conversion of Shares</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">1.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Surrender of Certificates; Stock Transfer Books</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">1.5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Dissenters&#146; Rights</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">1.6</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Treatment of Company Long-Term Incentive Compensation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">1.7</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Further Action</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="6"> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECTION&nbsp;2 </B></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE SURVIVING CORPORATION</B></P></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"><B>&nbsp;</B></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"><B>&nbsp;</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">2.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Certificate of Incorporation and Bylaws; Directors and Officers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECTION&nbsp;3 </B></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REPRESENTATIONS AND WARRANTIES OF THE
COMPANY</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">3.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Due Organization; Subsidiaries, Etc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">3.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Certificate of Incorporation and Bylaws</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">3.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Capitalization, Etc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">3.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>SEC Filings; Financial Statements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">3.5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Absence of Changes; No Material Adverse Effect</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">3.6</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Title to Assets</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">3.7</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Real Property</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">3.8</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Intellectual Property; Data Privacy</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">3.9</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Contracts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">3.10</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Liabilities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">3.11</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Compliance with Legal Requirements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">3.12</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Regulatory Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">3.13</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Compliance with Anti-Corruption Laws, Sanctions and Customs&nbsp;&amp; Trade Control Laws; Certain Business Practices</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">3.14</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No TID U.S. Business</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">3.15</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Governmental Authorizations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">3.16</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Tax Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">3.17</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Employee Matters; Benefit Plans</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">3.18</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Environmental Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">3.19</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Insurance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">3.20</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Legal Proceedings; Orders</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.21</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Authority; Binding Nature of Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.22</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Contravention;</FONT> Consents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.23</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Takeover Laws</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.24</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Opinion of Financial Advisors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.25</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Brokers and Other Advisors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.26</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acknowledgement by Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="7"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="6"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECTION&nbsp;4 </B></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB</B></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman"><B>&nbsp;</B></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt"></P>
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman"><B>&nbsp;</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Due Organization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Merger Sub</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Authority; Binding Nature of Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Contravention;</FONT> Consents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Disclosure</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Absence of Litigation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Funds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ownership of Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acknowledgement by Parent and Merger Sub</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Brokers and Other Advisors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Solvency</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and Development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.13</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Residency of Ultimate Parent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="7"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="6"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECTION&nbsp;5</B></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTAIN COVENANTS OF THE COMPANY</B></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman"><B>&nbsp;</B></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt"></P>
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman"><B>&nbsp;</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Access and Investigation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operation of the Acquired Corporations&#146; Business</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stockholder Meeting; Proxy Statement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Solicitation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="7"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="6"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECTION&nbsp;6 </B></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ADDITIONAL COVENANTS OF THE PARTIES</B></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman"><B>&nbsp;</B></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt"></P>
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman"><B>&nbsp;</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Board Recommendation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Filings, Consents and Approvals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Employee Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company 401(k)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnification of Officers and Directors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stockholder Litigation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional Agreements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Disclosure</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Takeover Laws</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;16 Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock Exchange Delisting; Deregistration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notification of Certain Events</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.13</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Merger Sub</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="7"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="6"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECTION&nbsp;7 </B></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONDITIONS PRECEDENT TO THE MERGER</B></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman"><B>&nbsp;</B></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt"></P>
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman"><B>&nbsp;</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Condition to the Obligations of Each Party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conditions to the Obligations of Parent and Merger Sub</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conditions to the Obligations of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="7"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="6"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECTION&nbsp;8 </B></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TERMINATION</B></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman"><B>&nbsp;</B></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt"></P>
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman"><B>&nbsp;</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effect of Termination</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expenses; Termination Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="7"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="6"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECTION&nbsp;9 </B></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MISCELLANEOUS PROVISIONS</B></P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman"><B>&nbsp;</B></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt"></P>
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman"><B>&nbsp;</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amendment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Waiver</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Survival of Representations and Warranties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entire Agreement; Counterparts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Applicable Legal Requirements; Jurisdiction; Specific Performance; Remedies</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assignability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transfer Tax</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Third Party Beneficiaries</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notices</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Severability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Obligation of Parent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Construction</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Exhibit A Certain Definitions </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT AND PLAN OF MERGER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>THIS AGREEMENT AND PLAN OF MERGER</B> (this &#147;<U>Agreement</U>&#148;) is made and entered into as of August&nbsp;4, 2025 by and among
Alcon Research, LLC, a Delaware limited liability company<I> </I>(&#147;<U>Parent</U>&#148;); Rascasse Merger Sub, Inc., a Delaware corporation and a wholly owned direct subsidiary of Parent (&#147;<U>Merger Sub</U>&#148;); and STAAR Surgical
Company, a Delaware corporation (the &#147;<U>Company</U>&#148;). Certain capitalized terms used in this Agreement are defined in <U>Exhibit A</U>. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RECITALS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) Parent
desires to acquire the Company through a merger of Merger Sub with and into the Company (the &#147;<U>Merger</U>&#148;),<B> </B>with the Company continuing as the surviving corporation in the Merger (the &#147;<U>Surviving Corporation</U>&#148;),<B>
</B>on the terms and subject to the conditions set forth in this Agreement, whereby (i)&nbsp;each issued and outstanding share of Company Common Stock (the &#147;<U>Shares</U>&#148;)<B> </B>as of the Effective Time (other than Excluded Shares and
Dissenting Shares) will be converted into the right to receive $28.00 per Share, in cash, without interest (the &#147;<U>Merger </U><U>Consideration</U>&#148;),<B> </B>and (ii)&nbsp;the Company shall become a wholly owned Subsidiary of Parent as a
result of the Merger. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) The Board of Directors has unanimously (i)&nbsp;determined that this Agreement and the Transactions, including
the Merger, on the terms and subject to the conditions set forth in this Agreement, are advisable, fair to and in the best interests of the Company and its stockholders, (ii)&nbsp;approved, adopted and declared advisable the execution and delivery
of, and entry into, this Agreement, and the performance by the Company of the covenants and agreements contained herein and the consummation of the Transactions, including the Merger, (iii)&nbsp;resolved to recommend that the stockholders of the
Company adopt this Agreement and (iv)&nbsp;directed that this Agreement and the Merger be submitted to the stockholders of the Company for adoption thereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) The boards of directors of Parent and Merger Sub have each approved this Agreement and declared it advisable for Parent and Merger Sub,
respectively, to enter into this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) Immediately following the execution of this Agreement, Parent, as the sole stockholder of
Merger Sub, will adopt this Agreement and the Transactions, including the Merger (the &#147;<U>Merger Sub Sole Stockholder Approval</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E) Parent, Merger Sub and the Company desire to make certain representations, warranties, covenants and agreements in connection with the
Merger and also to prescribe various conditions to the Merger. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In consideration of the foregoing and the respective representations, warranties, covenants and agreements set forth herein, the Parties agree
as follows: </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECTION&nbsp;1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>THE MERGER </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.1
The Closing</B>. Unless this Agreement shall have been terminated pursuant to <U>Section</U><U></U><U>&nbsp;8</U>, and unless otherwise mutually agreed in writing among the Company, Parent and Merger Sub, the consummation of the Merger (the
&#147;<U>Closing</U>&#148;) shall take place remotely via the electronic exchange of signatures on the third (3rd) Business Day after the satisfaction or, to the extent permitted hereunder, waiver of all conditions to the Merger set forth in
<U>Section</U><U></U><U>&nbsp;7</U> (other than those conditions that by their nature are to be satisfied at the Closing, but subject to the satisfaction or waiver (to the extent permitted hereunder) of such conditions). The date on which the
Closing occurs is referred to in this Agreement as the &#147;<U>Closing Date</U>.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.2 The Merger</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Subject to the provisions of this Agreement, as soon as practicable on the Closing Date, the Company and Merger Sub shall file or cause to
be filed a certificate of merger with the Secretary of State of the State of Delaware with respect to the Merger, in such form as required by, and executed and acknowledged in accordance with, the relevant provisions of the DGCL, and the Parties
shall take all such further actions as may be required by applicable Legal Requirements to make the Merger effective. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Merger
shall become effective upon the date and time of the filing of that certificate of merger with the Secretary of State of the State of Delaware or such later date and time as is agreed upon in writing by the Parties and specified in the certificate
of merger (such date and time the Merger is effective, the &#147;<U>Effective Time</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Upon the terms and subject to the
conditions set forth in this Agreement and the applicable provisions of the DGCL, at the Effective Time, Merger Sub shall be merged with and into the Company, the separate corporate existence of Merger Sub shall thereupon cease and the Company shall
continue as the Surviving Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Merger shall have the effects set forth in this Agreement and in the applicable provisions
of the DGCL. Without limiting the generality of the foregoing, at the Effective Time, all of the property, rights, privileges, immunities, powers and franchises of the Company and Merger Sub shall vest in the Surviving Corporation, and all of the
debts, liabilities and duties of the Company and Merger Sub shall become the debts, liabilities and duties of the Surviving Corporation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.3 Conversion of Shares</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) At the Effective Time, by virtue of the Merger and without any further action on the part of Parent, Merger Sub, the Company or any
stockholder of the Company: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) any Shares held immediately prior to the Effective Time by the Company (or held in the Company&#146;s
treasury) shall be cancelled and retired and shall cease to exist, and no consideration shall be delivered in exchange therefor; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii)
any Shares held immediately prior to the Effective Time by Parent or Merger Sub shall be cancelled and retired and shall cease to exist, and no consideration shall be delivered in exchange therefor; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) any Shares held immediately prior to the Effective Time by any direct or indirect Subsidiary of Parent or Merger Sub or any direct or
indirect Subsidiary of the Company shall be converted into such number of shares of stock of the Surviving Corporation such that each such Subsidiary shall own the same percentage of the outstanding capital stock of the Surviving Corporation
immediately following the Effective Time as such Subsidiary owned in the Company immediately prior to the Effective Time (such Shares, together with the Shares described in clause <U>(i)</U>&nbsp;and clause <U>(ii)</U>, the &#147;<U>Excluded
Shares</U>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) except as provided in <U>clauses (i)</U>, <U>(ii)</U>, and <U>(iii)</U>&nbsp;above, and subject to
<U>Section</U><U></U><U>&nbsp;1.3(b)</U>, each Share outstanding immediately prior to the Effective Time (excluding any Dissenting Shares, which shall have only those rights set forth in <U>Section</U><U></U><U>&nbsp;1.5</U>) shall be converted into
the right to receive the Merger Consideration, without interest and subject to any withholding of Taxes in accordance with <U>Section</U><U></U><U>&nbsp;1.4(e)</U>; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) each share of the common stock, $0.01 par value per share, of Merger Sub then outstanding shall be converted into one share of common
stock of the Surviving Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From and after the Effective Time, subject to this <U>Section</U><U></U><U>&nbsp;1.3(a)</U>, all
Shares shall no longer be outstanding and shall automatically be cancelled and shall cease to exist, and (a)&nbsp;each applicable holder of Shares (other than Dissenting Shares and Excluded Shares) shall cease to have any rights with respect
thereto, except the right to receive the Merger Consideration in accordance with this <U>Section</U><U></U><U>&nbsp;1.3</U>, without any interest thereon, upon the surrender of such Shares in accordance with <U>Section</U><U></U><U>&nbsp;1.4</U>,
(b) each applicable holder of Dissenting Shares shall cease to have any rights with respect thereto, except the rights specified in <U>Section</U><U></U><U>&nbsp;1.5</U> and (c)&nbsp;each applicable holder of Excluded Shares shall cease to have any
rights with respect thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Subject to Section&nbsp;1.3(b) of the Company Disclosure Schedule, if, between the date of this
Agreement and the Effective Time, the outstanding Shares are changed into a different number or class of shares by reason of any stock split, division or subdivision of shares, stock dividend, reverse stock split, consolidation of shares,
reclassification, recapitalization or other similar transaction, then the Merger Consideration shall be equitably adjusted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.4
Surrender of Certificates; Stock Transfer Books</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Prior to the Effective Time, Parent shall designate a bank or trust company
reasonably acceptable to the Company to act as agent (the &#147;<U>Exchange Agent</U>&#148;) for the purposes of exchanging Shares represented by a certificate evidencing such Shares (the &#147;<U>Certificates</U>&#148;) and Book-Entry Shares for
the Merger Consideration to which holders of such Shares shall become entitled pursuant to <U>Section</U><U></U><U>&nbsp;1.3</U>. On or prior to the Closing Date, Parent shall deposit, or shall cause
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to be deposited, with the Exchange Agent cash sufficient to pay the aggregate Merger Consideration payable pursuant to <U>Section</U><U></U><U>&nbsp;1.3(a)(iv)</U> (the &#147;<U>Payment
Fund</U>&#148;). The Payment Fund shall not be used for any purpose other than to pay the aggregate Merger Consideration in the Merger; <I>provided </I>that any interest or other income resulting from investment of the Payment Fund that results in
an amount being held in the Payment Fund that is greater than the amount payable pursuant to <U>Section</U><U></U><U>&nbsp;1.3</U> and this <U>Section</U><U></U><U>&nbsp;1.4</U> shall be promptly returned to Parent. The Payment Fund shall be
invested by the Exchange Agent as directed by the Surviving Corporation;<I> provided</I> that such investments shall be (w)&nbsp;in obligations of or guaranteed by the United States of America, (x)&nbsp;in commercial paper obligations rated <FONT
STYLE="white-space:nowrap">A-1</FONT> or <FONT STYLE="white-space:nowrap">P-1</FONT> or better by Moody&#146;s Investors Service, Inc. or Standard&nbsp;&amp; Poor&#146;s Corporation, respectively, (y)&nbsp;in certificates of deposit, bank repurchase
agreements or banker&#146;s acceptances of commercial banks with capital exceeding $1&nbsp;billion, or (z)&nbsp;in money market funds having a rating in the highest investment category granted by a recognized credit rating agency at the time of
acquisition or a combination of the foregoing and, in any such case, no such instrument shall have a maturity exceeding three (3)&nbsp;months. Notwithstanding anything to the contrary herein, the Equity Award Consideration will not be deposited with
the Exchange Agent and will be paid in accordance with <U>Section</U><U></U><U>&nbsp;1.6</U>. In the event the Payment Fund shall be insufficient to pay the aggregate Merger Consideration in accordance with this Agreement (including
<U>Section</U><U></U><U>&nbsp;1.3(a)(iv)</U> and in respect of any Dissenting Shares that shall be deemed to have been converted as of the Effective Time into the right to receive the Merger Consideration in accordance with the proviso in the first
sentence of <U>Section</U><U></U><U>&nbsp;1.5</U>), Parent shall promptly deposit, or cause to be deposited, additional funds with the Exchange Agent in an amount that is equal to the shortfall that is required to make such payment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) As soon as reasonably practicable after the Effective Time and in any event not later than the third (3rd) Business Day following the
Effective Time, the Surviving Corporation shall cause to be delivered to each Person who was, at the Effective Time, a holder of record of the Certificates or Book-Entry Shares, who, in each case, was entitled to receive the Merger Consideration
pursuant to <U>Section</U><U></U><U>&nbsp;1.3</U>, (A)&nbsp;a form of letter of transmittal, which shall be in reasonable and customary form and shall specify that delivery shall be effected, and risk of loss and title to the Certificates shall
pass, only upon proper delivery of the Certificates (or affidavits of loss in lieu thereof in accordance with <U>Section</U><U></U><U>&nbsp;1.4(f)</U>, if applicable) to the Exchange Agent, or a customary agent&#146;s message with respect to
Book-Entry Shares, and (B)&nbsp;instructions for use in effecting the surrender of the Certificates or Book-Entry Shares in exchange for the Merger Consideration issuable and payable in respect of such Shares pursuant to
<U>Section</U><U></U><U>&nbsp;1.3</U>. Upon surrender to the Exchange Agent of Certificates (or affidavits of loss in lieu thereof in accordance with <U>Section</U><U></U><U>&nbsp;1.4(f)</U>, if applicable) or Book-Entry Shares, together with such
letter of transmittal in the case of Certificates, duly completed and validly executed in accordance with the instructions thereto, and such other documents as may be reasonably required pursuant to the instructions, the holder of such Certificates
or Book-Entry Shares shall be entitled to receive in exchange therefor the Merger Consideration for each Share formerly evidenced by such Certificates or Book-Entry Shares, and such Certificates and Book-Entry Shares shall then be cancelled. No
interest shall accrue or be paid on the Merger Consideration payable upon the surrender of any Certificates or Book-Entry Shares for the benefit of the holder thereof. If the payment of any Merger Consideration is to be made to a Person other than
the Person in whose name the surrendered Certificates formerly evidencing the Shares is registered on the stock transfer books of the Company, it shall be a condition of payment that the Certificate so surrendered shall be endorsed properly or
otherwise be in proper form for transfer and that the Person requesting such payment </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
shall have paid all transfer and other similar Taxes required by reason of the payment of the Merger Consideration to a Person other than the registered holder of the Certificate surrendered
(&#147;<U>Other Person Transfer Taxes</U>&#148;), or shall have established to the reasonable satisfaction of the Surviving Corporation that such Other Person Transfer Taxes either have been paid or are not applicable. Except as required by Legal
Requirements, none of Parent, Merger Sub or the Surviving Corporation shall have any liability for the Other Person Transfer Taxes described in the immediately preceding sentence of this <U>Section</U><U></U><U>&nbsp;1.4(b)</U>; <I>provided</I>,
that if Legal Requirements impose any such liability on Parent, Merger Sub, or the Surviving Corporation, such Person requesting the payment as described in the immediately preceding sentence of this <U>Section</U><U></U><U>&nbsp;1.4(b)</U> shall
cause such Other Person Transfer Taxes to be paid on behalf of Parent, Merger Sub, or the Surviving Corporation (such that none of Parent, Merger Sub, or the Surviving Corporation has any economic responsibility for such Other Person Transfer
Taxes). Payment of the applicable Merger Consideration with respect to Book-Entry Shares shall only be made to the Person in whose name such Book-Entry Shares are registered. Until surrendered as contemplated by this
<U>Section</U><U></U><U>&nbsp;1.4</U>, each Certificate and Book-Entry Share (in each case, other than the Dissenting Shares (subject to <U>Section</U><U></U><U>&nbsp;1.5</U>) and Excluded Shares) shall be deemed at any time after the Effective Time
to represent only the right to receive the applicable Merger Consideration as contemplated by <U>Section</U><U></U><U>&nbsp;1.3</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)
At any time following the twelve (12)-month anniversary of the Effective Time, Parent shall be entitled to require the Exchange Agent to deliver to it any funds (with respect to the aggregate Merger Consideration to which holders of Shares shall
become entitled pursuant to <U>Section</U><U></U><U>&nbsp;1.3</U>) which had been made available to the Exchange Agent and not disbursed to holders of Certificates or Book-Entry Shares (including all interest and other income received by the
Exchange Agent in respect of all funds made available to it), and, thereafter, such holders shall be entitled to look to the Surviving Corporation (subject to abandoned property, escheat and other similar Legal Requirements) only as general
creditors thereof with respect to the Merger Consideration that may be payable upon due surrender of the Certificates or Book-Entry Shares held by them, without any interest thereon. Notwithstanding the foregoing, neither the Surviving Corporation
nor the Exchange Agent shall be liable to any holder of Certificates or Book-Entry Shares for the Merger Consideration delivered in respect of such share to a public official pursuant to any abandoned property, escheat or other similar Legal
Requirements. Any amounts remaining unclaimed by such holders at such time at which such amounts would otherwise escheat to or become property of any Governmental Body shall become, to the extent permitted by applicable Legal Requirements, the
property of the Surviving Corporation or its designee, free and clear of all claims or interest of any Person previously entitled thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) At the Effective Time, the stock transfer books of the Company with respect to the Shares shall be closed and thereafter there shall be no
further registration of transfers of Shares on the records of the Company. From and after the Effective Time, the holders of the Shares outstanding immediately prior to the Effective Time shall cease to have any rights with respect to such Shares
except as otherwise provided herein or by applicable Legal Requirements. If, after the Effective Time, Certificates or Book-Entry Shares are presented to the Surviving Corporation for any reason, they shall be cancelled and exchanged as provided in
this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;(i) Each of the Company, the Surviving Corporation, Parent, Merger Sub, the
Exchange Agent and their respective Affiliates, shall be entitled to deduct and withhold (or cause the Exchange Agent to deduct and withhold) from any amount payable to any Person pursuant to this Agreement such amounts as it is required by any
Legal Requirement to deduct and withhold with respect to Taxes. Each such withholding agent shall use commercially reasonable efforts to reduce or eliminate any such withholding, including by requesting any necessary Tax forms, including IRS <FONT
STYLE="white-space:nowrap">Form&nbsp;W-9</FONT> or the appropriate series of IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8,</FONT> as applicable, or any similar information under U.S. federal, state or local or
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> Legal Requirements. Each such withholding agent shall take all action that may be necessary to ensure that any such amounts so withheld are timely and properly remitted to the appropriate Governmental
Body. To the extent that amounts are so deducted or withheld and timely and properly remitted to the appropriate Governmental Body, such withheld amounts shall be treated for all purposes of this Agreement as having been paid to the Person in
respect of which such deduction and withholding was made (except in the case of any deduction or withholding under the Legal Requirements of Switzerland or any political subdivision thereof that is applicable as a result of the status of Parent or
any Affiliate of Parent as a tax resident of Switzerland, Parent or any Affiliate of Parent having any other nexus with Switzerland for Tax purposes or any payment hereunder being made from or through Switzerland (and, for the avoidance of doubt,
other than a deduction or withholding in respect of amounts payable or deliverable to a holder of Shares or Awards that is tax resident in Switzerland)). (ii) Each of Parent and Merger Sub acknowledges and agrees that no amount with respect to Taxes
is required to be deducted or withheld from any amounts payable or deliverable pursuant to <U>Section</U><U></U><U>&nbsp;1.3</U>, <U>Section</U><U></U><U>&nbsp;1.5</U>, <U>Section</U><U></U><U>&nbsp;1.6</U> or <U>Section</U><U></U><U>&nbsp;8.3</U>
under the Legal Requirements of Switzerland or any political subdivision thereof as in effect on the date of this Agreement (in each case, respectively, other than from amounts payable or deliverable to a holder of Shares or Awards that is tax
resident in Switzerland). (iii)&nbsp;Notwithstanding any other provision of this Agreement, Parent and Merger Sub shall ensure that none of the Company, the Surviving Corporation, Parent, Merger Sub, the Exchange Agent or any of their respective
Affiliates or agents shall deduct or withhold, or cause to be deducted or withheld, from any amounts payable or deliverable pursuant to <U>Section</U><U></U><U>&nbsp;1.3</U>, <U>Section</U><U></U><U>&nbsp;1.5</U>,
<U>Section</U><U></U><U>&nbsp;1.6</U> or <U>Section</U><U></U><U>&nbsp;8.3</U> any amount with respect to Taxes imposed under the Legal Requirements of Switzerland or any political subdivision thereof (in each case, respectively, other than amounts
payable or deliverable to a holder of Shares or Awards that is tax resident in Switzerland) other than as required by any change under the Legal Requirements of Switzerland after the date of this Agreement. Notwithstanding anything in this agreement
to the contrary, the sole remedy for a breach of the representation set forth in <U>Section</U><U></U><U>&nbsp;1.4(e)(ii)</U> shall be the application of <U>Section</U><U></U><U>&nbsp;1.4(e)(i)</U> and <U>(iii)</U>&nbsp;with respect to any
withholding under the Legal Requirements of Switzerland and, as applicable, <U>Section</U><U></U><U>&nbsp;1.3</U>, <U>Section</U><U></U><U>&nbsp;1.4(f)</U>, <U>Section</U><U></U><U>&nbsp;1.5</U>, <U>Section</U><U></U><U>&nbsp;1.6</U> and
<U>Section</U><U></U><U>&nbsp;8.3</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) If any Certificate shall have been lost, stolen or destroyed, upon the making of an affidavit
of that fact by the holder of the Shares formerly represented by that Certificate, or by a representative of that holder, claiming that Certificate to be lost, stolen or destroyed and, if required by the Surviving Corporation, the posting by that
holder of a bond, in such reasonable amount as Parent may direct, as indemnity against any claim that may be made against it with respect to such Certificate (which shall not exceed the Merger Consideration payable with respect to such Certificate),
the Exchange Agent will pay (less any amounts entitled to be deducted or withheld pursuant to <U>Section</U><U></U><U>&nbsp;1.4(e)</U>), in exchange for such lost, stolen or destroyed Certificate, the applicable Merger Consideration to be paid in
respect of the Shares formerly represented by such Certificate, as contemplated by this <U>Section</U><U></U><U>&nbsp;1</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.5 Dissenters</B><B>&#146;</B><B> Rights</B>. Notwithstanding anything to the contrary
contained in this Agreement, Shares outstanding immediately prior to the Effective Time, and held by holders who are entitled to appraisal rights under Section&nbsp;262 of the DGCL and have properly exercised and perfected their respective demands
for appraisal of such Shares in the time and manner provided in Section&nbsp;262 of the DGCL and, as of the Effective Time, have neither effectively withdrawn nor lost their rights to such appraisal and payment under the DGCL (the
&#147;<U>Dissenting Shares</U>&#148;), shall not be converted into the right to receive the Merger Consideration, but shall, by virtue of the Merger, be automatically cancelled and no longer outstanding, shall cease to exist and shall be entitled to
only such consideration as shall be determined pursuant to Section&nbsp;262 of the DGCL; <I>provided </I>that if any such holder shall have failed to perfect or shall have effectively withdrawn or lost such holder&#146;s right to appraisal and
payment under the DGCL, such holder&#146;s Shares shall be deemed to have been converted as of the Effective Time into the right to receive the Merger Consideration (less any amounts entitled to be deducted or withheld pursuant to
<U>Section</U><U></U><U>&nbsp;1.4(e)</U>), and such Shares shall no longer be deemed to be Dissenting Shares. The Company shall give prompt notice to Parent and Merger Sub of any demands received by the Company for appraisal of any Dissenting
Shares, withdrawals of such demands and any other instruments served pursuant to Section&nbsp;262 of the DGCL, in each case, prior to the Effective Time. Parent and Merger Sub shall have the right to direct and participate in (at their respective
cost and expense), and the Company shall have the opportunity to participate (at its cost and expense) in and be consulted with respect to, all negotiations and proceedings with respect to such demands, and prior to the Effective Time, neither
Parent, Merger Sub nor the Company shall, without the prior written consent of Parent and the Company, settle or offer to settle, or make any payment with respect to, any such demands, or agree or commit to do any of the foregoing. This
<U>Section</U><U></U><U>&nbsp;1.5</U>, and not <U>Section</U><U></U><U>&nbsp;6.6</U> or<U>&nbsp;Section 6.2(e)</U>, shall govern with respect to such appraisals and demands. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.6 Treatment of Company Long-Term Incentive Compensation</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) At the Effective Time, each Company Option which has a per Share exercise price that is less than the Merger Consideration (each, an
&#147;<U><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">In-the-Money</FONT></FONT> Company Option</U>&#148;) (whether or not then vested) shall be cancelled and the holder thereof shall be entitled to receive a cash payment equal
to (i)&nbsp;the excess of (A)&nbsp;the Merger Consideration over (B)&nbsp;the per Share exercise price under such <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">In-the-Money</FONT></FONT> Company Option, multiplied by
(ii)&nbsp;the total number of Shares subject to such <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">In-the-Money</FONT></FONT> Company Option immediately prior to the Effective Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) At the Effective Time, each Company Option that is not an
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">In-the-Money</FONT></FONT> Company Option (each, an
&#147;<U><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Out-of-the-Money</FONT></FONT></FONT> Company Option</U>&#148;) shall be cancelled at the Effective Time without any consideration payable
therefor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) At the Effective Time, each then outstanding Company RSU Award (whether or not then vested) that was granted prior to the
date hereof or that is held by a <FONT STYLE="white-space:nowrap">non-employee</FONT> member of the Board of Directors shall be cancelled and the holder thereof shall be entitled to receive a cash payment equal to the product of (i)&nbsp;the Merger
Consideration and (ii)&nbsp;the total number of Shares subject to such Company RSU Award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) At the Effective Time, each then
outstanding Company PSU Award (whether or not then vested) shall be cancelled and the holder thereof shall be entitled to receive a cash payment equal to the product of (i)&nbsp;the Merger Consideration and (ii)&nbsp;the total number of Shares
subject to such Company PSU Award immediately prior to the Effective Time, with performance deemed achieved at 160% of the target level. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) At the Effective Time, each then outstanding Company Cash Award shall vest in full (to
the extent unvested) and be paid as soon as reasonably practicable after the Effective Time, and in any event by the second regularly scheduled payroll date following the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) As soon as reasonably practicable after the Effective Time, and in any event by the second regularly scheduled payroll date following the
Closing Date, Parent shall cause the Surviving Corporation to, and the Surviving Corporation shall, pay the aggregate cash consideration payable pursuant to this <U>Section</U><U></U><U>&nbsp;1.6</U> with respect to <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">In-the-Money</FONT></FONT> Company Options, Company RSU Awards and Company PSU Awards (collectively, &#147;<U>Awards</U>&#148;) through, to the extent applicable, the Surviving Corporation&#146;s payroll (subject to any
required withholding Taxes) to the holders of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">In-the-Money</FONT></FONT> Company Options, Company RSU Awards and/or Company PSU Awards. Prior to the Effective Time, the Company shall
take all actions appropriate or necessary (under the Company Equity Plan and award agreements pursuant to which Company Options, Company RSU Awards and Company PSU Awards are outstanding or otherwise) to effect the transactions described in this
<U>Section</U><U></U><U>&nbsp;1.6</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) To the extent a payment pursuant in this <U>Section</U><U></U><U>&nbsp;1.6</U> would trigger a
Tax or penalty under Section&nbsp;409A of the Code, such payment shall be made on the earliest date that payment would not trigger such Tax or penalty. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Prior to the Effective Time, the Board of Directors or the appropriate committee of the Board of Directors, as applicable, shall adopt all
resolutions that it determines to be appropriate or necessary (under the Company Equity Plan and award agreements pursuant to which Company Options, Company RSU Awards and Company PSU Awards are outstanding or otherwise) to effect the transactions
described in this <U>Section</U><U></U><U>&nbsp;1.6</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.7 Further Action</B>(a) . If, at any time after the Effective Time, any
further action is reasonably determined by Parent to be necessary or desirable to carry out the purposes of this Agreement or vest the Surviving Corporation with full right, title and possession of and to all rights and property of Merger Sub and
the Company, the officers and directors of the Surviving Corporation and Parent shall be fully authorized (in the name of Merger Sub and/or in the name of the Company) to take such action. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECTION&nbsp;2 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>THE
SURVIVING CORPORATION </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.1 Certificate of Incorporation and Bylaws; Directors and Officers</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) As of the Effective Time, subject to <U>Section</U><U></U><U>&nbsp;6.5</U>, the certificate of incorporation of the Company shall by
virtue of the Merger and without any further action, be amended and restated to read in its entirety so that it reads to be the same as the certificate of incorporation of Merger Sub, as in effect immediately prior to the Effective Time, except that
(i)&nbsp;all references therein to Merger Sub shall be automatically amended to become references to the Surviving Corporation, (ii)&nbsp;the provisions naming the initial director(s) or incorporator(s) of Merger Sub shall be omitted and
(iii)&nbsp;the certificate of incorporation shall be amended to comply with <U>Section</U><U></U><U>&nbsp;6.5</U>, and, as so amended and restated, shall be the certificate of incorporation of the Surviving Corporation until thereafter changed or
amended as provided therein or by applicable Legal Requirements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) As of the Effective Time, the bylaws of the Surviving Corporation shall be amended and
restated to conform to the bylaws of Merger Sub as in effect immediately prior to the Effective Time, except that the bylaws shall be amended to comply with <U>Section</U><U></U><U>&nbsp;6.5,</U> until thereafter changed or amended as provided
therein or by applicable Legal Requirements, except that references to the name of Merger Sub shall be replaced by references to the name of the Surviving Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) As of the Effective Time, the directors and officers of the Surviving Corporation shall be the respective individuals who served as the
directors and officers of Merger Sub as of immediately prior to the Effective Time, until their respective successors are duly elected and qualified, or their earlier death, resignation or removal. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECTION&nbsp;3 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>REPRESENTATIONS AND WARRANTIES OF THE COMPANY </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company hereby represents and warrants to Parent and Merger Sub as follows (it being understood that each representation and warranty
contained in this <U>Section</U><U></U><U>&nbsp;3</U> is subject to (a)&nbsp;exceptions and disclosures set forth in the section or subsection of Section&nbsp;3 of the Company Disclosure Schedule corresponding to the particular section or subsection
in this <U>Section</U><U></U><U>&nbsp;3</U>, (b) any exception or disclosure set forth in any other section or subsection of the Company Disclosure Schedule to the extent it is reasonably apparent on the face of such disclosure that such exception
or disclosure is applicable to qualify such representation and warranty, and (c)&nbsp;disclosures in the Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> filed on February&nbsp;21, 2025 by the Company with the SEC and the Company
SEC Documents filed thereafter but at least one (1)&nbsp;day prior to the date of this Agreement (other than (i)&nbsp;any generally cautionary or forward-looking statements contained in the &#147;Risk Factors&#148; or &#147;Forward-Looking
Statements&#148; sections of such Company SEC Documents and (ii)&nbsp;any disclosures in any supplements, modifications or amendments to the Company SEC Documents filed on or after the date of this Agreement) to the extent it is reasonably apparent
on the face of such disclosure that such disclosure is applicable to qualify such representation and warranty; <I>provided</I> that clause <U>(c)</U>&nbsp;of this paragraph shall not apply to the representations and warranties set forth in
<U>Section</U><U></U><U>&nbsp;3.5(b)</U> (Absence of Changes; No Material Adverse Effect), <U>Section</U><U></U><U>&nbsp;3.1(a)</U> (other than the third and fourth sentences of <U>Section</U><U></U><U>&nbsp;3.1(a)</U>), the first sentence of
<U>Section</U><U></U><U>&nbsp;3.1(b)</U> (Due Organization; Subsidiaries, Etc.), <U>Section</U><U></U><U>&nbsp;3.2</U> (Certificate of Incorporation and Bylaws) and <U>Section</U><U></U><U>&nbsp;3.3</U> (Capitalization, Etc.). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.1 Due Organization; Subsidiaries, Etc</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware, and each of
the Company&#146;s Subsidiaries as of the date of this Agreement (including its jurisdiction of incorporation or organization and the percentage of the outstanding equity interests of each such Subsidiary owned by the Company and
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any other Person) are set forth on Section&nbsp;3.1 of the Company Disclosure Schedule (the Company and each such Subsidiary, an &#147;<U>Acquired Corporation</U>&#148; and collectively, the
&#147;<U>Acquired Corporations</U>&#148;). The Company has all necessary corporate or similar power and authority (i)&nbsp;to conduct its business in the manner in which its business is currently being conducted and (ii)&nbsp;to own and use its
assets in the manner in which its assets are currently owned and used, except as would not reasonably be expected to be material to the Acquired Corporations, taken as a whole. Each of the Company&#146;s Subsidiaries is duly organized, validly
existing and, where applicable, in good standing in its jurisdiction of incorporation or organization and has all necessary corporate or similar power and authority (i)&nbsp;to conduct its business in the manner in which its business is currently
being conducted and (ii)&nbsp;to own and use its assets in the manner in which its assets are currently owned and used, except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. Each Acquired
Corporation is qualified or licensed to do business as a foreign corporation, and, where applicable, is in good standing, in each jurisdiction where the nature of its business requires such qualification or licensing, except where the failure does
not have, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company owns
beneficially and of record all of the outstanding shares of capital stock or ordinary shares of the other Acquired Corporations, all of which are duly authorized and validly issued, fully paid or credited as fully paid, nonassessable (to the extent
such entity is a corporate entity and such concept exists in the jurisdiction of organization of such entity) free and clear of all Encumbrances and transfer restrictions, except for Encumbrances or transfer restrictions of general applicability as
may be provided under the Securities Act, applicable securities laws or organizational documents of such Acquired Corporations. Except for the shares of capital stock, ordinary shares or other equity interests of any Acquired Corporations, no
Acquired Corporation owns, directly or indirectly, any capital stock or equity interests in, or subscriptions, options, calls, warrants or rights (whether or not currently exercisable) to acquire, or other securities convertible into or exchangeable
or exercisable for, any capital stock or equity interests of any Entity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.2 Certificate of Incorporation and Bylaws</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company has delivered or made available to Parent copies that are accurate and complete of its certificate of incorporation and
bylaws, including all amendments thereto, as in effect on the date of this Agreement. The Company has delivered or made available to Parent copies that are accurate and complete in all material respects of the certificate of incorporation, bylaws or
other equivalent constitutional and organizational documents of each other Acquired Corporation, including all amendments thereto, as in effect on the date of this Agreement.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company is not in violation of its certificate of incorporation and is not in material violation of any of the provisions of its
bylaws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.3 Capitalization, Etc</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The authorized capital stock of the Company consists of&nbsp;60,000,000 Shares and 10,000,000 shares of preferred stock, par value $0.01
per share. As of the close of business on July&nbsp;30, 2025 (the &#147;<U>Capitalization Date</U>&#148;), there were (i) 49,177,405 Shares issued and outstanding (excluding any Shares held in the Company&#146;s treasury) and (ii)&nbsp;no shares of
preferred stock issued and outstanding. All of the outstanding shares of the capital stock of the Company have been duly authorized and validly issued, and are fully paid and nonassessable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) (i)&nbsp;None of the outstanding shares of capital stock of the Acquired Corporations
are entitled or subject to any preemptive right, right of repurchase or forfeiture, right of participation, right of maintenance or any similar right; (ii)&nbsp;none of the outstanding shares of capital stock of the Acquired Corporations are subject
to any right of first refusal in favor of any Acquired Corporation; (iii)&nbsp;there are no outstanding bonds, debentures, notes or other indebtedness of any Acquired Corporation having a right to vote (or that are convertible into or exercisable
for securities having the right to vote) on any matters on which the stockholders of the Acquired Corporations have a right to vote (&#147;<U>Voting Company Debt</U>&#148;); and (iv)&nbsp;there is no Contract relating to the voting or registration
of any shares of capital stock of the Acquired Corporations. No Acquired Corporation is under any obligation, or bound by any Contract pursuant to which it may become obligated, to repurchase, redeem or otherwise acquire any outstanding shares of
capital stock of the Acquired Corporations. The Shares (including any Shares issuable in respect of Company Options, Company PSU Awards, Company RSU Awards or otherwise issued under the Employee Plans) constitute the only outstanding class of
securities of the Company registered under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) As of the close of business on the Capitalization Date, (i)&nbsp;no
Shares were underlying outstanding unvested PSU Awards for which performance has been certified, (ii) 2,272,281 Shares were underlying outstanding Company Options, (iii) 818,039 Shares were underlying outstanding unvested Company PSU Awards (if the
target level of performance is achieved pursuant to performance vesting), (iv) 1,522,282 Shares were underlying outstanding unvested Company RSU Awards, and (v) 901,672 Shares were reserved for future issuance under the Company Equity Plan
(exclusive of Shares included in clauses (i), (ii), (iii) and (iv)). Other than as set forth in this <U>Section</U><U></U><U>&nbsp;3.3(c)</U>, there is no issued, reserved for issuance, outstanding or authorized restricted stock, restricted stock
unit, stock option, performance stock unit, stock appreciation, phantom stock, profit participation or similar rights or equity-based awards of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Except as set forth in this <U>Section</U><U></U><U>&nbsp;3.3</U> and except for Company Options, Company RSU Awards and Company PSU
Awards outstanding (and Shares issuable on the exercise, vesting or conversion thereof, as applicable), as of the close of business on the Capitalization Date, there are no: (i)&nbsp;outstanding shares of capital stock of or other equity securities
of any Acquired Corporation; (ii)&nbsp;outstanding subscriptions, options, calls, warrants, equity-based compensation awards, phantom stock, stock appreciations, rights (whether or not currently exercisable) to acquire any shares of capital stock,
restricted stock units, stock-based performance units, or any other right that is linked to, or the value of which is in any way based on or derived from, the value of any shares of capital stock or other equity securities of any Acquired
Corporation, or any Voting Company Debt, of any Acquired Corporation, in each case, other than securities or derivative securities not issued by any Acquired Corporation; (iii)&nbsp;outstanding securities, instruments, bonds, debentures, notes or
obligations that are or may become convertible into or exchangeable for any shares of the capital stock, other equity securities, or Voting Company Debt of any Acquired Corporation; or (iv)&nbsp;stockholder rights plans (or similar plans commonly
referred to as a &#147;poison pill&#148;) or Contracts under which any Acquired Corporation is or may become obligated to sell or otherwise issue any shares of its capital stock or any other equity securities or Voting Company Debt (clauses
(i)&nbsp;through (iv), collectively, &#147;<U>Company Securities</U>&#148;). There are no accrued and unpaid dividends with respect to any outstanding Shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Since the Capitalization Date through the date of this Agreement, the Company has not
issued any new Shares or other Company Securities except pursuant to the vesting of Company RSU Awards and Company PSU Awards outstanding as of the Capitalization Date in accordance with their terms or the exercise of Company Options outstanding as
of the Capitalization Date in accordance with their terms and, since the Capitalization Date, the Company has not issued any Company Options, Company RSU Awards or Company PSU Awards, or other equity-based awards, in each case, other than pursuant
to any offer of employment executed on or prior to the date of the Capitalization Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Each award of a Company Option, Company RSU
Award and Company PSU Award (i)&nbsp;was granted in material compliance with all applicable Legal Requirements of each jurisdiction where the recipient of such award was a resident and all applicable securities laws or exemptions therefrom and
(ii)&nbsp;was granted under the Company Equity Plan and is in material compliance with all requirements set forth in the Company Equity Plan. Each Company Option (A)&nbsp;has an exercise or strike price that is no less than the fair market value of
the Shares underlying such Company Option on the grant date and (B)&nbsp;does not constitute &#147;nonqualified deferred compensation&#148; for purposes of Section&nbsp;409A of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) The Company has made available to Parent complete and accurate copies of the (i)&nbsp;Company Equity Plan pursuant to which Company Stock
Options, Company RSU Awards and Company PSU Awards have been issued and (ii)&nbsp;forms of award agreements evidencing Company Stock Options, Company RSU Awards and Company PSU Awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) No Shares of the Company are owned by any Subsidiary of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.4 SEC Filings; Financial Statements</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Since January&nbsp;1, 2023, the Company has filed or furnished on a timely basis all reports, schedules, forms, statements and other
documents (including exhibits and all other information incorporated therein) required to be filed or furnished by the Company with the SEC (as supplemented, modified or amended since the time of filing, the &#147;<U>Company SEC
Documents</U>&#148;). As of their respective dates (or, if amended, supplemented or superseded by a filing prior to the date of this Agreement, then on the date of such most recent applicable amendment, supplement or superseding filing), the Company
SEC Documents complied as to form in all material respects with the applicable requirements of the Securities Act, the Exchange Act or the Sarbanes-Oxley Act of 2002, as amended (the &#147;<U>Sarbanes-Oxley Act</U>&#148;), as the case may be, and
the rules and regulations of the SEC promulgated thereunder applicable to those Company SEC Documents, and, except to the extent that information contained in such Company SEC Document has been revised, amended, modified or superseded (prior to the
date of this Agreement) by a later filed or furnished Company SEC Document, none of the Company SEC Documents when filed or furnished contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein
or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The financial statements (including any related notes and schedules) contained or
incorporated by reference in the Company SEC Documents (if amended, as of the date of the last such amendment prior to the date of this Agreement): (i)&nbsp;complied as to form in all material respects with the published rules and regulations of the
SEC applicable thereto at such time; (ii)&nbsp;were prepared in accordance with United States generally accepted accounting principles (&#147;<U>GAAP</U>&#148;) applied on a consistent basis throughout the periods covered (except as may be indicated
in the notes to such financial statements or, in the case of unaudited interim financial statements, as may be permitted by the SEC on Form <FONT STYLE="white-space:nowrap">10-Q,</FONT> Form <FONT STYLE="white-space:nowrap">8-K</FONT> or any
successor form under the Exchange Act); and (iii)&nbsp;fairly presented, in all material respects, the financial position of the Company as of the respective dates thereof and the results of operations and cash flows of the Company for the periods
covered thereby (subject, in the case of the unaudited financial statements, to the absence of notes and to normal <FONT STYLE="white-space:nowrap">year-end</FONT> adjustments and to any other adjustments described therein, including the notes
thereto). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company maintains, and since December&nbsp;31, 2023 has maintained, in all material respects a system of internal
control over financial reporting (as defined in Rule <FONT STYLE="white-space:nowrap">13a-15(f)</FONT> and <FONT STYLE="white-space:nowrap">15d-15(f)</FONT> under the Exchange Act) which is designed to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP. The Company maintains, and since December&nbsp;31, 2023 has maintained, in all material respects a system of disclosure
controls and procedures (as defined in Rule <FONT STYLE="white-space:nowrap">13a-15(e)</FONT> and <FONT STYLE="white-space:nowrap">15d-15(e)</FONT> under the Exchange Act) sufficient to ensure that information required to be disclosed by the Company
in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC&#146;s rules and forms. The Company&#146;s management has completed an assessment of the
effectiveness of the Company&#146;s system of internal control over financial reporting in compliance with the requirements of Section&nbsp;404 of the Sarbanes-Oxley Act for the fiscal year ended December&nbsp;31, 2023, and, except as set forth in
the Company SEC Documents filed prior to the date of this Agreement, that assessment concluded that those controls were effective. Since December&nbsp;31, 2023, neither the Company nor the Company&#146;s independent registered accountant has
identified or been made aware of: (A)&nbsp;any significant deficiency or material weakness in the design or operation of the internal control over financial reporting utilized by the Company, which is reasonably likely to adversely affect the
Company&#146;s ability to record, process, summarize and report financial information; or (B)&nbsp;any fraud, whether or not material, that involves the management or other employees of the Company who have a significant role in the Company&#146;s
internal control over financial reporting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Company is in compliance in all material respects with all current listing and
corporate governance requirements of Nasdaq. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Company is not a party to, nor does the Company have any obligation or other
commitment to become a party to, any <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet arrangements (as contemplated by Item 303 of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Exchange Act) or similar arrangements where,
in each case, the result, purpose or intended effect of such Contract is to avoid disclosure of any material transaction involving, or material liabilities of, the Company in the Company SEC Documents. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) As of the date of this Agreement, there are no outstanding or unresolved comments in
comment letters received from the SEC with respect to the Company SEC Documents. To the knowledge of the Company, (i)&nbsp;none of the Company SEC Documents is the subject of ongoing SEC review and (ii)&nbsp;there are no inquiries or investigations
by the SEC or any internal investigations pending or threatened, in each case, regarding any accounting practices of the Company. The Company has made available to Parent all correspondence between the Company, on the one hand, and the SEC, on the
other hand, since January&nbsp;1, 2023 through the date hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) The proxy statement of the Company to be filed with the SEC in
connection with the Merger and any amendments or supplements thereto (the &#147;<U>Proxy Statement</U>&#148;), when filed, distributed or otherwise disseminated to the Company&#146;s stockholders, as applicable, and at the time of the Stockholder
Meeting, will comply as to form in all material respects with the applicable requirements of the Exchange Act. The Proxy Statement, at the time of the filing of such Proxy Statement or any supplement or amendment thereto with the SEC, at the time
such Proxy Statement or any supplement or amendment is first distributed or otherwise disseminated to the Company&#146;s stockholders, and at the time of the Stockholder Meeting, will not contain any untrue statement of a material fact or omit to
state any material fact required to be stated therein or necessary in order to make the statements made therein, in light of the circumstances under which they were made, not misleading. Notwithstanding the foregoing, the Company makes no
representation with respect to statements made or incorporated by reference therein based on information supplied by or on behalf of Parent, Merger Sub or their Affiliates for inclusion or incorporation by reference in the Proxy Statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.5 </B><B>Absence of Changes; No Material Adverse Effect</B>.<B><SUP STYLE="font-size:75%; vertical-align:top"> </SUP></B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Since December&nbsp;27, 2024 to the date of this Agreement, except for discussions, negotiations and activities related to this Agreement
and the Transactions or any similar alternative transactions, the Acquired Corporations have operated in all material respects in the ordinary course of business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Since December&nbsp;27, 2024 to the date of this Agreement, there has not occurred any event, occurrence, circumstance, change or effect
that, individually or when taken together with all other events, occurrences, circumstances, changes or effects, has had or would reasonably be expected to have, a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Since December&nbsp;27, 2024 to the date of this Agreement, no Acquired Corporation has taken any actions that, if taken after the date of
the Agreement without Parent&#146;s written consent, would constitute a breach of the covenants set forth in any of clauses <U>(i)</U>, <U>(v)</U>, <U>(vi)</U>, or <U>(xvi)</U> (excluding, for purposes of <U>(xvi)</U>&nbsp;any investigator initiated
trials) of <U>Section</U><U></U><U>&nbsp;5.2(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.6 Title to Assets</B>. Except as would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect, (a)&nbsp;the Company and each other Acquired Corporation have good and valid title to all tangible assets owned by it and necessary for the conduct of the businesses of the Acquired
Corporations, taken as a whole, as currently conducted, and (b)&nbsp;such assets are owned by the Acquired Corporations free and clear of any material Encumbrances (other than Permitted Encumbrances). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.7 Real Property</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Acquired Corporations do not own any real property. None of the Acquired Corporations is a party to any agreement or option to
purchase any real property or interest therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Acquired Corporations hold valid and existing leasehold interests in the real
property that is leased or subleased by the Acquired Corporations from another Person (the &#147;<U>Leased Real Property</U>&#148;) free and clear of any Encumbrances other than Permitted Encumbrances, except as would not reasonably be expected to
have, individually or in the aggregate, a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Section&nbsp;3.7(c) of the Company Disclosure Schedule sets forth
an accurate and complete list of all material Leased Real Property as of the date of this Agreement. Copies of the Leases relating to such Leased Real Property that are true, correct and complete in all material respects as of the date of this
Agreement have been delivered to Parent. Except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, each Lease is in full force and effect, and is the valid and binding obligation of the
applicable Acquired Corporation party thereto, enforceable against the Acquired Corporation in accordance with its terms, except as such enforcement may be subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and other
similar laws of general applicability relating to or affecting creditors&#146; rights, and by general equitable principles. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Except as
would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, (i)&nbsp;none of the Acquired Corporations nor, to the Company&#146;s knowledge, any other party to any Lease, is in default under such Lease as
of the date of this Agreement, and no event has occurred or exists which with the passage of time or notice, or both, would constitute a default, (ii)&nbsp;no Acquired Corporation has received or delivered any written notice, claim, complaint or
objection regarding any violation or breach or default under any lease related to the Leased Real Property that has not since been cured or waived in writing and (iii)&nbsp;the Improvements (x)&nbsp;are in good condition and repair and (y)&nbsp;do
not require any renovations to continue to operate the business of the Acquired Corporations in the ordinary course of business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)
Except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, the present use of the Improvements on the Leased Real Property are in conformity with all applicable laws, rules, regulations and
ordinances, including all applicable zoning laws, ordinances and regulations and with all registered deeds, leases, restrictions of record or other agreements affecting such Leased Real Property and, to the knowledge of the Company, there is no
proposed change therein that would so affect any of the Leased Real Property or its use. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.8 Intellectual Propert</B><B>y; Data
Privacy</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Section&nbsp;3.8(a) of the Company Disclosure Schedule sets forth a list of all Registered IP included in the Company
Owned IP, such list being true, correct and complete in all material respects as of the date of this Agreement. Except as would not reasonably be expected to be material to the Acquired Corporations, taken as a whole, (i)&nbsp;one or more Acquired
Corporations </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
are the sole and exclusive beneficial and record owners of all Registered IP included in the Company Owned IP, and (ii)&nbsp;all Registered IP included in the Company Owned IP is subsisting and,
to the knowledge of the Company, not invalid or unenforceable. Except as had not had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, the Acquired Corporations own all Company Owned IP, free
and clear of all Encumbrances, other than Permitted Encumbrances, and have a valid and enforceable license or other right to use all other Intellectual Property Rights necessary to, or used or held for use in, the conduct of the business of the
Acquired Corporations as currently conducted; <I>provided</I> that this sentence is not a representation or warranty with respect to infringement, misappropriation or other violation of Intellectual Property Rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except as would not reasonably be expected to be material to the Acquired Corporations, taken as a whole, no interference, opposition,
reissue, reexamination proceeding, cancellation proceeding, or other Legal Proceeding (other than routine office examination proceedings with respect to pending applications) is pending or threatened in writing (i)&nbsp;in which the scope, validity,
enforceability or ownership of any Company Owned IP is being contested or challenged, or (ii)&nbsp;that is otherwise challenging or seeking to deny or restrict any rights of any Acquired Corporation in any Company Owned IP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company takes reasonable measures to protect the confidentiality of all Trade Secrets or confidential information included in the
Company Owned IP or otherwise disclosed in confidence to any Acquired Corporation and, to the knowledge of the Company, there has not been any disclosure of or unauthorized access to any such Trade Secrets or confidential information to any Person,
except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The consummation of
the Transactions will not result in the loss or impairment of or payment of any additional amounts with respect to, nor require the consent of any other Person in respect of, any Acquired Corporation&#146;s right to own, use, or hold for use any
Intellectual Property Rights as owned, used, or held for use (including for defensive purposes) in the conduct of the business as currently conducted and as contemplated to be conducted, except as would not reasonably be expected to be material to
the Acquired Corporations, taken as a whole. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Except as would not reasonably be expected to be material to the Acquired Corporations,
taken as a whole, (i)&nbsp;the conduct of each Acquired Corporation&#146;s business as currently conducted and as currently contemplated to be conducted does not infringe, misappropriate or otherwise violate, and, since July&nbsp;1, 2022, has not
infringed, misappropriated or otherwise violated, any Intellectual Property Rights owned by any other Person, and (ii)&nbsp;since July&nbsp;1, 2022, no Legal Proceeding has been asserted or, to the knowledge of the Company, has been threatened in
writing, against any Acquired Corporation alleging that the conduct of any Acquired Corporation&#146;s business infringes, misappropriates or otherwise violates, or will infringe, misappropriate or otherwise violate, any Intellectual Property Rights
of another Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) To the knowledge of the Company, since July&nbsp;1, 2022, no Person has infringed, misappropriated or otherwise
violated any Company Owned IP, except as would not reasonably be expected to be material, to the Acquired Corporations, taken as a whole. No Legal Proceeding is pending or, to the knowledge of the Company, has been threatened in writing since
July&nbsp;1, 2022 by any Acquired Corporation against any other Person alleging any such infringement, misappropriation or other violation of any such Company Owned IP, except as would not reasonably be expected to be material to the Acquired
Corporations, taken as a whole. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Section&nbsp;3.8(g) of the Company Disclosure Schedule contains a true and complete list
of any and all material Company Owned IP that was created, developed, invented or reduced to practice (in part or in whole) as of the date of this Agreement, (i)&nbsp;pursuant to, or in connection with, any Contract or other arrangement with any
Governmental Body or Governmental Body-affiliated entity, or university, college or other educational institution, or (ii)&nbsp;using any funding or facilities of any Governmental Body or Governmental Body-affiliated entity, or university, college
or other educational institution (collectively, &#147;<U>Government Funded IP</U>&#148;). Except as would not reasonably be expected to be material to the Acquired Corporations, taken as a whole, since July&nbsp;1, 2022, each Acquired Corporation
has taken all actions reasonably necessary to obtain, secure, maintain, enforce and protect such Acquired Corporation&#146;s right, title and interest in, to and under all material Government Funded IP, and each Acquired Corporation has complied in
all material respects with any and all Intellectual Property Right disclosure or licensing obligations under any applicable Contract or other arrangement referenced in <U>clause (i)</U>&nbsp;above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, (i)&nbsp;the Company IT
Systems operate in accordance with their specifications and related documentation and perform in a manner that permits the Acquired Corporations to conduct their respective businesses as currently conducted, (ii)&nbsp;the Acquired Corporations take
commercially reasonable actions to protect the confidentiality, integrity and security of the Company IT Systems (and all data and other information and transactions stored or contained therein or processed or transmitted thereby) against any
unauthorized use, access, interruption, modification or corruption, including the implementation of commercially reasonable data backup, disaster avoidance and recovery procedures and business continuity procedures, and (iii)&nbsp;since July&nbsp;1,
2022, to the knowledge of the Company, there has been no unauthorized use or access or security breaches, or interruption, modification, loss or corruption of any of the Company IT Systems (or any data or other information or transactions stored or
contained therein or processed or transmitted thereby). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Except as would not reasonably be expected to be material to the Acquired
Corporations, taken as a whole, since July&nbsp;1, 2022, each Acquired Corporation (and to the knowledge of the Company, any third party Processing personal data for or on behalf of an Acquired Corporation) has complied with all applicable Privacy
Requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) Except as would not reasonably be expected to be material to the Acquired Corporations, taken as a whole, (i)&nbsp;each
Acquired Corporation has implemented and maintains commercially reasonable security measures, compliant with generally accepted industry standards, that are designed to protect against the accidental or unlawful destruction, theft, loss or
unauthorized Processing, access, use, modification or disclosure of Personal Information, including through the deployment of appropriate administrative, technical and physical safeguards and have used their commercially reasonable efforts to
require any third party Processing such Personal Information on its behalf to have implemented all of the foregoing requirements, including by entering into written agreements with any such third party processor requiring that they meet the
requirements of Data Privacy Laws, and (ii)&nbsp;there has been no unauthorized access, use or disclosure or other security incidents or adverse events relating to Personal Information affecting any Acquired Corporation in any material respect,
including that which would require notification of individuals or any Governmental Body or any remedial action under Data Privacy Laws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) Since July&nbsp;1, 2022, no investigation by any Governmental Body has been initiated
and no Legal Proceeding has been asserted or, to the knowledge of the Company, threatened in writing (including through receipt of any notice) against any Acquired Corporation by any Person (i)&nbsp;regarding any collection, use, storage, transfer,
dissemination or other Processing of Personal Information in connection with any Acquired Corporation&#146;s business, or (ii)&nbsp;alleging a violation by any Acquired Corporation of Data Privacy Laws, in each case except as would not reasonably be
expected to be material to the Acquired Corporations, taken as a whole. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) Except as would not reasonably be expected to be material to
the Acquired Corporations, taken as a whole, neither the execution, delivery or performance of this Agreement, nor the consummation of any of the Transactions, will breach or otherwise cause any violation of any Privacy Requirements in respect of
which any Acquired Corporation is obligated to comply or adversely impair any Acquired Corporation&#146;s right to process Personal Information in the conduct of that Acquired Corporation&#146;s business in the manner and for the purposes currently
conducted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.9 Contracts</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Section&nbsp;3.9(a) of the Company Disclosure Schedule identifies each Contract (other than an Employee Plan), to which any Acquired
Corporation is a Party, or by which it is bound, that constitutes a Material Contract as of the date of this Agreement. For purposes of this Agreement, each of the following Contracts to which any Acquired Corporation is a party or by which it is
bound (other than an Employee Plan) constitutes a &#147;<U>Material Contract</U>&#148;: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) any Contract that is a settlement,
conciliation or similar Contract with any Governmental Body or other Person (A)&nbsp;pursuant to which an Acquired Corporation will be required after the date of this Agreement to pay monetary obligations in excess of $1,000,000 (excluding workers
compensation claims from employees or former employees of any Acquired Corporation that will be covered by insurance), in each case, net of any insurance coverage, (B)&nbsp;that contains material obligations or limitations on such Acquired
Corporation&#146;s conduct after the date of this Agreement (excluding customary confidentiality requirements, <FONT STYLE="white-space:nowrap">non-disparagement</FONT> requirements and other similar requirements) or (C)&nbsp;that is a corporate
integrity agreement, deferred prosecution agreement, monitoring agreement, consent decree, settlement order, plan of correction or similar agreement with or imposed by any Governmental Body that contains any ongoing obligations of an Acquired
Corporation; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) any Contract (A)&nbsp;materially limiting the freedom or right of any Acquired Corporation (or, following the Closing,
Parent or any of its Affiliates) to engage in any line of business or to compete with any other Person in any location or line of business, (B)&nbsp;containing any material &#147;most favored nations&#148; terms and conditions (including with
respect to pricing) granted by any Acquired Corporation, (C)&nbsp;containing material exclusivity obligations or otherwise materially limiting the freedom or right of any Acquired Corporation (or, following
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Closing, Parent or any of its Affiliates) to sell, distribute or manufacture any products or services to or for any other Person, (D)&nbsp;providing for the purchase or supply of minimum
quantity of goods or services that are material to the Acquired Corporations, taken as a whole, or (E)&nbsp;that is with a sole-source supplier of goods, supplies, inventory or services that are, in each case, material to the Acquired Corporations,
taken as a whole; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) any Contract that required, by its terms the payment or delivery of cash or other consideration by or to the
Acquired Corporations in an amount in excess of $5,000,000 during the twelve (12)&nbsp;months ended June&nbsp;30, 2025, and in each case (A)&nbsp;that cannot be cancelled by any Acquired Corporation without material penalty or breach on less than
ninety (90)&nbsp;days&#146; notice and (B)&nbsp;excluding commercially available <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">off-the-shelf</FONT></FONT> software and licenses, commercially available <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">software-as-a-service</FONT></FONT></FONT> offerings, material transfer agreements, generally available patent license agreements, and <FONT
STYLE="white-space:nowrap">non-exclusive</FONT> outbound license agreements (in each case, entered into in the ordinary course of business); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) each Contract (excluding purchase orders given or received in the ordinary course of business) with any Top Distributor or Top Supplier
of the Acquired Corporations; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) each Contract that provides for the acquisition or disposition of any assets or any businesses
(whether by merger, sale of stock, sale of assets or otherwise) involving in excess of $10,000,000 that (A)&nbsp;has not yet been consummated or (B)&nbsp;has outstanding any purchase price adjustment,
<FONT STYLE="white-space:nowrap">&#147;earn-out,&#148;</FONT> material indemnification or payment, or similar obligations on the part of any Acquired Corporation (excluding in each case any distribution, importation, consignment or similar
Contracts); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi) any Contract relating to outstanding indebtedness for borrowed money in an aggregate principal amount in excess of
$5,000,000 (whether incurred, assumed, guaranteed or secured by any asset) of any Acquired Corporation (other than indebtedness solely among Acquired Corporations); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii) each Lease under which any Acquired Corporation leases, subleases or licenses any real property (whether as lessor or lessee) involving
annual base rental payments in excess of $250,000; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(viii) each Contract relating to the sale of products, supplies or services that is
between an Acquired Corporation, on one hand, and a Governmental Body, on the other, that is material to the Acquired Corporations, taken as a whole; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ix) any material joint venture, partnership, limited liability company, collaboration or cooperation agreement or similar material Contract
relating to the formation or operation of joint ventures, partnerships, <FONT STYLE="white-space:nowrap">non-wholly</FONT> owned limited liability companies arrangements, or collaboration or cooperation arrangements similar to any of the foregoing;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(x) any Contract providing for any grant by the Acquired Corporations of manufacturing, marketing, sales or commercialization rights
that is material to the Acquired Corporations, taken as a whole; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xi) any <FONT STYLE="white-space:nowrap">co-advertising,</FONT> <FONT
STYLE="white-space:nowrap">co-development,</FONT> <FONT STYLE="white-space:nowrap">co-promotion,</FONT> collaboration or similar Contract that is material to the Acquired Corporations, taken as a whole; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xii) any Contract that prohibits the declaration or payment of dividends or distributions in respect of the capital stock of an Acquired
Corporation, the pledging of the capital stock or other equity interests of an Acquired Corporation, or the issuance of any guaranty by an Acquired Corporation; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xiii) any Contract pursuant to which any Acquired Corporation (i)&nbsp;is granted a license under any material Intellectual Property Right
owned by any third party, other than, to the extent entered into in the ordinary course of business, any material transfer agreements, clinical trial agreements, nondisclosure agreements, or licenses to generally and commercially available software
or technology or (ii)&nbsp;grants to any third party a license under any material Company Owned IP, other than any material transfer agreements, clinical trial agreements, nondisclosure agreements, and other agreements in which the license grant is
incidental or not material to performance thereunder; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xiv) any Collective Bargaining Agreement (other than any such agreement at the
industry-, sector-, or national-level); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xv) any Contract with any Affiliate, director, or executive officer of the Company (as such
term is defined in the Exchange Act), Person holding 15% or more of the Shares, or, to the knowledge of the Company, any Affiliate (other than the Company) or immediate family member of any of the foregoing; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xvi) any Contract that pertains to ongoing reimbursement obligations relating to any Acquired Corporation product by a private issuer or
Governmental Body, including governmental health authority (but excluding any Contracts with public hospitals or public healthcare providers), in any relevant jurisdiction; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xvii) any Contract that is material to the Acquired Corporations, taken as a whole, that requires (A)&nbsp;any consent or approval by a
third party to such Contract or (B)&nbsp;payment by any Acquired Corporation, in each case as a result of a change of control of the Company; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xviii) any other Contract that is currently in effect and has been filed (or is required to be filed) by the Company as an exhibit pursuant
to Item&nbsp;601(b)(10) of <FONT STYLE="white-space:nowrap">Regulation&nbsp;S-K&nbsp;under</FONT> the Securities Act as a &#147;material contract&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) As of the date of this Agreement, the Company has either delivered or made available to Parent an accurate and complete copy of each
Material Contract. Except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, (i)&nbsp;no Acquired Corporation nor, to the knowledge of the Company, any other party thereto is in breach of, or
default under, any Material Contract, (ii)&nbsp;no Acquired Corporation nor, to the knowledge of the Company, any other party to a Material Contract has taken or failed to take any action that with or without notice, lapse of time or both would
constitute a breach of or default under any Material Contract, and (iii)&nbsp;each Material Contract is, with respect to the Acquired Corporations and, to the knowledge of the Company, each other party thereto, a valid and binding agreement in full
force and effect, enforceable in accordance with its terms, except as such enforcement may be subject </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and other similar laws of general applicability relating to or affecting creditors&#146; rights, and by general
equitable principles. Since July&nbsp;1, 2024, to the knowledge of the Company, the Acquired Corporations have not received any notice regarding any violation or breach or default under any Material Contract that has not since been cured, except as
would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. As of the date of this Agreement, no Acquired Corporation has received any written notice from any third party to any Material Contract that such
party intends to terminate, or not renew, any Material Contract, except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.10 Liabilities</B>. The Acquired Corporations do not have any liabilities (whether accrued, absolute, contingent or otherwise) of the
type which would be required to be reflected or reserved against on a consolidated balance sheet of the Company and its Subsidiaries prepared in accordance with GAAP or the notes thereto, except for: (a)&nbsp;liabilities specifically disclosed,
reflected or reserved against in the most recent financial statements or notes thereto included in the Company SEC Documents filed prior to the date of this Agreement; (b)&nbsp;liabilities or obligations permitted or expressly contemplated by this
Agreement or otherwise incurred in connection with the Transactions; (c)&nbsp;liabilities for performance of obligations under Contracts binding upon the Acquired Corporations (other than resulting from any breach or acceleration thereof);
(d)&nbsp;liabilities incurred in the ordinary course of business since July&nbsp;1, 2024 (none of which is a liability for breach of contract, breach of warranty, tort, infringement, violation of Legal Requirements, or that relates to any cause of
action, claim or lawsuit that individually, or in the aggregate, would be material to the Company); and (e)&nbsp;liabilities that have not had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse
Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.11 Compliance with Legal Requirements</B>. Except as would not reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect, since July&nbsp;1, 2022, (a) the Acquired Corporations have been in compliance with all applicable Legal Requirements and (b)&nbsp;no Governmental Body has given any Acquired Corporation written notice of, or
charged any Acquired Corporation with, any violation of any applicable Legal Requirement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.12 Regulatory Matters</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, the Acquired Corporations
have filed with all applicable Regulatory Authorities all required material applications, filings, declarations, listings, registrations, reports or submissions. To the knowledge of the Company, all such applications, filings, declarations,
listings, registrations, reports or submissions were in material compliance with applicable Legal Requirements when filed, and, as of the date of this Agreement, no material deficiencies have been asserted in writing to any of the Acquired
Corporations by any applicable Regulatory Authority or Governmental Body with respect to any such applications, filings, declarations, listings, registrations, reports or submissions, except for those deficiencies that have been addressed in full by
the Company or as would not reasonably be expected to be material to the Acquired Corporations, taken as a whole. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except as would not reasonably be expected to have, individually or in the aggregate, a
Material Adverse Effect, all preclinical and clinical investigations conducted by, or on behalf of, the Acquired Corporations since July&nbsp;1, 2022 have been and are being conducted in material compliance with all applicable Legal Requirements,
including Good Clinical Practices requirements in each relevant jurisdiction, and including Legal Requirements restricting the use and disclosure of individually identifiable health information. Since July&nbsp;1, 2022, no Acquired Corporation has
received any material written notice from a Regulatory Authority with respect to any ongoing clinical or preclinical investigations requiring the termination, suspension or material modification of such studies or tests. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, since July&nbsp;1, 2022,
no Acquired Corporation has (i)&nbsp;made an untrue statement of a material fact or fraudulent statement to a Regulatory Authority, (ii)&nbsp;failed to disclose a material fact required to be disclosed to a Regulatory Authority, or (iii)&nbsp;to the
knowledge of the Company, committed any other act, made any statement or failed to make any statement, that (in any such case) would reasonably be expected to establish a reasonable basis for any Regulatory Authority to invoke any policy related to
fraud or untrue statements (e.g., the FDA&#146;s Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities Final Policy). Except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse
Effect, no Acquired Corporation is the subject of any pending, or, to the knowledge of the Company, threatened investigation by a Regulatory Authority with respect to the matters specified in the foregoing <U>clauses (i)</U> &#150; <U>(iii)</U>.
Except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, since July&nbsp;1, 2022 to the date of this Agreement, no Acquired Corporation nor, to the knowledge of the Company, any officers,
employees, agents or clinical investigators (acting on behalf of the business of the Acquired Corporation) has been suspended, disqualified, debarred or convicted of any crime by a Regulatory Authority or, to the knowledge of the Company, engaged in
any conduct that would reasonably be expected to result in debarment or exclusion under 21 U.S.C. Section&nbsp;335a, 42 U.S.C. <FONT STYLE="white-space:nowrap">Section&nbsp;1320a-7</FONT> or a similar Legal Requirement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) each Acquired Corporation and the products manufactured or marketed by or on behalf of such Acquired Corporation have, since July&nbsp;1,
2022, been in compliance with all Legal Requirements issued by a Regulatory Authority applicable to the operation of such Acquired Corporation&#146;s business; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) no Acquired Corporation or, to the knowledge of the Company, third party that manufactures or commercializes finished product on behalf
of the Acquired Corporations (but only in their capacity as such) has been subject to any enforcement, regulatory or administrative proceedings against or affecting such Acquired Corporation or such third party initiated by a Regulatory Authority
and no such enforcement, regulatory or administrative proceeding has been threatened in writing; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) no Acquired Corporation or,
to the knowledge of the Company, third party that manufactures or commercializes finished product on behalf of any Acquired Corporation (but only in their capacity as such) is party to or has any ongoing obligations pursuant to or under any
corporate integrity agreements, deferred prosecution agreements, monitoring agreements, consent decrees, settlement orders, plans of correction or similar agreements with or imposed by any Governmental Body. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Except as would not reasonably be expected to be material to the Acquired Corporations,
taken as a whole, since July&nbsp;1, 2022, (i) the products manufactured or marketed by or on behalf of the Acquired Corporations have complied in all material respects with all applicable Legal Requirements, including GMP, and (ii)&nbsp;the
promotional materials and claims made by the Acquired Corporations for the products manufactured or marketed by or on behalf of the Acquired Corporations have complied with all applicable Legal Requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, since July&nbsp;1, 2022,
(i) there have been no product recalls conducted by the Acquired Corporations, no product recalls of product manufactured by or on behalf of the Acquired Corporations, and no written requests from any Governmental Body requiring any Acquired
Corporation to cease manufacturing, marketing, distributing or selling any products of the Acquired Corporations, (ii)&nbsp;no Regulatory Authority has initiated an injunction, seizure, or import or export prohibition against any Acquired
Corporation, any product manufactured or marketed by or on behalf of any Acquired Corporation, or any third-party establishment that manufactures or tests product on behalf of any Acquired Corporation (but only in their capacity as such), and
(iii)&nbsp;no Acquired Corporation has received any written notice of adverse observational inspections or other written warning after inspection of a manufacturing facility similar to an FDA Form 483 from a Regulatory Authority, and, to the
knowledge of the Company, all adverse observations that have been received have been addressed to the satisfaction of the relevant Governmental Body. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Except as would not reasonably be expected to be material to the Acquired Corporations, taken as a whole, since July&nbsp;1, 2022, (i) no
third-party audit or inspection of any Acquired Corporation manufacturing facility has resulted in major findings requiring corrective actions, and (ii)&nbsp;the Acquired Corporations have taken all steps required to comply with any corrective
action plan arising out of any third party auditor or internal quality audit or inspection. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Since July&nbsp;1, 2022, no Acquired
Corporation has been, with respect to any Governmental Body, party to any consent decree, judgment, order, or settlement that (i)&nbsp;requires the payment of money by the Acquired Corporation to any Governmental Body or third party,
(ii)&nbsp;requires any recoupment of money from the Acquired Corporation by any Governmental Body or (iii)&nbsp;prohibits any activity currently conducted in the ordinary course of business by the Acquired Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) To the knowledge of the Company, since July&nbsp;1, 2022, no Person has filed against the Company a Legal Proceeding relating to the False
Claims Act of 1863 (31 U.S.C. &#167; 3729 <I>et seq</I>.) or equivalent state statute, which was disclosed to the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.13 Compliance with Anti-Corruption Laws, Sanctions and Customs</B><B></B><B>&nbsp;&amp;
Trade Control Laws; Certain Business Practices</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) None of the Acquired Corporations, none of their respective officers or
directors, and, to the knowledge of the Company, none of such Acquired Corporation&#146;s employees or other Representatives (in each case acting on behalf of such Acquired Corporation) has since April&nbsp;24, 2019, violated any Sanctions Laws, or
in the past five (5)&nbsp;years has (i)&nbsp;used any funds (whether of an Acquired Corporation or otherwise) for unlawful contributions, gifts, entertainment or other unlawful expenses relating to political activity, (ii)&nbsp;directly or
indirectly, unlawfully provided, offered, promised, or authorized the provision of anything of value to any Government Official or any person or entity to influence an official action or secure an improper advantage, (iii)&nbsp;otherwise violated in
any material respect any Anti-Corruption Laws, or (iv)&nbsp;violated in any material respect any Customs&nbsp;&amp; Trade Control Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) None of the Acquired Corporations, any of their directors or officers or, to the knowledge of the Company, any of their respective
employees or other Representatives acting on behalf of any of the Acquired Corporations, is a Sanctioned Person or a Restricted Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Since April&nbsp;24, 2019, none of the Acquired Corporations, any of their directors or officers, or, to the knowledge of the Company, any
of the their respective employees or other Representatives acting on behalf of any of the Acquired Corporations (i)&nbsp;is or has been a Sanctioned Person or Restricted Person or has acted unlawfully, directly or indirectly, on behalf of a
Sanctioned Person or Restricted Person; (ii)&nbsp;is unlawfully conducting or has unlawfully conducted any business in violation of Sanctions; (iii)&nbsp;is unlawfully engaged or has unlawfully engaged in making or receiving any contribution of
funds, goods or services to or for the benefit of any Sanctioned Person or Sanctioned Territory in violation of Sanctions; or (iv)&nbsp;is unlawfully dealing in or has unlawfully dealt in, or otherwise engaged in any transaction relating to, any
property or interests in property of any Sanctioned Person or Sanctioned Territory in violation of Sanctions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Company has in
place controls and systems reasonably designed to ensure compliance by the Acquired Corporations and their respective officers, directors, and employees and any such Acquired Corporation&#146;s other Representatives with Sanctions,
Customs&nbsp;&amp; Trade Control Laws, Anti-Corruption Laws, and Anti-Money Laundering Laws in each of the jurisdictions in which the Acquired Corporations do business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Company has maintained complete and accurate books and records and effective internal controls, in each case in all material respects,
in accordance with the Anti-Corruption Laws for the past five (5)&nbsp;years. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) For the past five (5)&nbsp;years (and since
April&nbsp;24, 2019, in the case of any alleged or actual violation of Sanctions), no Acquired Corporation has (i)&nbsp;made any voluntary, directed, or involuntary disclosure to any Governmental Body, there are no pending or, to the knowledge of
the Company, threatened, claims or any legal action against, or investigations, inquiries, or enforcement proceedings by any Governmental Body of, the Acquired Corporations, nor is there any judgment, penalty, or citation imposed (or, to the
knowledge of the Company, threatened to be imposed, including by a warning letter) upon the Acquired Corporations by or before any Governmental Body, in each case, in connection with any alleged violation of Sanctions, Customs&nbsp;&amp; Trade
Control Laws, or Anti-Corruption Laws or (ii)&nbsp;been the subject of any investigation related to any actual or potential violation of Anti-Corruption Laws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Since April&nbsp;24, 2019, no funds, proceeds or assets contributed, sold, or otherwise
made available to or for the benefit of any Acquired Corporation were obtained or derived from any criminal activities (including, without limitation, activity in violation of Anti-Corruption Laws, Anti-Money Laundering Laws, or Sanctions). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.14 No TID U.S. Business</B>. None of the Acquired Companies (a)&nbsp;produces, designs, tests, manufactures, fabricates, or develops one
or more &#147;critical technologies&#148; within the meaning of the DPA; (b)&nbsp;owns, operates, maintains, supplies, or services any &#147;covered investment critical infrastructure&#148; within the meaning of the DPA (where such activities are
covered by column 2 of Appendix A to 31 C.F.R. Part 800); or (c)&nbsp;maintains or collects, directly or indirectly, &#147;sensitive personal data&#148; of U.S. citizens within the meaning of the DPA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.15 Governmental Authorizations. </B>Except as would not, individually or in the aggregate, reasonably be expected to have a Material
Adverse Effect, the Acquired Corporations hold all material Governmental Authorizations necessary to enable the Acquired Corporations to conduct their business in the manner in which such business is currently being conducted (such Governmental
Authorizations, the &#147;<U>Company Governmental Authorizations</U>&#148;). The material Company Governmental Authorizations held by the Acquired Corporations are valid and in full force and effect and were not obtained in violation of
Anti-Corruption Laws, except as would not have, or reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. The Acquired Corporations are in compliance in all material respects with the terms and requirements of
such Company Governmental Authorizations, except as would not have, or reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.16 Tax Matters</B>. Except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;(i) each of the Tax Returns required to be filed by or on behalf of an Acquired Corporation with any Governmental Body (the
&#147;<U>Company Returns</U>&#148;) have been filed on or before the applicable due date (including any extensions of such due date), and have been prepared in accordance with all applicable Legal Requirements and are accurate and complete, and
(ii)&nbsp;all Taxes due and payable by an Acquired Corporation (whether or not shown on the Company Returns) have been paid in each case, to the relevant Governmental Body, in each case of the foregoing <U>clauses (i)</U>&nbsp;and <U>(ii)</U>,
except with respect to matters for which adequate reserves have been established in accordance with GAAP; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) no unresolved written claim
has been received within the past three (3)&nbsp;years by any Acquired Corporation from any Governmental Body in any jurisdiction where an Acquired Corporation does not file Tax Returns that such Acquired Corporation is or may be subject to Taxes in
that jurisdiction, except with respect to matters for which adequate reserves have been established in accordance with GAAP; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) no
extension or waiver of the statute of limitation period applicable to any Company Returns has been granted and is currently in effect, other than automatic or automatically granted extensions or waivers; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) no Legal Proceeding involving the IRS or any other Governmental Body is pending or has
been threatened in writing within the past three (3)&nbsp;years against or with respect to any Acquired Corporation in respect of any Tax, and no deficiency of Taxes has been asserted in writing as a result of any audit or examination by any
Governmental Body that has not been paid in full, settled or withdrawn in accordance with applicable Legal Requirements, in each case, except with respect to matters for which adequate reserves have been established in accordance with GAAP; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) for taxable years for which the applicable statute of limitations for an assessment of Taxes has not expired, no Acquired Corporation has
any liability for the Taxes of any other Person (other than the Acquired Corporations) under <FONT STYLE="white-space:nowrap">Section&nbsp;1.1502-6</FONT> of the Treasury Regulations (or any similar provision of state, local or <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> Legal Requirements), as a transferee or successor; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) during the <FONT
STYLE="white-space:nowrap">two-year</FONT> period preceding the date of this Agreement, none of the Acquired Corporations have been either a &#147;distributing corporation&#148; or a &#147;controlled corporation&#148; (within the meaning of
Section&nbsp;355(a)(1)(A) of the Code) in a distribution of stock intended to qualify for <FONT STYLE="white-space:nowrap">tax-free</FONT> treatment under Section&nbsp;355(a) of the Code (or any similar provisions of state law); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) no Acquired Corporation has participated in any &#147;listed transaction&#148; within the meaning of Treasury Regulations <FONT
STYLE="white-space:nowrap">Section&nbsp;1.6011-4(b)(2);</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) no Acquired Corporations will be required to include any item of
income in, or exclude any item of deduction from, the computation of taxable income for any taxable period (or portion thereof) ending after the Closing Date as a result of any (i)&nbsp;change in method of accounting, which change in method of
accounting is filed prior to the Closing Date and is for a taxable period ending on or prior to the Closing Date and results from transactions or events occurring, or accounting methods employed, prior to the Closing, (ii) &#147;closing
agreement&#148; as described in Section&nbsp;7121 of the Code (or any similar provision of state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> income Tax Legal Requirements) executed prior to the Closing, (iii)&nbsp;installment sale or
open transaction disposition made prior to the Closing, (iv)&nbsp;prepaid amount received or accrued deferred revenue accrued on or prior to the Closing Date, in each case, other than in the ordinary course of business, or (v)&nbsp;intercompany
transaction or excess loss account described in Treasury Regulations under Section&nbsp;1502 of the Code (or any corresponding provision of state or local income Tax Legal Requirements); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) no Acquired Corporation is party to or bound by any Tax allocation, Tax indemnity or Tax sharing agreement with any Person, other than any
agreement not primarily related to Taxes and entered into in the ordinary course of business and any agreement solely among the Acquired Corporations; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) there are no Encumbrances with respect to Taxes upon any of the assets or properties of any Acquired Corporation, other than Permitted
Encumbrances; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) each of the Acquired Corporations has duly and timely withheld all Taxes required to be
withheld from any payment to any Person, except for any Taxes with respect to which adequate reserves have been established in accordance with GAAP, and such withheld Taxes have been or will be duly and timely paid to the appropriate Governmental
Body, no Acquired Corporation is required to make any deferred payments pursuant to Section&nbsp;965(h) of the Code in any taxable period ending after the Closing Date; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) no Acquired Corporation has requested in writing from a Governmental Body any formal written private letter ruling that has not been
issued but would be binding on the Governmental Body and have continuing effect after the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding anything to the contrary
contained in this Agreement, the representations and warranties made in <U>Sections 3.16</U> and <U>3.17</U> are the sole and exclusive representations and warranties of the Acquired Corporations with respect to Taxes and no other representation or
warranty of the Acquired Corporations contained herein shall be construed to relate to Taxes (including compliance with any Legal Requirement). For the avoidance of doubt, no representation is made by the Acquired Corporations concerning the
existence or amount of any net operating loss, Tax basis or other Tax asset or, with respect to a taxable period (or portion thereof) ending after the Closing, any Tax liability. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.17 Employee Matters; Benefit Plans</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) As of the date of this Agreement, (i)&nbsp;none of the Acquired Corporations is a party to, bound by or is currently negotiating to enter
into, any Collective Bargaining Agreement and no employees of any of the Acquired Corporations are represented by a Labor Organization with respect to their employment with such Acquired Corporation and (ii)&nbsp;there are no negotiations with any
Labor Organization or other organization formed for a similar purpose, which might affect such employees&#146; terms and conditions of employment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Since July&nbsp;1, 2022 and to the date of this Agreement, there has not been any strike, lockout, material work slowdowns, picketing or
other union organizing activity, or, to the knowledge of the Company, any threat thereof, by any employees of any Acquired Corporation with respect to their employment with such Acquired Corporation. There are no materially unfair labor practice
complaints pending or, to the knowledge of the Company, threatened against any of the Acquired Corporations before the National Labor Relations Board or any other Governmental Body. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Section&nbsp;3.17(c) of the Company Disclosure Schedule sets forth an accurate and complete list of each material Employee Plan as of the
date of this Agreement (other than (i)&nbsp;offer letters for <FONT STYLE="white-space:nowrap">non-officer</FONT> employees of the Acquired Corporations in the United States that do not provide for severance, transaction or retention bonuses, change
in control payments or other contractual obligations, (ii)&nbsp;equity grant notices and related documentation under the Company Equity Plan, with respect to employees of the Acquired Corporations and (iii)&nbsp;employment agreements entered into
with <FONT STYLE="white-space:nowrap">non-officer</FONT> employees of the Acquired Corporations outside of the United States that are materially consistent with a form of agreement set forth in <U>Section</U><U></U><U>&nbsp;3.17(c) </U>of the
Company Disclosure Schedule). To the extent applicable, the Company has either delivered or made available to Parent prior to the execution of this Agreement with respect to each material Employee Plan set forth in Section&nbsp;3.17(c) of the
Company Disclosure Schedule accurate and complete copies of, as applicable: (A)&nbsp;all plan documents and all material amendments thereto, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and all related trust or other funding documents, and in the case of unwritten material Employee Plans, written descriptions thereof, (B)&nbsp;all determination letters, rulings, opinion letters,
information letters or advisory opinions issued by the IRS or the United States Department of Labor, (C)&nbsp;the most recently filed annual return/report (Form 5500) and accompanying schedules and attachments thereto, (D)&nbsp;the most recently
prepared actuarial report and financial statements and (E)&nbsp;the most recent prospectus or summary plan descriptions and any material modifications thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) To the knowledge of the Company, all individuals who are performing, and for the three (3)-year period preceding the date of this
Agreement have performed, services for any Acquired Corporation while classified as independent contractors have been properly so classified for all purposes. In the past two (2)&nbsp;years, no Acquired Corporation has received written notice from
any Person challenging the classification of these individuals as independent contractors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Neither the Company nor any other Person
that would be or, at any relevant time, would have been considered a single employer with the Company under the Code or ERISA has ever sponsored, maintained, administered, contributed to, has been required to contribute to or has or is reasonably
expected to have any direct or indirect liability with respect to, any plan subject to Title IV of ERISA or Code Section&nbsp;412, including any &#147;single employer&#148; defined benefit plan or any &#147;multiemployer plan,&#148; each as defined
in Section&nbsp;4001 of ERISA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) No Acquired Corporation is or has ever been an employer of, or been associated or connected with an
employer of, any defined benefit pension arrangement. No Acquired Corporation has any obligation (written or oral) to fund or contribute to or has any liability (whether current, future or contingent) in respect of a defined benefit pension
arrangement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Since July&nbsp;1, 2022, no employee or former employee of any Acquired Corporation transferred to that Acquired
Corporation pursuant to the Transfer Regulations and no such employee or former employee prior to such transfer participated in a defined benefit pension scheme that made provision for benefits other than related to old age, invalidity or death.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Each of the Employee Plans that is intended to be qualified under Section&nbsp;401(a) of the Code has obtained a favorable
determination letter (or opinion letter, if applicable) as to its qualified status under the Code, each such Employee Plan has timely adopted all currently effective amendments to the Code and to the Company&#146;s knowledge there are no events that
have occurred that would reasonably be expected to affect adversely the qualified status of any such Employee Plan. Each trust created under any such Employee Plan is exempt from Tax under Section&nbsp;501(a) of the Code and has been so exempt since
its creation. Each of the Employee Plans is now and has been operated in compliance in all material respects with its terms and all applicable Legal Requirements, including ERISA and the Code. The Acquired Corporations are, and have been in material
compliance with all of their obligations under and in respect of each Employee Plan and all applicable Legal Requirements with respect to each Employee Plan. No events have occurred with respect to any Employee Plan that would reasonably be expected
to result in any material payment or assessment by or against any Acquired Corporation of any excise Tax under ERISA or the Code. The Acquired Corporations are not and could not reasonably be expected to be subject to either a material liability
pursuant to Section&nbsp;502 of ERISA or a material Tax imposed pursuant to Section&nbsp;4975 or 4976 of the Code. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Except to the extent required under Section&nbsp;601 <I>et seq</I>. of ERISA or 4980B of
the Code (or any other similar state or local Legal Requirement), none of the Acquired Corporations nor any Employee Plan has any present or future obligation to provide post-employment or post-retirement welfare benefits to or make any payment to,
or with respect to, any present or former employee, officer or director of any Acquired Corporation pursuant to any Employee Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j)
Except as provided in <U>Section</U><U></U><U>&nbsp;1.6</U>, the consummation of the Transactions (including in combination with other events or circumstances) will not (i)&nbsp;entitle any current or former employee, director, officer, or
independent contractor of any of the Acquired Corporations to any severance pay, bonus, retention, or other similar payment or benefit, (ii)&nbsp;enhance any benefits or accelerate the time of payment or vesting or trigger any payment, or increase
the amount of compensation or benefits due to any such employee, director, officer, or independent contractor, (iii)&nbsp;directly or indirectly cause any Acquired Corporation to transfer or set aside any material assets to fund any benefits under
any Employee Plan or (iv)&nbsp;limit or restrict the right of any of the Acquired Corporations or, after Closing, Parent, to merge, amend or terminate any Employee Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) No Employee Plan, individually or collectively, could reasonably be expected to give rise to the payment of any amount that would not be
deductible due to the application of Section&nbsp;280G of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) Each Employee Plan, and any award thereunder, that is or forms
part of a &#147;nonqualified deferred compensation plan&#148; within the meaning of Section&nbsp;409A or 457A of the Code has been operated in material compliance with, and the Acquired Corporations have materially complied in practice and operation
with, all applicable requirements of Sections 409A and 457A of the Code. None of the Acquired Corporations has any obligation to <FONT STYLE="white-space:nowrap">gross-up,</FONT> indemnify or otherwise reimburse any current or former employee,
director, officer or independent contractor for any Tax incurred by such Person under Section&nbsp;409A, 457A or 4999 of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m)
There are no, and since July&nbsp;1, 2022, there have been no, material Legal Proceeding pending against or involving, or, to the Company&#146;s knowledge, threatened against or involving any Employee Plan, employee or independent contractor of any
Acquired Corporation before any arbitrator or any Governmental Body, including the IRS, Equal Employment Opportunity Commission or the United States Department of Labor. The Acquired Corporations are, and have been since July&nbsp;1, 2022, in
material compliance with all applicable Legal Requirements with respect to employment and labor matters, including those relating to labor relations, wages, vacation, hours of work, holiday pay calculation, overtime, employee classification,
discrimination, harassment, sexual harassment, child labor, civil rights, pay equity, disability rights and benefits, employee leave issues, affirmative action, equal opportunity, work authorization, immigration, safety and health, information
privacy and security, workers&#146; compensation, unemployment insurance, plant closures, redundancies and layoffs, continuation coverage under group health plans, wage payment and the payment and withholding of Taxes. Since July&nbsp;1, 2019, (i)
no allegations of sexual harassment, sexual misconduct or discrimination have been made against any Key Employee and (ii)&nbsp;neither the Acquired Corporations nor any Key Employee has entered into any written settlement agreement related to any
such allegations of sexual harassment, sexual misconduct or discrimination made by any Person. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) The Acquired Corporations are, and have been since July&nbsp;1, 2022, in material
compliance with the Worker Adjustment and Retraining Notification Act and any comparable foreign, state or local law (&#147;<U>WARN</U>&#148;) and have no material outstanding liabilities or other material outstanding obligations thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) Each Employee Plan that covers employees, directors or officers that are not located primarily within the United States (i)&nbsp;has been
maintained in material compliance with its terms and applicable Legal Requirements, (ii)&nbsp;if intended to qualify for special tax treatment, meets all the requirements for such treatment in all material respects, and (iii)&nbsp;if required, to
any extent, to be funded, book-reserved or secured by an insurance policy, is in all material respects funded, book-reserved or secured by an insurance policy, as applicable, in accordance with applicable requirements and, if applicable, based on
reasonable actuarial assumptions in accordance with applicable accounting principles. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.18 Environmental Matters</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Acquired Corporations are and, except for matters which have been fully resolved, have been since July&nbsp;1, 2020 in compliance in
all respects with all applicable Environmental Laws, which compliance includes obtaining, maintaining or complying with all Governmental Authorizations required under Environmental Laws for the operation of their business, except as would not
reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) There is no Legal Proceeding relating to
or arising under any Environmental Law that is pending, or to the knowledge of the Company threatened in writing against any Acquired Corporation or with respect to any Leased Real Property, except as would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Except as would not reasonably be expected to have, individually or in
the aggregate, a Material Adverse Effect: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) since July&nbsp;1, 2020, no Acquired Corporation has received any written notice, report
or other information alleging or entered into any legally binding agreement, order, settlement, judgment, injunction or decree acknowledging uncompleted, outstanding or unresolved violations, liabilities or requirements on the part of any Acquired
Corporation relating to or arising under Environmental Laws; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) to the knowledge of the Company, there are and have been no Hazardous
Materials present or Releases on, under, at or from the Leased Real Property or any real property formerly owned or leased by the Acquired Corporations, or any other locations where Hazardous Material attributable to any Acquired Corporation has
been sent to, in each case in a manner and concentration that would reasonably be expected to result in any claim against or liability of an Acquired Corporation under any Environmental Law; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) no Acquired Corporation has assumed or retained any currently known liability of
another Person or Entity relating to Environmental Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Except as would not reasonably be expected to be material to the Acquired
Corporations, taken as whole, the Acquired Corporations have delivered or otherwise made available for inspection to Parent copies of any material reports, audits, assessments (including all Phase I environmental site assessments and Phase II
environmental site assessments), studies, analyses, tests or monitoring prepared since July&nbsp;1, 2022 and in the possession or control of the Company or any of the other Acquired Corporations pertaining to: (i)&nbsp;any unresolved material
liabilities under Environmental Law; (ii)&nbsp;any Hazardous Materials in, on, beneath or adjacent to any property currently or formerly owned, operated or leased by, and reasonably likely to result in material liabilities of, any Acquired
Corporation; or (iii)&nbsp;any Acquired Corporation&#146;s noncompliance in any material respect with applicable Environmental Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.19 Insurance</B>. Section&nbsp;3.19 of the Company Disclosure Schedule sets forth an accurate and complete list of all material insurance
policies relating to the business, assets and operations of the Acquired Corporations as of the date of this Agreement (collectively, the &#147;<U>Insurance Policies</U>&#148;), and the Company has delivered or made available to Parent an accurate
and complete copy of each such Insurance Policy as of the date of this Agreement. Except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, (a)&nbsp;the Acquired Corporations maintain insurance
coverage in such amounts and covering such risks as are in accordance in all material respects with customary industry practice for companies of similar size and stage of development, (b)&nbsp;all Insurance Policies are in full force and effect and
all premiums due thereunder have been paid in full, (c)&nbsp;no written notice of cancellation or modification has been received (other than a notice in connection with ordinary renewals) with respect to any Insurance Policy, and (d)&nbsp;there is
no existing default or event which, with the giving of notice or lapse of time or both, would constitute a default or breach of any Insurance Policy with respect to any Acquired Corporation. As of the date of this Agreement, there is no claim
pending under any of the Insurance Policies as to which coverage has been questioned or denied by the underwriters of such policies, in each case, except for any such claim that would not reasonably be expected to be material to the Acquired
Corporations, taken as a whole. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.20 Legal Proceedings; Orders</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) As of the date of this Agreement, there are no material Legal Proceedings pending (or, to the knowledge of the Company, threatened)
against any Acquired Corporation or, to the knowledge of the Company, against any present or former officer, director or employee of an Acquired Corporation in such individual&#146;s capacity as such, except as would not reasonably be expected to
have, individually or in the aggregate, a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) As of the date of this Agreement, to the knowledge of the Company,
there is no order, writ, injunction or judgment to which an Acquired Corporation is subject (excluding customary confidentiality requirements and other similar administrative requirements), except as would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) As of the date of this Agreement, to the knowledge of the Company, no material
investigation or review by any Governmental Body with respect to an Acquired Corporation is pending or being threatened in writing (excluding customary inspections by any Governmental Body conducted in the ordinary course of the Acquired
Corporations&#146; business). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.21 Authority; Binding Nature of Agreement</B>. The Company has the corporate power and authority to
execute and deliver and to perform its obligations under this Agreement and to consummate the Transactions, subject to obtaining the affirmative vote of the holders of a majority of all the outstanding Shares voting to adopt this Agreement and the
Merger at the Stockholder Meeting (the &#147;<U>Company </U><U>Stockholder Approval</U>&#148;). The Company Stockholder Approval is the only vote of the holders of any of the Company&#146;s capital stock that is necessary in connection with the
consummation of the Merger. The Board of Directors has unanimously (i)&nbsp;determined that this Agreement and the Transactions, including the Merger, on the terms and subject to the conditions set forth in this Agreement, are advisable, fair to and
in the best interests of the Company and its stockholders, (ii)&nbsp;approved, adopted and declared advisable the execution and delivery of, and entry into, the Merger Agreement and the performance by the Company of the covenants and agreements
contained herein and the consummation of the Transactions, including the Merger and (iii)&nbsp;resolved to recommend that the stockholders of the Company adopt this Agreement (such recommendation in the preceding <U>clause (iii)</U>, the
&#147;<U>Company Board Recommendation</U>&#148;), which Company Board Recommendation, except as permitted otherwise in accordance with <U>Section</U><U></U><U>&nbsp;6.1</U>, has not been subsequently withdrawn or modified in a manner adverse to
Parent as of the date of this Agreement. This Agreement has been duly executed and delivered by the Company, and assuming due authorization, execution and delivery by Parent and Merger Sub, this Agreement constitutes the legal, valid and binding
obligation of the Company and is enforceable against the Company in accordance with its terms, except as such enforcement may be subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and other similar laws of general
applicability relating to or affecting creditors&#146; rights, and by general equitable principles. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.22 <FONT
STYLE="white-space:nowrap">Non-Contravention;</FONT> Consents</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Assuming compliance with the applicable provisions of the DGCL,
the HSR Act and other Antitrust Laws, the rules and regulations of the SEC and Nasdaq, and obtainment of the Company Stockholder Approval, the execution and delivery of this Agreement by the Company and the consummation of the Transactions, will
not: (i)&nbsp;cause a violation of any of the provisions of the certificate of incorporation or bylaws (or other organizational documents) of any Acquired Corporation; (ii)&nbsp;cause a violation by any Acquired Corporation of any Legal Requirement
applicable to an Acquired Corporation, or to which an Acquired Corporation is subject; (iii)&nbsp;require any consent or notice under, conflict with, result in breach of, or constitute a default under (or an event that with notice or lapse of time
or both would become a default), or give rise to any right of payment, purchase, termination, amendment, cancellation, acceleration or other adverse change of any right or obligation or the loss of any benefit to which an Acquired Corporation is
entitled under any provision of any Material Contract; or (iv)&nbsp;result in an Encumbrance (other than a Permitted Encumbrance) on any of the property or assets of any Acquired Corporation, except in the case of each of <U>clauses (ii)</U>,
<U>(iii)</U> and <U>(iv)</U>, as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except for the filing of the certificate of merger with the Secretary of State of the
State of Delaware or as may be required by the Exchange Act (including the filing with the SEC of the Proxy Statement and such reports under the Exchange Act as may be required in connection with this Agreement and the Transactions), the DGCL, the
HSR Act and any applicable filing, notification or approval in any foreign jurisdiction required by any Antitrust Law, and the applicable rules and regulations of the SEC and Nasdaq, the Acquired Corporations are not required to give notice to, make
any filing with, or obtain any Consent from any Governmental Body (including any Regulatory Authority) at any time prior to the Closing in connection with the execution and delivery of this Agreement by the Company, or the consummation by the
Company of the Merger or the other Transactions, except those that the failure to make or obtain would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.23 Takeover Laws</B>. Assuming the accuracy of the representations and warranties of Parent and Merger Sub set forth in
<U>Section</U><U></U><U>&nbsp;4.8</U>, the Board of Directors has taken and will take all actions so that the restrictions applicable to business combinations contained in Section&nbsp;203 of the DGCL and any other relevant Takeover Law are, and
will be, inapplicable to the execution, delivery and performance of this Agreement and to the consummation of the Merger and the other Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.24 Opinion of Financial Advisors</B>. The Board of Directors has received the oral opinion of Citigroup Global Markets Inc. (to be
confirmed by delivery of a written opinion), that, as of the date of such opinion and subject to the various assumptions, limitations, qualifications and other matters set forth therein, the Merger Consideration to be received by the holders of
Shares in the Merger pursuant to this Agreement is fair, from a financial point of view, to such holders. The Company shall provide a copy of such written opinion to Parent solely for informational purposes and on a
<FONT STYLE="white-space:nowrap">non-reliance</FONT> basis promptly after the execution of this Agreement by each of the Parties hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.25 Brokers and Other Advisors</B>. Except for Citigroup Global Markets Inc., no investment banker, broker, financial advisor or finder
engaged by or on behalf of the Company or any of its Subsidiaries in connection with the Transactions is entitled to any fee or any commission in connection with this Agreement or upon consummation of the Transactions (including the Merger) based on
arrangements made by or on behalf of the Company or any of its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.26 Acknowledgement by Company</B>. The Company is not
relying and has not relied on any representations or warranties whatsoever regarding the Transactions or the subject matter of this Agreement, express or implied, except for the representations and warranties expressly set forth in
<U>Section</U><U></U><U>&nbsp;1.4(e)(ii)</U> and <U>Section</U><U></U><U>&nbsp;4</U>, as qualified therein, and in the certificate contemplated by <U>Section</U><U></U><U>&nbsp;7.3(c)</U>. Such representations and warranties by Parent and Merger Sub
constitute the sole and exclusive representations and warranties of Parent and Merger Sub in connection with the Transactions and the Company understands, acknowledges and agrees that all other representations and warranties of any kind or nature
whether express, implied or statutory are specifically disclaimed by the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECTION&nbsp;4 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Parent and Merger Sub represent and warrant to the Company as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.1 Due Organization</B>. Each of Parent and Merger Sub is a corporation or other Entity duly organized, validly existing and, where
applicable, in good standing under the laws of its jurisdiction of organization and has all necessary corporate or similar power and authority: (i)&nbsp;to conduct its business in the manner in which its business is currently being conducted; and
(ii)&nbsp;to own and use its assets in the manner in which its assets are currently owned and used. Each of Parent and Merger Sub is qualified or licensed to do business as a foreign corporation, and, where applicable, is in good standing, in each
jurisdiction where the nature of its business requires such qualification or licensing, except where the failure does not have, and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.2 Merger Sub</B>. Merger Sub has not engaged, and prior to the Effective Time will not engage, in any business activities or conduct any
operations, and has no assets, liabilities or obligations of any nature, other than in connection with the execution of this Agreement and the Transactions and those incident to Merger Sub&#146;s formation. Either Parent or a wholly owned Subsidiary
of Parent owns, and at all times prior to the Effective Time will own, beneficially and of record all of the outstanding capital stock of Merger Sub, free and clear of all Encumbrances and transfer restrictions, except for Encumbrances or transfer
restrictions of general applicability as may be provided under the Securities Act, applicable securities laws or the organizational documents of Merger Sub. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.3 Authority; Binding Nature of Agreement</B>. Parent and Merger Sub have the corporate or other power and authority to execute and
deliver and perform their obligations under this Agreement, and to consummate the Transactions, subject to the Merger Sub Sole Stockholder Approval. The board of directors of each of Parent and Merger Sub have approved the respective execution,
delivery and performance by Parent and Merger Sub of this Agreement, and the consummation of the Transactions, including the Merger, subject to the Merger Sub Sole Stockholder Approval. The Merger Sub Sole Stockholder Approval is the only vote of
the holders of any of Merger Sub&#146;s or Parent&#146;s capital stock that is necessary in connection with the consummation of the Transactions and the Merger and will be delivered immediately following the execution of this Agreement. This
Agreement has been duly executed and delivered by Parent and Merger Sub, and assuming due authorization, execution and delivery by the Company, this Agreement constitutes the legal, valid and binding obligation of Parent and Merger Sub and is
enforceable against Parent and Merger Sub in accordance with its terms, except as such enforcement may be subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and other similar laws of general applicability relating to
or affecting creditors&#146; rights, and by general equitable principles. No vote of Ultimate Parent&#146;s shareholders is necessary to approve this Agreement or any of the Transactions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.4 <FONT STYLE="white-space:nowrap">Non-Contravention;</FONT> Consents</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Assuming compliance with the applicable provisions of the DGCL, the HSR Act and other Antitrust Laws, and, if applicable, the rules and
regulations of the SEC and any national securities exchange, the execution and delivery of this Agreement by Parent and Merger Sub, and the consummation of the Transactions, will not: (i)&nbsp;cause a violation of any of the provisions of the
certificate of incorporation or bylaws (or other organizational documents) of Parent or Merger Sub; (ii)&nbsp;cause a violation by Parent or Merger Sub of any Legal Requirement applicable to Parent or Merger Sub, or to which Parent or Merger Sub are
subject; (iii)&nbsp;require any consent or notice under, conflict with, result in breach of, or constitute a default under (or an event that with notice or lapse of time or both would become a default), or give rise to any right of payment,
purchase, termination, amendment, cancellation, acceleration or other adverse change of any right or obligation or the loss of any benefit to which Parent or Merger Sub is entitled under any provision of any Contract; or (iv)&nbsp;result in an
Encumbrance (other than a Permitted Encumbrance) on any of the property or assets of Parent or Merger Sub, except in the case of <U>clauses (ii)</U>, <U>(iii)</U> and <U>(iv)</U>&nbsp;above, as would not reasonably be expected to have, individually
or in the aggregate, a Parent Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except for the filing of the certificate of merger with the Secretary of State
of the State of Delaware or as may be required by the Exchange Act, Takeover Laws, the DGCL, the HSR Act and any applicable filing, notification or approval in any foreign jurisdiction required by any Antitrust Law, and the applicable rules and
regulations of the SEC and any national securities exchange, neither Parent nor Merger Sub, nor any of Parent&#146;s other Affiliates, is required to give notice to, make any filing with or obtain any Consent from any Governmental Body at any time
prior to the Closing in connection with the execution and delivery of this Agreement by Parent and Merger Sub or the consummation by Parent or Merger Sub of the Merger or the other Transactions, except those that the failure to make or obtain would
not, individually or in the aggregate, reasonably be expected to have a Parent Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.5 Disclosure</B>. None of
the written information with respect to Parent, Merger Sub or their Affiliates supplied or to be supplied by or on behalf of Parent, Merger Sub or their Affiliates, for inclusion or incorporation by reference in the Proxy Statement will, (i)&nbsp;at
the time such document is filed with the SEC, (ii)&nbsp;at any time such document is amended or supplemented, (iii)&nbsp;at the time such Proxy Statement or any supplement or amendment is first distributed or otherwise disseminated to the
Company&#146;s stockholders, and (iv)&nbsp;at the time of the Stockholder Meeting, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements made
therein, in light of the circumstances under which they were made, not misleading. Notwithstanding the foregoing, Parent and Merger Sub make no representation with respect to statements made or incorporated by reference therein based on written
information supplied by or on behalf of the Company for inclusion or incorporation by reference in the Proxy Statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.6 Absence of
Litigation</B>. As of the date of this Agreement, there is no Legal Proceeding pending (or, to the knowledge of Parent, threatened), against Parent or Merger Sub, except as would not, and would not reasonably be expected to, individually or in the
aggregate, have a Parent Material Adverse Effect. As of the date of this Agreement, neither Parent nor Merger Sub is subject to any continuing order of, consent decree, settlement agreement or similar written
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
agreement with, or continuing investigation or review by, or being threatened in writing by, any Governmental Body, or any order, writ, judgment, injunction, decree, determination or award of any
Governmental Body or settlement agreement or similar written agreement, except as would not, and would not reasonably be expected to, individually or in the aggregate, have a Parent Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.7 Funds</B>. As of the date hereof and at the Effective Time, Parent will have immediately available funds in an amount sufficient to
consummate the Transactions and to pay all fees and expenses in connection with the consummation of the Transactions (including immediately available funds in an amount sufficient to pay the Merger Consideration as and when due, the cash portion of
the Equity Award Consideration payable following the Effective Time and for any repayment or refinancing of any outstanding indebtedness of the Company and/or its Subsidiaries contemplated by, or required in connection with the transactions
described in this Agreement) (such amounts, collectively, the &#147;<U>Financing Amounts</U>&#148;). For the avoidance of doubt, the obligations of Parent and Merger Sub hereunder are not subject to any condition with respect to Parent&#146;s or
Merger Sub&#146;s ability to obtain financing for the Merger or the Transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.8 Ownership of Shares</B>. Neither Ultimate Parent
nor any of its Subsidiaries nor any &#147;Affiliate&#148; or &#147;Associate&#148; (as each such term is defined in Section&nbsp;203 of the DGCL) of Ultimate Parent or any of its Subsidiaries, is, or has been at any time during the period commencing
three (3)&nbsp;years prior to the date hereof through the date hereof, an &#147;interested stockholder&#148; (as such term is defined in Section&nbsp;203 of the DGCL) of the Company. Neither Ultimate Parent nor Merger Sub, nor any of their
respective Subsidiaries owns (as defined in Section&nbsp;203 of the DGCL) or beneficially owns (as defined in Rule <FONT STYLE="white-space:nowrap">13d-3(a)</FONT> of the Exchange Act) or has a right to acquire any Shares or other securities
convertible into, exchangeable into or exercisable for Shares, except pursuant to this Agreement (other than through passive investments, pension or employee benefit plans or trusts for Parent&#146;s or its Affiliates&#146; employees, or limited
partnership funds, mutual funds or similar entities that Parent or its Affiliates have invested in, in all cases that Parent and its Affiliates do not directly or indirectly control the management or policies thereof). There are no voting trusts or
other agreements or understandings to which Parent or Merger Sub or any of their Affiliates is a party with respect to the voting of capital stock or other equity interests of the Company or any of its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.9 Acknowledgement by Parent and Merger Sub</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Neither Parent nor Merger Sub is relying and neither Parent nor Merger Sub has relied on any representations or warranties whatsoever
regarding the Transactions or the subject matter of this Agreement, express or implied, except for the representations and warranties expressly set forth in <U>Section</U><U></U><U>&nbsp;3</U>, as qualified therein and by the Company Disclosure
Schedule, and in the certificate contemplated by <U>Section</U><U></U><U>&nbsp;7.2(d)</U>. Such representations and warranties by the Acquired Corporations constitute the sole and exclusive representations and warranties of the Acquired Corporations
in connection with the Transactions and each of Parent and Merger Sub understands, acknowledges and agrees that all other representations and warranties of any kind or nature whether express, implied or statutory are specifically disclaimed by the
Acquired Corporations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each of Parent and Merger Sub acknowledges and agrees that it and its Representatives
have received access to books and records, facilities, equipment, contracts and other assets of the Acquired Corporations and that it and its Representatives have had a full opportunity to meet with the management of the Company and to discuss the
business and assets of the Acquired Corporations. In connection with the due diligence investigation of the Acquired Corporations by Parent and Merger Sub and their respective Affiliates or Representatives, Parent and Merger Sub and their respective
Affiliates and Representatives have received and may continue to receive after the date of this Agreement from the Company, the other Acquired Corporations and their respective Affiliates and Representatives certain estimates, projections, forecasts
and other forward-looking information, as well as certain business plan information, regarding the Acquired Corporations and their respective businesses and operations. Parent and Merger Sub hereby acknowledge that there are uncertainties inherent
in attempting to make such estimates, projections, forecasts and other forward-looking statements, as well as in such business plans, and that Parent and Merger Sub will have no claim against any Acquired Corporations, or any of their respective
Affiliates, stockholders or Representatives, or any other Person with respect thereto unless and then only to the extent that any such information is expressly included in a representation or warranty contained in this Agreement or in any
certificate contemplated by <U>Section</U><U></U><U>&nbsp;7.2(d)</U> and delivered by the Company or any of its Representatives in connection with the Transactions. Accordingly, Parent and Merger Sub hereby acknowledge and agree that neither the
Acquired Corporations nor any of their respective Affiliates, stockholders or Representatives, or any other Person, has made or is making any express or implied representation or warranty with respect to such estimates, projections, forecasts,
forward-looking statements or business plans unless any such information is expressly included in a representation or warranty contained in this Agreement or in any certificate contemplated by this Agreement and delivered by the Company or any of
its Representatives in connection with the Transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.10 Brokers and Other Advisors</B>. Except for Morgan Stanley&nbsp;&amp; Co.
LLC, no investment banker, broker, financial advisor or finder in connection with the Transactions is entitled to any fee or any commission in connection with this Agreement or upon consummation of the Transactions (including the Merger) based on
arrangements made by or on behalf of Parent or any of its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.11 Solvency</B>. None of Parent or Merger Sub is entering
into the Transactions with the actual intent to hinder, delay or defraud creditors of the Company or any of its Subsidiaries. As of the Closing and the Effective Time, assuming that the conditions set forth in <U>Section</U><U></U><U>&nbsp;7.1</U>
and <U>Section</U><U></U><U>&nbsp;7.2</U> have been satisfied or waived, and after giving effect to any indebtedness being incurred on such date in connection herewith, Parent and its Subsidiaries (including the Surviving Corporation and its
Subsidiaries), on a consolidated basis, will be solvent, such that (i)&nbsp;they are able to pay their respective indebtedness and other liabilities, contingent or otherwise, as such indebtedness and other liabilities become due in the usual course
of business; (ii)&nbsp;they have a total &#147;fair saleable value&#148; (determined on a going concern basis) of assets not less than the sum of their liabilities, contingent or otherwise, as of such date; (iii)&nbsp;they do not have unreasonably
small capital and liquidity with which to conduct their business; and (iv)&nbsp;the fair value of the assets of Parent and its Subsidiaries on a consolidated basis, at a fair valuation, exceed the debts and liabilities, direct, subordinated,
contingent or otherwise, of Parent and its Subsidiaries on a consolidated basis. Parent is not entering into this Agreement with the actual intent to hinder, delay or defraud either present or future creditors of itself or of the Company and its
Subsidiaries. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.12 Research and Development</B>. Neither Parent, nor any Affiliate or Subsidiary of
Parent, is researching or developing, and for the one (1)-year period prior to the date hereof has not researched or developed, for commercial sale or use, any phakic intraocular lens for the treatment of refractive errors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.13 Tax Residency of Ultimate Parent</B>. Ultimate Parent is tax resident solely in Switzerland. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECTION&nbsp;5 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>CERTAIN COVENANTS OF THE COMPANY </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.1 Access and Investigation</B>. During the period from the date of this Agreement until the earlier of the Effective Time and the
termination of this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;8</U> (the &#147;<U><FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period</U>&#148;), upon reasonable advance notice to the Company, the Company shall, and shall cause the
Acquired Corporations and Representatives of the Acquired Corporations to, provide Parent and Parent&#146;s Representatives with reasonable access during normal business hours to the Company&#146;s designated Representatives, facilities, assets and
existing books, records, documents and information relating to the Acquired Corporations, and promptly provide Parent and Parent&#146;s Representatives with all reasonably requested information regarding the business of the Acquired Corporations and
such additional financial, Tax, operating and other data and information regarding the Acquired Corporations, as Parent may reasonably request, in each case, for purposes reasonably related to the consummation of the Transactions;
<I>provided</I>,<I> however</I>, that any such access shall be conducted at Parent&#146;s expense, at a reasonable time, under the supervision of appropriate personnel of the Acquired Corporations and in such a manner as not to unreasonably
interfere with the normal operation of the business of the Acquired Corporations. Nothing herein shall require any of the Acquired Corporations to provide access or disclose any information to Parent or Parent&#146;s Representatives if such access
or disclosure: (i)&nbsp;would jeopardize any attorney-client or other legal privilege in the reasonable judgment of the Company (so long as the Acquired Corporations have used commercially reasonable efforts to permit such inspection of or to
disclose such information on a basis that does not waive such privilege with respect thereto), (ii)&nbsp;would contravene any applicable Legal Requirement or constitute a breach of any Contract to which it is a party or by which it is bound (so long
as the Acquired Corporations have used commercially reasonable efforts to permit disclosure to the extent permitted by Legal Requirements or such Contract), (iii) relates to a litigation where the Company or any of its Affiliates, on the one hand,
and Parent or any of its Affiliates, on the other hand, are adverse parties, (iv)&nbsp;subject to, and without limiting, the requirements of <U>Section</U><U></U><U>&nbsp;5.4</U> and <U>Section</U><U></U><U>&nbsp;6.1</U>, specifically relates to the
negotiation and execution of this Agreement or to transactions potentially competing with or alternative to the Transactions or proposals from other third parties relating to any competing or alternative transactions (including Acquisition
Proposals), including any actions of the Board of Directors (or any committee thereof) with respect to any of the foregoing, whether prior to or after the execution of this Agreement, (v)&nbsp;would reasonably be expected to result in the disclosure
of Trade Secrets or other commercially sensitive information, or (vi)&nbsp;involves any invasive sampling, testing or investigation of water, groundwater, soil, sediment, soil vapor, air, or other environmental media at any of the Leased Real
Property. With respect to the information disclosed pursuant to this <U>Section</U><U></U><U>&nbsp;5.1</U>, Parent shall comply with, and shall cause Parent&#146;s Representatives to comply with, all obligations under the Confidentiality Agreement,
dated October&nbsp;4, 2024, between the Company </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and Alcon Vision, LLC (the &#147;<U>Confidentiality Agreement</U>&#148;), and the Clean Team Agreement, dated November&nbsp;15, 2024, between the Company and Alcon Vision, LLC (the &#147;<U>Clean
Team Agreement</U>&#148;). Notwithstanding the foregoing, the Company may as it reasonably deems advisable and necessary (after consultation with its outside legal counsel) designate any commercially or competitively sensitive materials provided
pursuant to this <U>Section</U><U></U><U>&nbsp;5.1</U> as (i) &#147;Outside Counsel Only&#148;, in which case such materials and the information contained therein shall be given to the outside counsel of Parent and will not be disclosed by such
outside counsel to employees, officers, or directors of Parent or its Subsidiaries without the advance written consent from the Company or its legal counsel, or (ii) &#147;Clean Team Information,&#148; pursuant to and as defined in the Clean Team
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.2 Operation of the Acquired Corporations</B><B>&#146;</B><B> Business</B>. During the
<FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period, except (i)&nbsp;as required or expressly contemplated by this Agreement or as required by applicable Legal Requirements, (ii)&nbsp;with the prior written consent of Parent (which consent
shall not be unreasonably withheld, conditioned or delayed) or (iii)&nbsp;as set forth in Section&nbsp;5.2 of the Company Disclosure Schedule: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) the Company shall, and shall cause each Acquired Corporation to, use commercially reasonable efforts to conduct its business in the
ordinary course and use its commercially reasonable efforts to preserve intact its material business organizations and existing relationships with employees, customers, suppliers, distributors, licensors, licensees, Regulatory Authorities and other
persons with whom the Acquired Corporations have business relationships that are material to the Acquired Corporations, taken as a whole; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) the Company shall not, and shall cause the other Acquired Corporations not to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;(A) establish a record date for, declare, set aside or pay any dividend or make any other distribution in respect of any shares of
its capital stock (including the Shares), other than dividends and distributions paid by wholly owned Subsidiaries of the Company to the Company or to any of the Company&#146;s other wholly owned Subsidiaries, (B)&nbsp;repurchase, redeem or
otherwise reacquire any of the Shares, or any rights, warrants or options to acquire any of the Shares, other than: (1)&nbsp;repurchases of Shares outstanding as of the date of this Agreement pursuant to the Company&#146;s right (under written
commitments in effect as of the date of this Agreement) to purchase Shares held by a Company Associate; (2)&nbsp;forfeitures or repurchases of Company Options, Company RSU Awards, or Company PSU Awards (or Shares issued upon the exercise or vesting
thereof) outstanding on the date of this Agreement (or granted after the date of this Agreement in accordance with the terms hereof) pursuant to the terms of any such Company Option, Company RSU Award, or Company PSU Award in effect as of the date
of this Agreement (or as in effect on the date of grant with respect to awards granted after the date of this Agreement in accordance with the terms hereof) between the Company and a Company Associate; or (3)&nbsp;in connection with withholding to
satisfy the exercise price or Tax obligations with respect to Company Options, Company RSU Awards or Company PSU Awards or (C)&nbsp;enter into or adopt any &#147;poison pill&#148; or similar stockholder rights plan; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) split, combine, subdivide or reclassify any Shares or other equity interests, except
for any such transaction by a wholly owned Subsidiary of the Company which remains a wholly owned Subsidiary of the Company after consummation of such transaction; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) sell, issue, grant, deliver, pledge, transfer, encumber or authorize the sale, issuance, grant, delivery, pledge, transfer or
encumbrance of (A)&nbsp;any capital stock, equity interest or other security of any Acquired Corporation, or Voting Company Debt, (B)&nbsp;any option, call, warrant, restricted securities or right to acquire any capital stock, equity interest or
other security of any Acquired Corporation, or Voting Company Debt, or (C)&nbsp;any instrument convertible into or exchangeable for any capital stock, equity interest or other security of any Acquired Corporation, or Voting Company Debt;
<I>provided</I>, <I>however</I>, the Company and the other Acquired Corporations (1)&nbsp;may issue Shares as required to be issued upon the exercise or vesting of Company Options, Company RSU Awards, and Company PSU Awards that, in each case, are
outstanding as of the date of this Agreement (or granted after the date of this Agreement in accordance with the terms hereof) and as required pursuant to the terms of such awards as in effect on the date of this Agreement (or to the terms of such
awards granted after the date of this Agreement in accordance with the terms hereof), and (2)&nbsp;may issue capital stock, equity interests, voting securities or Voting Company Debt solely to the Company or from any Acquired Corporation other than
the Company to the Company&#146;s wholly owned Subsidiaries; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) except as set forth in the Company Disclosure Schedule, as
contemplated by <U>Section</U><U></U><U>&nbsp;1.6</U> or as required under any Employee Plan as in effect on the date of this Agreement, (A)&nbsp;establish, adopt, enter into, terminate or materially amend any Employee Plan, (B)&nbsp;amend or waive
any of its rights under, or accelerate the vesting or payment under, any provision of any Employee Plan, (C)&nbsp;grant or increase any severance, transaction, retention or termination pay to any current or former employee, officer, director or
independent contractor of any of the Acquired Corporations, (D)&nbsp;pay or grant any bonus or grant any employee, officer, director or independent contractor of any of the Acquired Corporations any increase in compensation or benefits,
(E)&nbsp;grant any equity, equity-based or other incentive awards to, or discretionarily accelerate the vesting or payment of any such awards held by, any current or former employee, officer, director or independent contractor of any of the Acquired
Corporations, (F)&nbsp;hire any individual who would be a Key Employee or promote any individual into a position which would make that individual a Key Employee, or hire any new consultant with total annual compensation in excess of $250,000 (for
clarity, other than any consultant previously engaged by the Company whose contract may be up for renewal), (G) terminate or give notice to terminate the employment of any Key Employees other than for cause or gross misconduct, or (H)&nbsp;announce
or agree to any mass layoffs or plant closings (each as defined under WARN); <I>provided</I>, <I>however</I>, the Company may: (1)&nbsp;amend any Employee Plan to the extent required by applicable Legal Requirements or, with respect to health and
welfare plans, in the ordinary course of business as part of annual plan renewal procedures; (2)&nbsp;issue offer letters for <FONT STYLE="white-space:nowrap">at-will</FONT> employment (or employment agreements in
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> jurisdictions) in connection with the hiring of <FONT STYLE="white-space:nowrap">non-Key</FONT> Employees in the ordinary course of business; and (3)&nbsp;enter into agreements with new consultants in
the ordinary course of business (and on terms consistent with the terms entered into with similarly situated consultants by the Company); <I>provided</I>, <I>further</I>, that, in the case of <U>clauses (2)</U>&nbsp;and <U>(3)</U> above, such offer
letters (or employment agreements in <FONT STYLE="white-space:nowrap">non-U.S.</FONT> jurisdictions) or consulting agreements (i)&nbsp;solely in the case of individual consultants (for clarity, other than any consultant previously engaged by the
Company whose contract may be up for renewal), do not contemplate or provide for, as applicable, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
total annual compensation in excess of $250,000 (or the local equivalent), (ii) are terminable without penalty on less than ninety (90)&nbsp;days&#146; advance notice (or in <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> jurisdictions, such longer period as required by applicable Legal Requirements or consistent with notice periods applicable to other similarly situated employees of the Acquired Corporations in the
applicable jurisdictions), and (iii)&nbsp;do not provide for severance (except in <FONT STYLE="white-space:nowrap">non-U.S.</FONT> jurisdictions as required by applicable Legal Requirements or consistent with severance applicable to other similarly
situated employees of the Acquired Corporations), change in control benefits, retention bonuses or other material contractual benefits; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) amend or permit the adoption of any amendment to its certificate of incorporation or bylaws or other charter or similar organizational
documents; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi)&nbsp;(A) form any subsidiary, (B)&nbsp;acquire any equity interest in or material portion of the assets of any other
Entity, or (C)&nbsp;enter into any material joint venture, partnership, or similar arrangement, except (i)&nbsp;in the cases of <U>clauses (B)</U>&nbsp;and <U>(C)</U>, in transactions between the Company and a wholly owned Acquired Corporation or
between wholly owned Acquired Corporations and (ii)&nbsp;for purchases of supplies, raw material, inventory and similar assets in the ordinary course of business consistent with past practice; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii) make or authorize any capital expenditures exceeding $5,000,000 in the aggregate in any calendar year; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(viii) lease, license, sublicense, pledge, sell or otherwise dispose of, divest or <FONT STYLE="white-space:nowrap">spin-off,</FONT>
relinquish, create or incur any Encumbrance (other than any Permitted Encumbrances) on, transfer or assign, any material asset or material real or personal property (other than Intellectual Property Rights, which are addressed in
<U>Section</U><U></U><U>&nbsp;5.2(b)(ix)</U> below, and cash), except (A)&nbsp;in the ordinary course of business, (B)&nbsp;pursuant to dispositions of obsolete, surplus or worn out assets that are no longer useful in the conduct of the business of
the Acquired Corporations, (C)&nbsp;capital expenditures permitted by <U>Section</U><U></U><U>&nbsp;5.2(b)(vii)</U>, (D) transactions between the Company and any other wholly owned Acquired Corporation or between wholly owned Acquired Corporations,
(E)&nbsp;pursuant to existing Contracts in effect prior to the execution of this Agreement or (F)&nbsp;for a purchase price (or if no purchase price is received, with a value) not in excess of $5,000,000 in aggregate in any fiscal year; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ix) lease, license, sublicense, pledge, sell, or otherwise dispose of, divest or <FONT STYLE="white-space:nowrap">spin-off,</FONT> abandon,
waive, create or incur any Encumbrance (other than a Permitted Encumbrance) on, relinquish or permit to lapse (other than any Registered IP expiring at the end of its statutory term or any withdrawal or abandonment of existing applications for
Registered IP that have not yet been granted), grant any other right or immunity under (whether present or contingent, including any option, right of first refusal or other preferential right, <FONT STYLE="white-space:nowrap">non-assert</FONT> or
covenant not to sue), transfer or assign, or fail to take any action necessary to maintain, enforce or protect, any Company Owned IP (other than at the end of the statutory term for Registered IP), except (A)&nbsp;granting <FONT
STYLE="white-space:nowrap">non-exclusive</FONT> licenses in the ordinary course of business or (B)&nbsp;transactions between the Company and a wholly owned Acquired Corporation or between wholly owned Acquired Corporations, in each case, in the
ordinary course of business; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(x)&nbsp;(A) lend money or make capital contributions or advances to or make investments
in, any Person, or incur, issue, assume or guarantee any indebtedness for borrowed money (except for advances to employees and consultants for travel and other business related expenses in the ordinary course of business and in compliance with the
Company&#146;s policies related thereto), other than between the Company and a wholly owned Acquired Corporation or between wholly owned Acquired Corporations or (B)&nbsp;invest or <FONT STYLE="white-space:nowrap">re-invest</FONT> any funds or
monies in any financial instruments, cryptocurrency or securities that do not qualify as cash, cash equivalents or commercial paper, certificates of deposit, U.S. treasury securities or corporate debt securities with a maturity of less than two
(2)&nbsp;years as of the date of such investment or reinvestment; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xi) except as otherwise required or expressly permitted pursuant to
Sections 6.3 and 6.4 or renewals of Contracts on substantially similar terms (subject to any changes to address changes in applicable Law or to reflect immaterial updates to the counterparties&#146; forms) or extensions of Contracts in the ordinary
course of business consistent with past practice, (A)&nbsp;amend or modify in any material respect, waive or settle any material rights or claims under, or voluntarily terminate, any Material Contract in a manner which is adverse to the Acquired
Corporation, (B)&nbsp;enter into any Contract that would constitute a Material Contract pursuant to <U>Section</U><U></U><U>&nbsp;3.9(a)(ii)(A)-(D)</U>, <U>(a)(iii)</U>, <U>(a)(v)</U>, <U>(a)(ix)</U>, <U>(a)(x)</U>, <U>(a)(xi)</U>, <U>(a)(xiii)</U>
or <U>(a)(xiv)</U> if it were in effect on the date of this Agreement, or (C)&nbsp;elect or elect not to extend any Lease in respect of material Leased Real Property; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xii) except in the ordinary course of business: (A)&nbsp;make any change to any accounting method or any change to any accounting period, in
each case, used for Tax purposes; (B)&nbsp;except in the ordinary course of business, rescind or change any Tax election; (C)&nbsp;file an amended Tax Return; (D)&nbsp;enter into a closing agreement with any Governmental Body regarding any Tax
liability or assessment (or surrender a right to a Tax refund); (E) settle, compromise or consent to any Tax claim or assessment for an amount materially in excess of the amount reserved therefor in the Company SEC Documents; or (F)&nbsp;waive or
extend the statute of limitations with respect to the filing of any Tax Return (except in connection with automatic or automatically granted extensions of time to file Tax Returns granted in the ordinary course of business); in each case of the
immediately preceding <U>clauses (A)</U>&nbsp;through <U>(F)</U>, if such action would materially increase the Tax Liability of the Acquired Corporations, taken as a whole (it being agreed and understood that
<U>Section</U><U></U><U>&nbsp;5.2(b)(i)</U> through <U>(xi)</U>&nbsp;and <U>Section</U><U></U><U>&nbsp;5.2(b)(xiii)</U> through <U>(xxi</U>)&nbsp;shall not apply to Tax compliance matters, except for <U>Section</U><U></U><U>&nbsp;5.2(b)(xxi)</U>
insofar as it relates to this <U>Section</U><U></U><U>&nbsp;5.2(b)(xii)</U>); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xiii) settle, satisfy, release, waive or compromise any
Legal Proceeding or other claim (or threatened Legal Proceeding or other claim) (other than any Legal Proceeding or other claim in respect of Taxes, which shall be governed by <U>clause (xii)</U>&nbsp;above) against any Acquired Corporation, other
than any settlements, satisfactions, releases, waivers or compromises that involve (A)&nbsp;with respect to monetary obligations, monetary obligations by the Acquired Corporations of not more than $500,000 (individually) or $2,000,000 (in the
aggregate) (in each case net of insurance proceeds) and (B)&nbsp;no other material <FONT STYLE="white-space:nowrap">non-monetary</FONT> obligation of any Acquired Corporation (excluding confidentiality,
<FONT STYLE="white-space:nowrap">non-disparagement,</FONT> and similar customary provisions); <I>provided</I> that the settlement, satisfaction, release, waiver or compromise of any Legal Proceeding or claim brought by the stockholders of the
Company against the Company or its directors relating to the Transactions or a breach of this Agreement or any other agreements contemplated hereby shall be subject to <U>Section</U><U></U><U>&nbsp;1.5</U> or <U>Section</U><U></U><U>&nbsp;6.6</U>,
as applicable; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xiv) enter into, amend or terminate any Collective Bargaining Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xv) waive, release or adversely amend or knowingly fail to enforce the restrictive covenant obligations in any Contracts with any current or
former Company Associate; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xvi)&nbsp;(A) initiate any new clinical trial (excluding, for the avoidance of doubt, any investigator
initiated trials), or (B)&nbsp;except if ordered by a Regulatory Authority, terminate, undertake a protocol amendment for, materially modify an existing agreement with a contract research organization relating to, or otherwise materially impede the
conduct of, any ongoing clinical trial; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xvii) voluntarily terminate, withdraw or let lapse the terms of any material Governmental
Authorization; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xviii) fail to use commercially reasonable efforts to maintain in full force and effect the existing Insurance Policies
or, alternatively, to renew or replace such Insurance Policies with new insurance policies that have terms that are no less favorable in the aggregate; <I>provided </I>that the Acquired Corporations, in no event, shall be required to maintain
Insurance Policies or obtain new or replacement insurance policies to the extent that the coverage provided thereunder is duplicative of existing insurance coverage; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xix) materially change any financial accounting methods or practices used by any Acquired Corporation, except as required by GAAP or
applicable Legal Requirements (including the Financial Accounting Standards Board or any similar organization, Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> of the Exchange Act or applicable Legal Requirement); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xx) adopt a plan or agreement of complete or partial liquidation or dissolution, merger, consolidation, restructuring, recapitalization or
other reorganization of any of the Acquired Corporations; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xxi) authorize any of, or agree or commit to take, any of the actions
described in the foregoing <U>clauses (i)</U>&nbsp;through <U>(xx)</U> of this <U>Section</U><U></U><U>&nbsp;5.2(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing,
nothing contained herein shall give to Parent or Merger Sub, directly or indirectly, rights to control or direct the operations of the Acquired Corporations prior to the Effective Time. Prior to the Effective Time, each of Parent and the Company
shall exercise, consistent with the terms and conditions hereof, complete control and supervision of its and its, if applicable, Subsidiaries&#146; respective operations consistent with applicable Legal Requirements, including the Antitrust Laws.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.3 Stockholder Meeting; Proxy Statement</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company shall establish a record date for, duly call, give notice of, convene and hold a meeting of its stockholders (together with
any adjournments or postponements thereof, the &#147;<U>Stockholder Meeting</U>&#148;) as promptly as reasonably practicable after the earliest to occur of (i)&nbsp;the date on which the SEC confirms that it has no further comments on the Proxy
Statement, (ii)&nbsp;the receipt of confirmation from the SEC that it will not be reviewing the Proxy Statement or (iii)&nbsp;if the SEC has failed to affirmatively notify the Company that it will or will not
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
be reviewing the Proxy Statement within ten (10)&nbsp;calendar days after the initial filing of the Proxy Statement with the SEC, the tenth (10th) day after such filing (the earliest of such
dates described in <U>(i)</U>-<U>(iii)</U>, the &#147;<U>SEC Clearance Date</U>&#148;), for the purpose of (A)&nbsp;voting on the matters requiring Company Stockholder Approval; and (B)&nbsp;in accordance with Section&nbsp;14A of the Exchange Act
and the applicable SEC rules issued thereunder, seeking advisory approval of a proposal to the Company&#146;s stockholders for a <FONT STYLE="white-space:nowrap">non-binding,</FONT> advisory vote to approve certain compensation that may become
payable to the Company&#146;s executive officers in connection with the completion of the Merger; <I>provided</I>, that the Company shall use its reasonable best efforts to cause the Stockholder Meeting to occur no later than the forty-fifth (45th)
calendar day following the SEC Clearance Date. Notwithstanding the foregoing, the Company may postpone or adjourn to a later date the Stockholder Meeting, on no more than two (2)&nbsp;occasions (but excluding any postponements or adjustments made
pursuant to <U>clause (i)</U>&nbsp;below) without the prior written consent of Parent (such consent not to be unreasonably withheld, conditioned or delayed), for a period of up to ten (10)&nbsp;Business Days for each such postponement or adjournment
(and shall postpone or adjourn the Stockholder Meeting at the request of Parent under the circumstances described in the following <U>clauses (iii)</U>&nbsp;and <U>(iv)</U>, on no more than two (2)&nbsp;occasions, for a period of time requested by
Parent not to exceed ten (10)&nbsp;Business Days for each such postponement or adjournment): (i)&nbsp;with the written consent of Parent, not to be unreasonably withheld or delayed, (ii)&nbsp;after consultation with Parent, to the extent necessary
(as determined by the Board of Directors in good faith) to ensure that any required supplement or amendment to the Proxy Statement is provided to the Company&#146;s stockholders as required by applicable Legal Requirements in advance of the
Stockholder Meeting, (iii)&nbsp;for the absence of a quorum necessary to conduct the business of the Stockholder Meeting, (iv)&nbsp;to allow reasonable additional time to solicit additional proxies if the Company has not received proxies
representing a sufficient number of votes to adopt this Agreement, whether or not a quorum is present or (v)&nbsp;if required by applicable Legal Requirements, <I>provided</I> that, (x)&nbsp;any postponement or adjournment that would require the
setting of a new record date shall require the prior written consent (such consent not to be unreasonably withheld, conditioned or delayed) of both Parent and the Company, and (y)&nbsp;the Stockholder Meeting will not be postponed or adjourned
beyond the date that is six (6)&nbsp;Business Days prior to the End Date without the prior written consent of Parent. Unless and until a Company Adverse Recommendation Change has occurred in accordance with <U>Section</U><U></U><U>&nbsp;6.1</U>, the
Board of Directors shall make the Company Board Recommendation and use its reasonable best efforts to obtain the Company Stockholder Approval, including to solicit proxies in favor of the adoption of the Agreement. The Company shall otherwise comply
in all material respects with all Legal Requirements applicable to the Stockholder Meeting. Unless this Agreement is terminated in accordance with <U>Section</U><U></U><U>&nbsp;8.1</U>, (a) the Company shall submit this Agreement to its stockholders
at the Stockholder Meeting even if the Board of Directors shall have made a Company Adverse Recommendation Change or proposed or announced any intention to do so, and (b)&nbsp;the Company agrees that it shall not submit to the vote of the
stockholders of the Company any Acquisition Proposal (whether or not a Superior Offer) prior to the vote of the Company&#146;s stockholders with respect to the Merger at the Stockholder Meeting. The notice of such Stockholder Meeting shall state
that a resolution to adopt this Agreement and the Merger will be considered at the Stockholder Meeting, and no other matters shall be considered or voted upon at the Stockholder Meeting without Parent&#146;s prior written consent (other than
(i)&nbsp;a <FONT STYLE="white-space:nowrap">non-binding,</FONT> advisory vote to approve or disapprove certain compensation that may become payable to the Company&#146;s named executive officers in connection with the completion of the Merger and
(ii)&nbsp;whether to adjourn the Stockholder Meeting in accordance with </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
this <U>Section</U><U></U><U>&nbsp;5.3(a)</U>) (such consent not to be unreasonably withheld, conditioned or delayed). Following dissemination of the definitive Proxy Statement, the Company shall
cooperate with and keep Parent informed on a reasonably current basis regarding voting results, and unless and until a Company Adverse Recommendation Change has occurred in accordance with <U>Section</U><U></U><U>&nbsp;6.1</U>, its solicitation
efforts. As promptly as practicable after the date of this Agreement, the Company shall conduct a &#147;broker search&#148; in accordance with <FONT STYLE="white-space:nowrap">Rule&nbsp;14a-13&nbsp;of</FONT> the Exchange Act assuming that, for such
purposes only, the record date of the Stockholder Meeting will be twenty (20)&nbsp;Business Days after the date the broker search is conducted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except to the extent expressly permitted by <U>Section</U><U></U><U>&nbsp;6.1</U>, (i) the Board of Directors shall recommend that the
Company&#146;s stockholders vote in favor of the adoption of this Agreement and the Merger at the Stockholder Meeting and (ii)&nbsp;the Proxy Statement shall include the Company Board Recommendation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) As promptly as practicable after the date hereof, the Company shall prepare and file with the SEC the Proxy Statement in preliminary form
(but in no event later than twenty (20)&nbsp;Business Days after the date of this Agreement). As soon as practicable thereafter, the Company shall file the definitive Proxy Statement and use its commercially reasonable efforts to mail to its
stockholders the Proxy Statement and all other proxy materials for the Stockholder Meeting. If necessary in order to comply with applicable securities laws, after the Proxy Statement shall have been so mailed, the Company shall promptly circulate
amended, supplemental or supplemented proxy material, and, if required in connection therewith, <FONT STYLE="white-space:nowrap">re-solicit</FONT> proxies. The Company and Parent, as the case may be, shall furnish all information concerning the
Company or Parent as the other Party may reasonably request in connection with the preparation and filing with the SEC of the Proxy Statement. Subject to applicable Legal Requirements, Parent and its legal counsel shall be given a reasonable
opportunity to review and comment on the Proxy Statement before such document (or any amendment or supplement thereto) is filed with the SEC, and the Company shall consider in good faith any comments reasonably proposed by Parent and its legal
counsel. Subject to applicable Legal Requirements, the Company shall, as promptly as practicable after receipt thereof, provide Parent and its legal counsel with copies of any written comments, and advise Parent and its legal counsel of any oral
comments, with respect to the Proxy Statement (or any amendment or supplement thereto) received from the SEC or its staff, provide Parent and its legal counsel a reasonable opportunity to review the Company&#146;s proposed response to such comments,
and consider in good faith any comments reasonably proposed by Parent and its legal counsel. The Company shall cause the Proxy Statement to comply as to form in all material respects with the applicable requirements of the Exchange Act and the rules
of the SEC and Nasdaq. Each of the Company, Parent and Merger Sub shall correct any information provided by it for use in the Proxy Statement as promptly as reasonably practicable if and to the extent such information contains any untrue statement
of a material fact or omits to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.4 No Solicitation</B>.(a) For the purposes of this Agreement, &#147;<U>Acceptable
Confidentiality Agreement</U>&#148; means any customary confidentiality agreement that (i)&nbsp;contains provisions that are not materially less favorable to the Company than those contained in the Confidentiality Agreement (it being understood that
such agreement need not contain any &#147;standstill&#148; or similar provisions or otherwise prohibit the making of any Acquisition Proposal) and (ii)&nbsp;does not prohibit any Acquired Corporation from complying with its obligations to provide
information to Parent in accordance with this <U>Section</U><U></U><U>&nbsp;5.4</U> and <U>Section</U><U></U><U>&nbsp;6.1</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except
as permitted by this <U>Section</U><U></U><U>&nbsp;5.4</U>, during the <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period, the Acquired Corporations shall not, and shall use commercially reasonable efforts to cause their Representatives not
to, directly or indirectly, (i)&nbsp;continue any solicitation, knowing encouragement, discussions or negotiations with any Persons that may be ongoing as of the date of this Agreement with respect to an Acquisition Proposal; (ii)&nbsp;(A) solicit,
initiate or knowingly facilitate or encourage (including by way of furnishing <FONT STYLE="white-space:nowrap">non-public</FONT> information) any inquiries regarding, or the making of any proposal or offer that constitutes, or would reasonably be
expected to lead to, an Acquisition Proposal, (B)&nbsp;engage in, continue or otherwise participate in any discussions or negotiations regarding, or furnish to any other Person any <FONT STYLE="white-space:nowrap">non-public</FONT> information in
connection with, or for the purpose of soliciting or knowingly encouraging or facilitating, an Acquisition Proposal or any proposal or offer that would reasonably be expected to lead to an Acquisition Proposal (other than to state that the terms of
this provision prohibit such discussion) or (C)&nbsp;enter into any letter of intent, acquisition agreement, agreement in principle or similar agreement with respect to an Acquisition Proposal or any proposal or offer that would reasonably be
expected to lead to an Acquisition Proposal (other than an Acceptable Confidentiality Agreement in accordance with <U>Section</U><U></U><U>&nbsp;5.4(c)</U>); or (iii)&nbsp;waive or release any Person from, intentionally forebear in the enforcement
of, or amend any standstill agreement or any standstill provisions of any other Contract, or take any action to exempt any Person (other than Parent, Merger Sub or their Affiliates) from the restrictions on &#147;business combinations&#148; or any
similar provision contained in applicable Takeover Laws or the organizational and other governing documents of an Acquired Corporation, unless, solely in the case of this <U>clause (iii)</U>, the Board of Directors determines in good faith, after
consultation with the Company&#146;s outside legal counsel, that the failure to do so would reasonably be expected to be inconsistent with the fiduciary duties of the Board of Directors to the Company&#146;s stockholders under applicable Legal
Requirements. In furtherance of the foregoing, promptly following (and no later than one (1)&nbsp;Business Day after) the execution and delivery of this Agreement, the Company shall (1)&nbsp;request that each such Person or group and its
representatives (other than Parent and its representatives) that has, prior to the execution and delivery of this Agreement, executed a confidentiality agreement or otherwise received <FONT STYLE="white-space:nowrap">non-public</FONT> information
about the Company or its Subsidiaries from, or on behalf of, the Company, in each case in connection with such Person&#146;s or group&#146;s consideration of an Acquisition Proposal, promptly return or destroy all
<FONT STYLE="white-space:nowrap">non-public</FONT> information furnished to such Person or group by or on behalf of the Company or any of its Subsidiaries prior to the date of this Agreement in accordance with the applicable confidentiality
agreement and (2)&nbsp;promptly terminate all physical and electronic data room access for such Persons or group and their representatives to diligence or other <FONT STYLE="white-space:nowrap">non-public</FONT> information regarding the Company or
any of its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding anything to the contrary contained in this Agreement, if at any time on or after the date of
this Agreement and prior to the Company Stockholder Approval, any Acquired Corporation or any of their Representatives receives an unsolicited written Acquisition Proposal from any Person or group of Persons, which Acquisition Proposal was made or
renewed on or after the date of this Agreement, (i)&nbsp;the Company and its Representatives may contact such Person or group of Persons solely to clarify the terms and conditions thereof or inform </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such Person or group of Persons of the existence of the provisions of this <U>Section</U><U></U><U>&nbsp;5.4</U> and (ii)&nbsp;if the Board of Directors determines in good faith, after
consultation with financial advisors and outside legal counsel, that such Acquisition Proposal constitutes or could reasonably be expected to lead to a Superior Offer, then the Company and its Representatives may (A)&nbsp;furnish, pursuant to an
Acceptable Confidentiality Agreement, information (including <FONT STYLE="white-space:nowrap">non-public</FONT> information) with respect to the Acquired Corporations to the Person or group of Persons who has made such Acquisition Proposal;
<I>provided</I>,<I> </I>that the Company shall as promptly as practicable (and in any event within one (1)&nbsp;Business Day) provide to Parent any material <FONT STYLE="white-space:nowrap">non-public</FONT> information concerning the Acquired
Corporations that is provided to any Person to the extent access to such information was not previously provided to Parent or its Representatives and (B)&nbsp;engage in or otherwise participate in discussions or negotiations with the Person or group
of Persons making such Acquisition Proposal. Within one (1)&nbsp;Business Day after the Board of Directors makes a determination contemplated by the foregoing <U>clause (ii)</U>&nbsp;with respect to an Acquisition Proposal, the Company shall provide
written notice to Parent of such determination of the Board of Directors described in the preceding <U>clause (ii)</U>, together with the identity of such Person or group making such Acquisition Proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) During the <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period, the Company shall (i)&nbsp;promptly (and in any event within one
(1)&nbsp;Business Day after the receipt thereof) notify Parent if any Acquisition Proposal or any inquiry, proposal or offer that would reasonably be expected to lead to an Acquisition Proposal, is received by any Acquired Corporation and provide to
Parent (x)&nbsp;an unredacted copy of any such written Acquisition Proposal, inquiry, proposal or offer (including any proposed term sheet, letter of intent, acquisition agreement or similar agreement with respect thereto) and a summary of any
unwritten material terms and conditions thereof, and (y)&nbsp;the name(s) of the Person or group of Persons making such written Acquisition Proposal, inquiry, proposal or offer, and (ii)&nbsp;keep Parent reasonably informed of any material
developments, discussions or negotiations regarding any such Acquisition Proposal on a prompt basis (and in any event within one (1)&nbsp;Business Day of such material development, discussion or negotiation). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Nothing in this <U>Section</U><U></U><U>&nbsp;5.4</U> or elsewhere in this Agreement shall prohibit the Company from (i)&nbsp;taking and
disclosing to the stockholders of the Company a position contemplated by or otherwise making any disclosure as is required under Rule <FONT STYLE="white-space:nowrap">14e-2(a),</FONT> Rule <FONT STYLE="white-space:nowrap">14d-9</FONT> or Item
1012(a) of Regulation <FONT STYLE="white-space:nowrap">M-A</FONT> promulgated under the Exchange Act, including any &#147;stop, look and listen&#148; communication pursuant to Rule <FONT STYLE="white-space:nowrap">14d-9(f)</FONT> promulgated under
the Exchange Act, or (ii)&nbsp;making any disclosure to the stockholders of the Company that is required by applicable Legal Requirements; <I>provided</I>,<I> however</I>, that this <U>Section</U><U></U><U>&nbsp;5.4(e)</U> shall not permit the Board
of Directors to make a Company Adverse Recommendation Change, except to the extent permitted by <U>Section</U><U></U><U>&nbsp;6.1(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The Company agrees that in the event any (i)&nbsp;Acquired Corporation, (ii)&nbsp;director or officer of the Company (acting in its
capacity as such on behalf of the Company) or (iii)&nbsp;financial, investor relations or legal advisor to the Company acting at the direction of, or on behalf of, a director or officer of an Acquired Corporation, in each case takes any action that,
if taken by the Company, would constitute a breach of this <U>Section</U><U></U><U>&nbsp;5.4</U>, the Company shall be deemed to be in breach of this <U>Section</U><U></U><U>&nbsp;5.4</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECTION&nbsp;6 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ADDITIONAL COVENANTS OF THE PARTIES </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.1 Company Board Recommendation</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Subject to <U>Section</U><U></U><U>&nbsp;6.1(b)</U>, during the <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period, neither the
Board of Directors nor any committee thereof shall (i)(A) withdraw, qualify or modify in a manner adverse to Parent or Merger Sub, or publicly propose to withdraw, qualify or modify in a manner adverse to Parent or Merger Sub, the Company Board
Recommendation or (B)&nbsp;adopt, approve, recommend or declare advisable, or publicly propose to adopt, approve, recommend or declare advisable, any Acquisition Proposal, (ii)&nbsp;adopt, approve, recommend or declare advisable, or publicly propose
to adopt, approve, recommend or declare advisable, or allow the Company to execute or enter into, any letter of intent, agreement in principle, memorandum of understanding, merger agreement, acquisition agreement, joint venture agreement, or similar
Contract with respect to any Acquisition Proposal (excluding an Acceptable Confidentiality Agreement in accordance with <U>Section</U><U></U><U>&nbsp;5.4(c)</U>), (iii)&nbsp;fail to publicly reaffirm the Company Board Recommendation within five
(5)&nbsp;Business Days after Parent so requests in writing (which request may be made once per applicable public Acquisition Proposal, <I>provided</I> that Parent shall be entitled to make a new request each time there is a publicly disclosed
material change in such applicable Acquisition Proposal), or (iv)&nbsp;fail to recommend against acceptance of any tender offer or exchange offer that is publicly commenced for the Shares within ten (10)&nbsp;Business Days after Parent so requests
in writing (which request may be made once per applicable public Acquisition Proposal, <I>provided</I> that Parent shall be entitled to make a new request each time there is a publicly disclosed material change in such applicable Acquisition
Proposal) (any action described in the foregoing <U>clauses (i)</U>&nbsp;through <U>(iv)</U>, a &#147;<U>Company Adverse Recommendation Change</U>&#148;); <I>provided</I> that, for the avoidance of doubt, any determination or action by the Board of
Directors or any committee thereof to the extent permitted by <U>Section</U><U></U><U>&nbsp;5.4</U> or this <U>Section</U><U></U><U>&nbsp;6.1</U> shall not be, and shall not be deemed to be, in and of itself a breach or violation of this
<U>Section</U><U></U><U>&nbsp;6.1</U> and shall not, unless a Company Adverse Recommendation Change has occurred, give Parent a right to terminate this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;8.1(d)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding anything to the contrary contained in this Agreement, at any time prior to the Company Stockholder Approval: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) if any Acquired Corporation has received after the date of this Agreement a written Acquisition Proposal from any Person that has not
been withdrawn and after consultation with outside legal counsel and financial advisors, the Board of Directors shall have determined, in good faith, that such Acquisition Proposal constitutes a Superior Offer, (x)&nbsp;the Board of Directors may
make a Company Adverse Recommendation Change, or (y)&nbsp;solely if such Acquisition Proposal did not result from a material breach of <U>Section</U><U></U><U>&nbsp;5.4</U>, the Company may terminate this Agreement pursuant to
<U>Section</U><U></U><U>&nbsp;8.1(e)</U> to enter into a Specified Agreement with respect to such Superior Offer, in each case under clauses (x)&nbsp;and (y), if and only if: (A)&nbsp;the Board of Directors determines in good faith, after
consultation with the Company&#146;s outside legal counsel and financial advisors, that the failure to do so would be inconsistent with the fiduciary duties of the Board of Directors under applicable Legal Requirements (it being understood that any
such determination in and of itself shall not be deemed a Company Adverse Recommendation Change), </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(B) the Company shall have given Parent prior written notice of its intention to consider making a Company Adverse Recommendation Change or terminating this Agreement pursuant to
<U>Section</U><U></U><U>&nbsp;8.1(e)</U>, which notice shall include the material terms and conditions of the applicable Acquisition Proposal, an unredacted copy of any such written Acquisition Proposal and the identity of the Person making such
Acquisition Proposal, at least four (4)&nbsp;Business Days prior to making any such Company Adverse Recommendation Change or termination (a &#147;<U>Determination Notice</U>&#148;, and such period, the &#147;<U>Notice Period</U>&#148;) (which notice
shall not constitute a Company Adverse Recommendation Change or termination), and, if requested in writing by Parent, during such four (4)&nbsp;Business Day period shall have negotiated in good faith with respect to any revisions to the terms of
this Agreement or another proposal to the extent proposed by Parent so that such Acquisition Proposal would cease to constitute a Superior Offer, and (C)&nbsp;after considering in good faith any proposals made by Parent during such period, if any,
after consultation with outside legal counsel and financial advisors, the Board of Directors shall have determined, in good faith, that such Acquisition Proposal continues to be a Superior Offer and that the failure to make the Company Adverse
Recommendation Change or terminate this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;8.1(e)</U> would be inconsistent with the fiduciary duties of the Board of Directors under applicable Legal Requirements. Issuance of any &#147;stop, look
and listen&#148; communication by or on behalf of the Company pursuant to Rule <FONT STYLE="white-space:nowrap">14d-9(f)</FONT> promulgated under the Exchange Act shall not be considered a Company Adverse Recommendation Change and shall not require
the giving of a Determination Notice or compliance with the procedures set forth in this <U>Section</U><U></U><U>&nbsp;6.1</U>. The provisions of this <U>Section</U><U></U><U>&nbsp;6.1(b)(i)</U> shall also apply to any material amendment to any
Acquisition Proposal and shall require a new Determination Notice for each such material amendment; <I>provided</I>, that references to four (4)&nbsp;Business Days shall be deemed to be two (2)&nbsp;Business Days, such that the new Notice Period
shall be two (2)&nbsp;Business Days; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) other than in connection with an Acquisition Proposal, the Board of Directors may make a
Company Adverse Recommendation Change in response to an Intervening Event, if and only if: (A)&nbsp;the Board of Directors determines in good faith, after consultation with the Company&#146;s outside legal counsel and financial advisors, that the
failure to do so would be inconsistent with the fiduciary duties of the Board of Directors under applicable Legal Requirements (it being understood that any such determination in and of itself shall not be deemed a Company Adverse Recommendation
Change), (B) the Company shall have given Parent a Determination Notice, specifying in reasonable detail the facts and circumstances for such potential Company Adverse Recommendation Change, at least four (4)&nbsp;Business Days prior to making any
such Company Adverse Recommendation Change and, if requested in writing by Parent, during such four (4)&nbsp;Business Day period shall have negotiated in good faith with respect to any revisions to the terms of this Agreement or another proposal to
the extent proposed by Parent so that a Company Adverse Recommendation Change would no longer be necessary, and (C)&nbsp;(1) the Company shall have given Parent the four (4)&nbsp;Business Day period after the Determination Notice to propose
revisions to the terms of this Agreement or make another proposal so that a Company Adverse Recommendation Change would no longer be necessary, and (2)&nbsp;after considering in good faith the proposals made by Parent during such period, if any,
after consultation with outside legal counsel and financial advisors, the Board of Directors shall have determined, in good faith, that the failure to make the Company Adverse Recommendation Change would continue to be inconsistent with the
fiduciary duties of the Board of Directors under applicable Legal Requirements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.2 Filings, Consents and Approvals</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Subject to the terms and conditions of this Agreement, the Parent and the Company shall, and shall cause their respective controlled
Affiliates to, cooperate with each other and use their respective reasonable best efforts to take, or cause to be taken, and to do, or cause to be done, and to assist and cooperate with each other in doing, all things necessary, proper or advisable,
to consummate and make effective the Merger and the Transactions as promptly as practicable, but in no case later than the End Date, including: (i)&nbsp;preparing and filing all registrations, declarations, filings or documentation necessary to
effect all necessary actions or nonactions, Consents, waivers, clearances, decisions, declarations, and the lapse of waiting periods by or from any Governmental Body (including any Regulatory Authority), (ii) obtaining as promptly as practicable
after the date of this Agreement, and maintaining, all necessary actions or&nbsp;nonactions, Consents, waivers, clearances, decisions, declarations, approvals from third parties (including Governmental Bodies and Regulatory Authorities), and
(iii)&nbsp;executing and delivering any additional instruments necessary to consummate the Transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding anything to
the contrary contained in this Agreement, and in furtherance of Parent&#146;s reasonable best efforts under this Section&nbsp;6.2, Parent shall, and shall cause its controlled Affiliates to, take all actions, and do, or cause to be done, all things
necessary, proper or advisable to eliminate each and every impediment under any Antitrust Law, to permit and cause the satisfaction of the conditions set forth in <U>Section</U><U></U><U>&nbsp;7.1(b)</U> and <U>Section</U><U></U><U>&nbsp;7.1(c)</U>,
and to otherwise cause the Closing to occur as promptly as reasonably practicable, and in any event prior to the End Date, including (i)&nbsp;proposing, negotiating, committing to, effecting, agreeing to and executing, by consent decree, settlement,
undertaking, stipulation or otherwise, the license, hold separate or disposition of any asset, product, product line, or business of Ultimate Parent, the Company, or any of their respective controlled Affiliates, (ii)&nbsp;terminating, transferring
or creating relationships, contractual rights or other obligations of Ultimate Parent, the Company, or their respective controlled Affiliates, or (iii)&nbsp;otherwise taking or committing to take any actions or agree to any undertakings that would
limit Ultimate Parent&#146;s or its controlled Affiliates&#146; freedom of action with respect to, or their ability to retain, or impose obligations on Ultimate Parent&#146;s or its controlled Affiliates&#146; future operation with respect to any
asset, product, product line or business of Ultimate Parent, the Company, or any of their respective controlled Affiliates (each of <U>clauses (i)</U>&#150;<U>(iii)</U>, a &#147;<U>Remedy Action</U>&#148;); <I>provided, however</I>, that,
notwithstanding the foregoing, (A)&nbsp;Parent shall not be required to sell or divest any asset, product, product line, or business of Ultimate Parent, the Company, or any of their respective Affiliates, (B)&nbsp;Parent shall not be required to
take any Remedy Action that would, individually or in the aggregate, reasonably be expected to result in an Adverse Remedy Impact, and (C)&nbsp;the Company shall only be required to take or commit to take any Remedy Action as requested by Parent
pursuant to this <U>Section</U><U></U><U>&nbsp;6.2</U> if such Remedy Action is binding on the Company only in the event the Closing occurs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding anything to the contrary contained in this Agreement, in no event shall Parent or any of its Affiliates be obligated to
litigate, participate in litigation or otherwise contest any administrative or judicial action or Legal Proceeding, decree, judgment, injunction or other order, whether temporary, preliminary or permanent, challenging the Transactions with respect
to any Antitrust Law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Parent shall not, and shall cause its controlled Affiliates not to, effect or agree to
any business combination (whether structured as a merger, business combination, tender offer, exchange offer or similar transaction) or the acquisition of any assets, licenses, rights, product lines, operations or businesses of any Person that would
reasonably be expected to prevent the receipt of the Requisite Regulatory Approvals or to otherwise prevent, impede or impair the consummation of the Merger by the End Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Subject to the terms and conditions of this Agreement, Parent and the Company shall (and shall cause their respective controlled
Affiliates, if applicable, to): (i) furnish to the other such necessary information and reasonable assistance as the other party may request in connection with its preparation of any filing or submission that is necessary or advisable under the HSR
Act or other applicable Antitrust Laws, (ii)&nbsp;promptly, but in no event later than twenty (20)&nbsp;Business Days after the date of this Agreement (or at such later date as mutually agreed to by the Parties), make an appropriate filing of all
notification and report forms as required by the HSR Act with respect to the Transactions, and (iii)&nbsp;as promptly as reasonably practicable after the date of this Agreement, but in no event later than thirty-five (35)&nbsp;Business Days after
the date of this Agreement, submit all other filings or notifications (or drafts thereof) in connection with any other Requisite Regulatory Approval. Parent and the Company shall not extend or agree to extend any waiting period under the HSR Act
(including by withdrawing and refiling its filing under the HSR Act) or any other Antitrust Law or enter into any agreement with any Governmental Body to delay, or otherwise to not consummate as promptly as practicable, the Merger or the other
Transactions, except with the prior written consent of the Parties (such consent not to be unreasonably withheld). Parent or its Affiliates shall pay all filing fees for the filings required to be made under the HSR Act and for any other filings or
notifications required to be made with, or obtained from, any other Governmental Bodies in connection with the Transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Without
limiting the generality of anything contained in this <U>Section</U><U></U><U>&nbsp;6.2</U>, during the <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period, Parent and its controlled Affiliates, on the one hand, and the Company and its
controlled Affiliates, on the other, shall (i)&nbsp;give the other prompt notice of the making or commencement of any notice, communication, request, inquiry, investigation, action or Legal Proceeding brought, or threatened to be brought, by a
Governmental Body, or by a third party before any Governmental Body (such third party, an &#147;<U>Applicable Third Party</U>&#148;), in each case, with respect to the Merger or the other Transactions and relating to Antitrust Laws, (ii)&nbsp;keep
the other party reasonably informed as to the status of any such notice, communication, request, inquiry, investigation, action or Legal Proceeding in each case, with respect to the Merger or the other Transactions and relating to Antitrust Laws,
(iii)&nbsp;promptly inform the other party of, and give the other party reasonable advance notice of, and the opportunity to participate in, any communication to or from any Governmental Body or Applicable Third Party with respect to the Merger or
the other Transactions and relating to Antitrust Laws, (iv)&nbsp;promptly furnish to the other party with copies of documents provided to or received from any Governmental Body or an Applicable Third Party that relates to the Merger or the other
Transactions and relating to Antitrust Laws (subject to redaction or withholding of documentation that (A)&nbsp;would jeopardize any attorney-client or other legal privilege in the reasonable judgment of the applicable party (so long as such party
shall have used commercially reasonable efforts to permit such inspection of or to disclose such information on a basis that does not waive such privilege with respect thereto), (B)&nbsp;would contravene any applicable Legal Requirement or
constitute a breach of any Contract to which it is a party or by which it is bound (so long as such party has used commercially reasonable </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
efforts to permit disclosure to the extent permitted by Legal Requirements or such Contract), (C) specifically relates to a litigation where the Company or any of its Affiliates, on the one hand,
and Parent or any of its Affiliates, on the other hand, are adverse parties, (D)&nbsp;subject to, and without limiting, the requirements of <U>Section</U><U></U><U>&nbsp;5.4</U> and <U>Section</U><U></U><U>&nbsp;6.1</U>, specifically relates to the
negotiation and execution of this Agreement or to transactions potentially competing with or alternative to the Transactions or proposals from other third parties relating to any competing or alternative transactions (including Acquisition
Proposals), including any actions of the Board of Directors (or any committee thereof) with respect to any of the foregoing, whether prior to or after the execution of this Agreement, or (E)&nbsp;relates to any Trade Secrets or other commercially
sensitive information), (v) consult and cooperate with the other party and consider in good faith the views of the other party in connection with any analysis, appearance, communication, filing, submission, presentation, memorandum, brief, argument,
opinion or proposal made or submitted to any Governmental Body or Applicable Third Party with respect to the Merger or the other Transactions and relating to Antitrust Laws, and (vi)&nbsp;except as may be prohibited by any Governmental Body or by
any Legal Requirement, give the other party reasonable advance notice of, and permit the other party (or their authorized Representatives) to be present at and participate in each meeting or conference and to have access to and be consulted in
connection with any argument, opinion or proposal made or submitted to any Governmental Body or Applicable Third Party, in each case, with respect to the Merger or the other Transactions and relating to Antitrust Laws. Subject to compliance with its
obligations in this Section&nbsp;6.2, Parent shall control the strategy on behalf of the Parties relating to regulatory approvals under the Antitrust Laws that are required to consummate the Merger or the other Transactions; <I>provided</I> that,
without limiting this Section&nbsp;6.2, Parent shall, and shall cause its controlled Affiliates to, consult with the Company with respect to, and the Company shall be kept apprised of, proposed strategy and other significant decisions with respect
to such regulatory approvals, and the Company may offer comments or suggestions with respect to such regulatory approvals, which Parent shall, and shall cause its controlled Affiliates to, consider in good faith. Any Party may, as they deem
advisable and necessary, designate any commercially or competitively sensitive materials provided to the other under this Section&nbsp;6.2 as &#147;outside counsel only.&#148; Such materials and the information contained therein shall be given only
to outside counsel of the recipient and will not be disclosed by such outside counsel to employees, officers, or directors of the recipient without the advance written consent of the party providing such materials. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.3 Employee Matters</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) During the period commencing on the Closing Date and ending on the first anniversary of the Closing Date, Parent shall, or shall cause one
of its Affiliates to, provide each employee of the Company or its Subsidiaries as of immediately prior to the Effective Time and who remains employed by the Surviving Corporation or its Subsidiaries following the Closing Date (each, a
&#147;<U>Continuing Employee</U>&#148;) with (i)&nbsp;a base salary or wage level and target annual cash bonus opportunities that, in each case, are no less favorable than those provided to similarly-situated employees of Parent or its Subsidiaries
(<U>provided</U> that base salary or wage may not be reduced from the level in effect for such Continuing Employee as of immediately prior to the Effective Time), (ii) employee benefits that are substantially comparable in the aggregate to the
employee benefits (excluding post-employment welfare benefits, defined benefit pension benefits, equity-based compensation and transaction or retention bonuses) provided to similarly situated employees of Parent or its Subsidiaries and
(iii)&nbsp;severance benefits in accordance with the Company severance arrangements set forth on Section&nbsp;6.3(a) of the Company Disclosure Schedule. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) For purposes of vesting, eligibility to participate and benefit accrual under the
employee benefit plans of Parent and its Affiliates in which a Continuing Employee participates following the Closing Date (each, a &#147;<U>New Plan</U>&#148;), each Continuing Employee shall be credited with his or her years of service with the
Acquired Corporations and their respective predecessors before the Effective Time, to the same extent as such employee was entitled before the Effective Time to credit for such service under any corresponding Employee Plan in which such employee
participated immediately prior to the Effective Time; <I>provided</I> that the foregoing shall not apply to the extent that its application would result in a duplication of benefits; <I>provided</I>, <I>further</I> that the foregoing shall not apply
for purposes of benefit accrual under any defined benefit pension plan or for purposes under any retiree welfare arrangement or long-term incentive arrangement. In addition and without limiting the generality of the foregoing,<U></U>&nbsp;for
purposes of each New Plan providing medical, dental, pharmaceutical or vision benefits to any Continuing Employee, Parent shall, and shall cause its Affiliates to, cause all eligibility waiting periods, pre-existing condition exclusions and <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">actively-at-work</FONT></FONT> requirements of such New Plan to be waived for such employee and his or her covered dependents, unless such conditions would not have been waived under a
comparable Employee Plan in which such employee participated immediately prior to the Effective Time (the &#147;<U>Old Plan</U>&#148;), and Parent shall, and shall cause its Affiliates to, cause any eligible expenses incurred by such employee and
his or her covered dependents during the portion of the plan year of the Old Plans ending on the date such employee&#146;s participation in the corresponding New Plan begins to be taken into account under such New Plan for purposes of satisfying all
deductible, coinsurance and maximum <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> requirements applicable to such employee and his or her covered dependents for the applicable plan year as if such
amounts had been paid in accordance with such New Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) No provision of this Agreement: (i)&nbsp;shall be deemed to guarantee or
create any right to employment or engagement or continued employment or engagement for any period of time, or preclude the ability of the Company, the Surviving Corporation, Parent or any of their respective Affiliates, to terminate any Continuing
Employee for any reason, (ii)&nbsp;shall be deemed or construed to amend, establish, or modify any benefit or compensation plan, program, agreement, contract, policy or arrangement, or (iii)&nbsp;create any third party beneficiary rights or
obligations in any person (including any current or former service provider or employee of the Company, the Surviving Corporation, Parent or any of its Affiliates (or any beneficiaries or dependents thereof)). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.4 Company 401(k)</B>. The Board of Directors (or the appropriate committee thereof) shall adopt resolutions and take such corporate
action as is necessary or appropriate to terminate the Company 401(k) Savings Plan (the &#147;<U>Company 401(k) Plan</U>&#148;), effective as of the day prior to the Closing Date, contingent upon the occurrence of the Closing, unless Parent notifies
the Company in writing not less than ten (10)&nbsp;Business Days before the Effective Time that it has determined not to terminate the Company 401(k) Plan. If the Company 401(k) Plan is terminated, as provided herein, Parent shall, or shall cause
one of its Affiliates to, have in effect a tax qualified defined contribution retirement plan as of the Effective Time that includes a qualified cash or deferred arrangement within the meaning of Section&nbsp;401(k) of the Code (the &#147;<U>Parent
401(k) Plan</U>&#148;) under which each regular Continuing Employee who is actively employed at the Closing and is not considered a temporary or contract employee shall be immediately eligible to participate and
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
shall receive credit for prior service as a regular employee with the Company and its predecessors. Such service credit shall be applied to any applicable waiting periods or vesting provisions of
Parent&#146;s U.S. defined contribution retirement plans. As soon as practicable following the Closing, the account balances under the Company 401(k) Plan shall be distributed to the participants, and Parent shall permit such Continuing Employees to
make rollover contributions to the Parent 401(k) Plan of &#147;eligible rollover distributions&#148; within the meaning of Section&nbsp;401(a)(31) of the Code (excluding promissory notes evidencing participant loans) in the form of cash, in an
amount equal to the full account balance distributed to such Continuing Employee from the Company 401(k) Plan. All resolutions adopted or executed in connection with the termination of the Company 401(k) Plan shall be subject to Parent&#146;s prior
review and comment, and all reasonable comments of Parent will be considered by the Company in good faith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.5 Indemnification of
Officers and Directors</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) For a period of six (6)&nbsp;years from and after the Effective Time, Parent agrees that all rights to
indemnification, advancement of expenses and exculpation from liabilities for acts or omissions occurring at or prior to the Effective Time (whether asserted or claimed prior to, at or after the Effective Time) now existing in favor of the current
or former directors or officers of any Acquired Corporation pursuant to the organizational documents thereof and any indemnification or other similar agreements of any Acquired Corporation, in each case as in effect on the date of this Agreement,
shall continue in full force and effect in accordance with their terms and shall not be amended, repealed or otherwise modified in any manner that would adversely affect the rights thereunder of any of such current or former directors or officers,
except to the extent required by applicable Legal Requirements, and Parent shall cause the Acquired Corporations to perform their respective obligations thereunder. Without limiting the foregoing, during the period commencing at the Effective Time
and ending on the sixth (6th) anniversary of the Effective Time, Parent shall cause the Surviving Corporation and its Subsidiaries to indemnify and hold harmless each individual who is as of the date of this Agreement, or who becomes prior to the
Effective Time, a director or officer of any Acquired Corporation or who is as of the date of this Agreement, or who thereafter commences prior to the Effective Time, serving at the request of any Acquired Corporation as a director or officer of
another Person (the &#147;<U>Indemnified Persons</U>&#148;), against all claims, losses, liabilities, damages, judgments, inquiries, fines and reasonable fees, costs and expenses, including attorneys&#146; fees and disbursements, incurred in
connection with any Legal Proceeding, claim, action, suit or proceeding, whether civil, criminal, administrative or investigative (including with respect to matters existing or occurring at or prior to the Effective Time, including this Agreement
and the transactions and actions contemplated hereby), arising out of or pertaining to the fact that the Indemnified Person is or was a director or officer of any Acquired Corporation or is or was serving at the request of any Acquired Corporation
as a director or officer of another Person, whether asserted or claimed prior to, at or after the Effective Time, to the fullest extent permitted under applicable Legal Requirements. In the event of any such claim, action, suit or proceeding,
(x)&nbsp;each Indemnified Person will be entitled to advancement of expenses incurred in the defense of any such claim, action, suit or proceeding from the Surviving Corporation or its Subsidiaries, as applicable, in accordance with the
organizational documents and any indemnification or other similar agreements of the Surviving Corporation or its Subsidiaries, as applicable, as in effect on the date of this Agreement; <I>provided</I> that any Indemnified Person to whom expenses
are advanced provides an undertaking, if required by the DGCL or the Surviving Corporation&#146;s or any of its Subsidiaries&#146; certificate of incorporation or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
bylaws (or comparable organizational documents) or any such indemnification or other similar agreements, as applicable, to repay such advances if it is ultimately determined by final adjudication
that such Indemnified Person is not entitled to indemnification, and (y)&nbsp;the Surviving Corporation and its Subsidiaries, as applicable, shall reasonably cooperate in the defense of any such matter; <I>provided</I> that if the Surviving
Corporation or any of its Subsidiaries advances expenses in accordance with clause (x)&nbsp;of this <U>Section</U><U></U><U>&nbsp;6.5(a)</U>, Parent shall be entitled to assume the defense of such claim, action, suit, or proceeding, if appropriate,
with counsel satisfactory to the Indemnified Person upon delivery to the Indemnified Person of written notice of its election to do so, and after delivery of such notice, neither the Surviving Corporation nor any of its Subsidiaries shall be liable
to the Indemnified Person for any expenses subsequently incurred by the Indemnified Person in connection with such defense, other than reasonable expenses of investigation, <I>provided</I>, <I>however</I>, that (i)&nbsp;the Indemnified Person shall
have the right to employ separate counsel in any such claim, action, suit, or proceeding provided that the expenses of such counsel incurred after delivery of notice by Parent of its assumption of such defense shall be at the Indemnified
Person&#146;s own expense, and (ii)&nbsp;the expenses of counsel employed by the Indemnified Person shall be at the expense of Surviving Corporation or its Subsidiaries if (A)&nbsp;the employment of counsel by the Indemnified Person has previously
been authorized by Parent, (B)&nbsp;the Indemnified Person shall have reasonably concluded that there may be a conflict of interest between Parent (or the Surviving Corporation), on the one hand, and the Indemnified Person, on the other hand, in the
conduct of any such defense, or (C)&nbsp;Parent fails to diligently prosecute such defense; <I>provided</I>, <I>further</I>, none of Parent, the Surviving Corporation or any of their Subsidiaries shall settle, compromise or consent to the entry of
any judgment in any such claim, action, suit, or proceeding, unless such settlement, compromise or consent relates only to monetary damages and does not include any criminal liability or admission of wrongdoing or such Indemnified Person otherwise
consents in writing to such settlement, compromise or consent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Prior to the Closing Date, in consultation with Parent, the Company
shall use reasonable best efforts to purchase (and if the Company does not purchase prior to the Closing Date, the Surviving Corporation may purchase on the Closing Date, in lieu of complying with the final sentence of this
<U>Section</U><U></U><U>&nbsp;6.5(b)</U>),&#147;tail&#148; directors&#146; and officers&#146; liability insurance for the Acquired Corporations and their current and former directors, officers and employees who are covered by the directors&#146; and
officers&#146; liability insurance maintained by or for the benefit of the Acquired Corporations as of the date of this Agreement (the &#147;<U>Current D&amp;O Insurance</U>&#148;), such &#147;tail&#148; insurance to provide coverage in an amount
and on terms not less favorable to the insureds thereunder (including with respect to limits and retentions) than the Current D&amp;O Insurance with respect to claims arising from facts or events that occurred at or before the Effective Time;
<I>provided</I> that in no event shall the total cost of any such &#147;tail&#148; insurance exceed 300% of the aggregate annual premium most recently paid by the Acquired Corporations for the Current D&amp;O Insurance (the &#147;<U>Maximum
Amount</U>&#148;). Parent and the Surviving Corporation shall maintain such &#147;tail&#148; insurance in full force and effect for a period of six (6)&nbsp;years following the Closing Date and continue to honor the obligations thereunder. In the
event that as of the Closing Date the &#147;tail&#148; directors&#146; and officers&#146; liability insurance under the first sentence of this <U>Section</U><U></U><U>&nbsp;6.5(b)</U> has not been purchased, for a period of six (6)&nbsp;years from
and after the Effective Time, the Surviving Corporation shall, and Parent shall cause the Surviving Corporation to, either cause to be maintained in effect the Current D&amp;O Insurance or provide substitute insurance (with insurance carriers having
at least an <FONT STYLE="white-space:nowrap">&#147;A-&#148;</FONT> financial strength rating by A.M. Best with respect to directors&#146; and officers&#146; liability insurance) for the Acquired Corporations and their current and former
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
directors, officers and employees who are covered by the Current D&amp;O Insurance, in either case, providing coverage not less favorable to the insureds thereunder (including with respect to
limits and retentions) than the Current D&amp;O Insurance with respect to claims arising from facts or events that occurred at or before the Effective Time, except that in no event shall the Surviving Corporation be required to pay with respect to
any annual period for such insurance more than the Maximum Amount, and if the Surviving Corporation is unable to obtain the insurance required by this <U>Section</U><U></U><U>&nbsp;6.5(b)</U> it shall obtain as much comparable insurance as possible
for the years within such six (6)-year period for a premium equal to the Maximum Amount. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) In the event that any Acquired Corporation
or any of its successors or assigns (i)&nbsp;consolidates with or merges into any other Person and is not the continuing or surviving corporation or Entity of such consolidation or merger or (ii)&nbsp;transfers or conveys all or substantially all of
its properties and assets to any Person, then in each such case, the Acquired Corporation, as applicable, shall cause proper provision to be made so that the successors and assigns of such Acquired Corporation assume the obligations set forth in
this <U>Section</U><U></U><U>&nbsp;6.5</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The provisions of this <U>Section</U><U></U><U>&nbsp;6.5</U> (i)&nbsp;shall survive the
consummation of the Merger and (ii)&nbsp;are intended to be for the benefit of, and will be enforceable by, each indemnified or insured party (including the Indemnified Persons) contemplated by this <U>Section</U><U></U><U>&nbsp;6.5</U>, and his or
her heirs, successors, assigns and representatives, and (iii)&nbsp;are in addition to, and not in substitution for, any other rights to indemnification, advancement of expenses, exculpation or contribution that any such Person may have by contract
or otherwise. Unless required by an applicable Legal Requirement, this <U>Section</U><U></U><U>&nbsp;6.5</U> may not be amended, altered or repealed after the Effective Time in such a manner as to adversely affect the rights of any Indemnified
Person or any of their successors, assigns or heirs without the prior written consent of the affected Indemnified Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.6
Stockholder Litigation</B>. The Company shall promptly notify Parent in writing of any Stockholder Litigation and shall keep Parent reasonably and promptly informed regarding any such Stockholder Litigation.&nbsp;The Company shall give Parent the
opportunity to (a)&nbsp;participate in (but not control) the defense, prosecution, settlement or compromise of any Stockholder Litigation, and (b)&nbsp;consult with legal counsel to the Company regarding the defense, prosecution, settlement or
compromise with respect to any such Stockholder Litigation.&nbsp;For purposes of this <U>Section</U><U></U><U>&nbsp;6.6</U>, &#147;participate&#148; means that Parent will be kept reasonably apprised of proposed strategy and other significant
decisions with respect to the Stockholder Litigation (to the extent that the attorney-client privilege between the Company and its legal counsel is not undermined or otherwise adversely affected), and Parent may offer comments or suggestions with
respect to such Stockholder Litigation which the Company shall consider in good faith; <I>provided</I> that the Company shall not settle or compromise or agree to settle or compromise any Stockholder Litigation without Parent&#146;s prior written
consent (which consent shall not be unreasonably withheld, conditioned or delayed). This<U>&nbsp;Section</U><U></U><U>&nbsp;6.6</U>, and not<U>&nbsp;Section</U><U></U><U>&nbsp;6.2(e)</U>, shall govern with respect to any Stockholder Litigation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.7 Additional Agreements</B>. Subject to the terms and conditions of this Agreement, including <U>Section</U><U></U><U>&nbsp;6.2(a)</U>,
Parent and the Company shall use reasonable best efforts to take, or cause to be taken, all actions necessary to consummate the Merger and make effective the other Transactions. Without limiting the generality of the foregoing, subject to the terms
and conditions of this Agreement, each Party to this Agreement shall use reasonable best efforts (or in the case of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the agreements set forth on Section&nbsp;6.7 of the Company Disclosure Schedule, shall use its best efforts) to: (i)&nbsp;make all filings (if any) and give all notices (if any) required to be
made and given by such Party pursuant to any Material Contract in connection with the Merger and the other Transactions to the extent reasonably requested in writing by Parent and (ii)&nbsp;seek each Consent (if any) required to be obtained pursuant
to any Material Contract by such Party in connection with the Transactions to the extent requested in writing by Parent; <I>provided</I>, <I>however</I>, notwithstanding anything to the contrary herein (including in
<U>Section</U><U></U><U>&nbsp;6.2)</U>, each of the Parties acknowledges and agrees that (x)&nbsp;obtaining any such Consent described in the foregoing clauses (i)&nbsp;and (ii) shall not be a condition to the Merger, except to the extent
contemplated, if at all, by <U>Section</U><U></U><U>&nbsp;7.1(c)</U> and (y)&nbsp;no Party nor any of its Affiliates shall be required to pay or commit to pay to any Person that is not a Governmental Body, whose Consent is being solicited, any cash
or other consideration, or make any commitment or incur any liability or other obligation to any such Person, in each case, which payment, commitment, incurrence or other obligation is not conditioned on the occurrence of the Closing or otherwise
reimbursed by Parent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.8 Disclosure</B>. The initial press release relating to this Agreement shall be a joint press release
reasonably mutually agreed between the Company and Parent. Thereafter, the Company and Parent shall consult with the other Party before issuing any further press release(s) or otherwise making any public statement (to the extent not previously
issued or made in accordance with this Agreement) with respect to the Merger, this Agreement or any of the other Transactions and consider in good faith any comments reasonably proposed by the other Party or its Representatives; <I>provided</I>,
that neither Party shall issue any such press release or public statement without the other Party&#146;s written consent (such consent not to be unreasonably withheld, conditioned or delayed). Notwithstanding the foregoing, the Parties shall not be
required by this <U>Section</U><U></U><U>&nbsp;6.8</U> to provide any other Party with such consultation or consent right relating to (i)&nbsp;any public statements (including responses to questions from the press, analysts, investors or those
attending industry conferences, earnings calls, internal announcements to employees and disclosures in Company SEC Documents) so long as such statements are consistent in all material respects with previous press releases, public disclosures or
public statements (as applicable) made by Parent or the Company in compliance with this <U>Section</U><U></U><U>&nbsp;6.8</U>; and (ii)&nbsp;any public statements relating to any dispute between the Parties relating to this Agreement. In addition,
notwithstanding the foregoing, (i)&nbsp;each Party may, without the prior consent of any other Party, but subject to giving advance notice and the opportunity to review and comment as is feasible to the other Party, issue any such press release or
make any such public announcement or statement as may be required by any applicable Legal Requirement; and (ii)&nbsp;no Party need consult with any other Party in connection with any press release, public statement or filing to be issued or made
(x)&nbsp;pursuant to <U>Section</U><U></U><U>&nbsp;5.4(e)</U>, (y) with respect to any Acquisition Proposal or Company Adverse Recommendation Change or (z)&nbsp;after any Company Adverse Recommendation Change. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.9 Takeover Laws</B>. If any Takeover Law may become, or may purport to be, applicable to the Transactions, each of Parent and the Company
and the members of their respective boards of directors shall use their respective reasonable best efforts to grant such approvals and take such actions as are reasonably necessary so that the Transactions may be consummated as promptly as
practicable on the terms and conditions contemplated hereby and otherwise act to lawfully eliminate the effect of any Takeover Law on any of the Transactions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.10 Section</B><B></B><B>&nbsp;16 Matters</B>. The Company, and the Board of Directors,
shall, to the extent necessary, take appropriate action, prior to or as of the Effective Time, to approve, for purposes of Section&nbsp;16(b) of the Exchange Act, the disposition and cancellation or deemed disposition and cancellation of Shares,
Company Options, Company RSU Awards and Company PSU Awards, resulting from the Transactions by each applicable individual who is or would otherwise be subject to Section&nbsp;16 of the Exchange Act, and to cause such dispositions (or deemed
dispositions) and/or cancellations to be exempt under Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> promulgated under the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.11 Stock Exchange Delisting; Deregistration</B>. Prior to the Closing Date, each of the Parties shall cooperate with the other Parties
and use its reasonable best efforts to take, or cause to be taken, all actions, and do or cause to be done all things, reasonably necessary, proper or advisable on its part under applicable Legal Requirements and rules and policies of Nasdaq to
enable the delisting by the Surviving Corporation of the Shares from Nasdaq and the deregistration of the Shares under the Exchange Act as promptly as practicable after the Effective Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.12 Notification of Certain Events</B>. Subject to applicable Legal Requirements, each of the Company and Parent shall promptly notify the
other of any Legal Proceeding commenced or, to any Party&#146;s knowledge, threatened in writing against, such Party or any of its Subsidiaries or otherwise relating to, involving or affecting such Party or any of its Subsidiaries, in each case in
connection with, arising from or otherwise relating to the Merger or any other Transaction; <I>provided</I>, <I>however</I>, that any failure to deliver such notice may not, in and of itself, form the basis for a claim that any of the conditions set
forth in Section&nbsp;7 are not satisfied or that a Party has a right to terminate under Section&nbsp;8, and no such notice shall cure any breach of, or <FONT STYLE="white-space:nowrap">non-compliance</FONT> with, any of the other representations,
warranties, covenants or agreements of the Parties or the conditions to the obligations of the Parties under this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.13
Merger Sub</B>. Prior to the Effective Time, Merger Sub shall not engage in any activities of any nature except as provided in or contemplated by this Agreement. Promptly following the execution of this Agreement, Parent shall, in its capacity as
the sole stockholder of Merger Sub, execute and deliver, in accordance with applicable Legal Requirements and Merger Sub&#146;s organizational documents, the Merger Sub Sole Stockholder Approval. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECTION&nbsp;7 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>CONDITIONS PRECEDENT TO THE MERGER </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.1 Condition to the Obligations of Each Party</B>. The respective obligations of each Party to effect the Merger are subject to the
satisfaction (or waiver by the Company, Parent and Merger Sub, to the extent permitted by applicable Legal Requirements) as of the Closing of each of the following conditions: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) the Company Stockholder Approval shall have been obtained; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) there shall be no temporary restraining order, preliminary or permanent injunction, final judgment or other order issued, and remaining in
effect, by any Governmental Body of competent jurisdiction in any jurisdiction set forth in Section&nbsp;7.1(b) of the Company Disclosure Schedule (a &#147;<U>Specified Governmental Body</U>&#148;) prohibiting or enjoining the consummation of the
Merger, nor shall any Legal Requirement have been promulgated, enacted, issued or deemed applicable to the Merger by any Specified Governmental Body which remains in effect and prohibits or makes illegal the consummation of the Merger; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;(i) the waiting period (or any extension thereof) applicable to consummation of the
Merger under the HSR Act shall have expired or been terminated, as well as any agreement not to close embodied in a &#147;timing agreement&#148; between the parties and a Governmental Body, and (ii)&nbsp;all other actions or <FONT
STYLE="white-space:nowrap">non-actions,</FONT> Consents, waivers, clearances, decisions, declarations, approvals, and the lapse of waiting periods with respect to the Transactions, in each case as listed in Section&nbsp;7.1(c)(i) of the Company
Disclosure Schedule, shall have been made, terminated, expired or obtained, as applicable, <I>provided</I>, that Section&nbsp;7.1(c)(i) of the Company Disclosure Schedule shall be deemed updated to include such additional jurisdictions in the list
set forth on Section&nbsp;7.1(c)(ii) of the Company Disclosure Schedule as mutually agreed in good faith by Parent and the Company within fifteen (15)&nbsp;days following the date of this Agreement (all such actions or
<FONT STYLE="white-space:nowrap">non-actions,</FONT> waivers, Consents, clearances, decisions, declarations, approvals, and the lapse of waiting periods, including under the HSR Act, of such jurisdictions being the &#147;<U>Requisite Regulatory
Approvals</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.2 Conditions to the Obligations of Parent and Merger Sub</B>. The obligations of each of Parent and Merger Sub
to effect the Merger are subject to the satisfaction (or waiver by Parent, on its own behalf and on behalf of Merger Sub, to the extent permitted by applicable Legal Requirements) as of the Closing of each of the following conditions: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) the representations
and warranties of the Company set forth in <U>Section</U><U></U><U>&nbsp;3.3(a)</U>, <U>(c)</U>, and <U>(e)</U> (Capitalization, Etc.) of the Agreement shall be accurate, except for any <I>de minimis</I> inaccuracies, as of the date of the Agreement
and at and as of the Closing Date as if made on and as of the Closing Date (except to the extent any such representation or warranty expressly relates to an earlier date or period, in which case as of such date or period); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) the representations and warranties of the Company set forth in <U>Section</U><U></U><U>&nbsp;3.1(a)</U> (other than the fourth sentence
of <U>Section</U><U></U><U>&nbsp;3.1(a))</U>, <U>Section</U><U></U><U>&nbsp;3.1(b)</U> (Due Organization; Subsidiaries, Etc.), <U>Section</U><U></U><U>&nbsp;3.2</U> (other than the second sentence of <U>clause (a)</U>) (Certificate of Incorporation
and Bylaws), <U>Section</U><U></U><U>&nbsp;3.3(d)</U>, <U>Section</U><U></U><U>&nbsp;3.3(b)</U> and <U>(h)</U> (Capitalization, Etc.), <U>Section</U><U></U><U>&nbsp;3.21</U> (Authority; Binding Nature of Agreement),
<U>Section</U><U></U><U>&nbsp;3.23</U> (Takeover Laws), and <U>Section</U><U></U><U>&nbsp;3.25</U> (Brokers and Other Advisors) of the Agreement shall be accurate (disregarding for this purpose all &#147;Material Adverse Effect&#148; and
&#147;materiality&#148; qualifications contained in such representations and warranties) in all material respects as of the date of the Agreement and at and as of the Closing Date as if made on and as of the Closing Date (except to the extent any
such representation or warranty expressly relates to an earlier date or period, in which case as of such date or period); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) the
representations and warranties of the Company set forth in <U>Section</U><U></U><U>&nbsp;3.5(b)</U> (Absence of Changes; No Material Adverse Effect) of the Agreement shall be accurate in all respects as of the date of the Agreement and at and as of
the Closing Date as if made on and as of the Closing Date (except to the extent any such representation or warranty expressly relates to an earlier date or period, in which case as of such date or period); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) the representations and warranties of the Company set forth in the Agreement (other
than those referred to in <U>clauses (i)</U>, <U>(ii)</U> and <U>(iii)</U>&nbsp;immediately above) shall be accurate (disregarding for this purpose all &#147;Material Adverse Effect&#148; and &#147;materiality&#148; qualifications contained in such
representations and warranties, except that the word &#147;material&#148; in the definition of &#147;Material Contracts&#148; shall not be disregarded) as of the date of the Agreement and at and as of the Closing Date as if made on and as of the
Closing Date (except to the extent any such representation or warranty expressly relates to an earlier date or period, in which case as of such date or period), except where the failure of such representations and warranties to be so true and
correct has not had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) the
Company shall have complied in all material respects with or performed in all material respects the covenants and agreements it is required by this Agreement to comply with or perform at or prior to the Closing Date; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) since the date of the Agreement, no Material Adverse Effect shall have occurred that is continuing; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Parent and Merger Sub shall have received a certificate executed on behalf of the Company by an executive officer of the Company and dated
as of the Closing Date confirming that the conditions set forth in <U>Sections 7.2(a)</U>&#150;<U>(c)</U> have been satisfied. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.3
Conditions to the Obligations of the Company</B>. The obligations of the Company to effect the Merger are subject to the satisfaction (or waiver by the Company, to the extent permitted by applicable Legal Requirements) as of the Closing of each of
the following conditions: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) the representations and warranties of Parent and Merger Sub set forth in <U>Section</U><U></U><U>&nbsp;4.1</U> (Due Organization),
<U>Section</U><U></U><U>&nbsp;4.3</U> (Authority; Binding Nature of Agreement) and <U>Section</U><U></U><U>&nbsp;4.10</U> (Brokers and Other Advisors) of the Agreement shall be accurate in all material respects (disregarding for this purpose all
&#147;Parent Material Adverse Effect&#148; and &#147;materiality&#148; qualifications contained in such representations and warranties) as of the date of the Agreement and at and as of the Closing Date as if made on and as of the Closing Date
(except to the extent any such representation or warranty expressly relates to an earlier date or period, in which case as of such date or period); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) the representations and warranties of Parent and Merger Sub set forth in this Agreement (other than those referred to in <U>clause
(i)</U>&nbsp;immediately above) shall be accurate (disregarding for this purpose all &#147;Parent Material Adverse Effect&#148; and &#147;materiality&#148; qualifications contained in such representations and warranties) as of the date of the
Agreement and at and as of the Closing Date as if made on and as of the Closing Date (except to the extent any such representation or warranty expressly relates to an earlier date or period, in which case as of such date or period), except where the
failure of such representations and warranties to be so true and correct has not had, and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Parent and Merger Sub shall have complied in all material respects with or performed in
all material respects the covenants and agreements they are required by this Agreement to comply with or perform at or prior to the Closing Date; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) the Company shall have received a certificate executed on behalf of Parent by an executive officer of Parent and dated as of the Closing
Date confirming that the conditions set forth in <U>Sections 7.3(a)</U> and <U>(b)</U>&nbsp;have been satisfied. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECTION&nbsp;8
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>TERMINATION </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.1 Termination</B>. This Agreement may be terminated prior to the Closing:</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) by mutual written consent of Parent and the Company; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) by either Parent or the Company if the Closing shall not have occurred on or prior to 11:59 p.m. Eastern Time, on the date that is the
twelve (12)-month anniversary of the date of this Agreement (the &#147;<U>End Date</U>&#148;); <I>provided</I>, <I>however</I>, that in the case of this <U>Section</U><U></U><U>&nbsp;8.1(b)</U>, (x) if on the End Date all of the conditions set forth
in <U>Section</U><U></U><U>&nbsp;7</U>, other than <U>Sections 7.1(b)</U> or <U>7.1(c)</U> thereof, shall have been satisfied (other than conditions that by their nature are to be satisfied at the Closing, each of which is then capable of being
satisfied) or waived (to the extent waivable under applicable Legal Requirements), then the End Date shall automatically be extended by a period of three (3)&nbsp;months (and all references to the End Date herein shall be as so extended); and
(y)&nbsp;the right to terminate this Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;8.1(b)</U> shall not be available to any Party whose breach of this Agreement has proximately caused or resulted in the Merger not being consummated by
such date or to any Party that has failed to use its reasonable best efforts as required by <U>Section</U><U></U><U>&nbsp;6.2</U>; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) by
either Parent or the Company if a Specified Governmental Body of competent jurisdiction shall have issued an order, decree or ruling, or shall have taken any other action, having the effect of permanently restraining, enjoining or otherwise
prohibiting the consummation of the Merger or making the consummation of the Merger illegal, which order, decree, ruling or other action shall be final and nonappealable;<I> provided</I>, <I>however</I>, that the right to terminate this Agreement
pursuant to this <U>Section</U><U></U><U>&nbsp;8.1(c)</U> shall not be available to any Party whose breach of this Agreement has proximately caused or resulted in the issuance of such final and nonappealable order, decree, ruling or other action or
to any Party that has failed to use its reasonable best efforts as required by <U>Section</U><U></U><U>&nbsp;6.2</U> to remove such order, decree, ruling or other action; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) by Parent, prior to obtaining the Company Stockholder Approval, if the Board of Directors shall have failed to include the Company Board
Recommendation in the Proxy Statement when mailed, or shall have effected a Company Adverse Recommendation Change; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) by the Company,
prior to obtaining the Company Stockholder Approval, in order to, subject to and in accordance with <U>Section</U><U></U><U>&nbsp;6.1(b)(i)</U>, accept a Superior Offer and substantially concurrently enter into a binding written definitive
acquisition agreement providing for the consummation of a transaction that constitutes a Superior Offer (a &#147;<U>Specified Agreement</U>&#148;); <I>provided </I>that such termination shall be effective only if the Company in accordance with
<U>Section</U><U></U><U>&nbsp;8.3</U> pays or causes to be paid to Parent or its designee the Termination Fee by wire transfer of same day funds prior to or concurrently with the execution of the Specified Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) by Parent, if a breach of any representation or warranty contained in this Agreement or
failure to perform any covenant or obligation in this Agreement on the part of the Company shall have occurred such that a condition set forth in <U>Section</U><U></U><U>&nbsp;7.2(a)</U> or <U>7.2(b)</U> would not be satisfied and cannot be cured by
the Company by the End Date, or if capable of being cured in such time period, shall not have been cured within thirty (30)&nbsp;Business Days of the date Parent gives the Company written notice of such breach or failure to perform (which notice
shall specify in reasonable detail the nature of such breach); <I>provided</I>, <I>however</I>, that Parent shall not have the right to terminate this Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;8.1(f)</U> if either Parent or Merger Sub
is then in breach of any representation, warranty, covenant or obligation hereunder which breach would permit the Company to terminate this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;8.1(g)</U> (without giving effect to the proviso
therein); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) by the Company, if a breach of any representation or warranty contained in this Agreement or failure to perform any
covenant or obligation in this Agreement on the part of Parent or Merger Sub shall have occurred such that a condition set forth in <U>Section</U><U></U><U>&nbsp;7.3(a)</U> or <U>7.3(b)</U> would not be satisfied and cannot be cured by Parent or
Merger Sub, as applicable, by the End Date, or, if capable of being cured in such time period, shall not have been cured within thirty (30)&nbsp;Business Days of the date the Company gives Parent written notice of such breach or failure to perform
(which notice shall specify in reasonable detail the nature of such breach); <I>provided</I>, <I>however</I>, that the Company shall not have the right to terminate this Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;8.1(g)</U> if the
Company is then in breach of any representation, warranty, covenant or obligation hereunder which breach would permit Parent to terminate this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;8.1(f) </U>(without giving effect to the proviso
therein); or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) by either Parent or the Company, if the Company Stockholder Approval has not been obtained by reason of the failure to
obtain the required vote upon a final vote taken thereon at the Stockholder Meeting (and any adjournment or postponement thereof). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.2
Effect of Termination</B>. In the event of the termination of this Agreement as provided in <U>Section</U><U></U><U>&nbsp;8.1</U>, written notice thereof shall be given to the other Party or Parties, specifying the provision hereof pursuant to which
such termination is made, and this Agreement shall be of no further force or effect and there shall be no liability on the part of Parent, Merger Sub or the Company or any of their respective former, current or future officers, directors, partners,
stockholders, managers, members or Affiliates following any such termination; <I>provided</I>, <I>however</I>, that (i)&nbsp;the final sentence of <U>Section</U><U></U><U>&nbsp;5.1</U>, this <U>Section</U><U></U><U>&nbsp;8.2</U>,
<U>Section</U><U></U><U>&nbsp;8.3</U> and <U>Section</U><U></U><U>&nbsp;9</U> shall survive the termination of this Agreement and shall remain in full force and effect in accordance with their terms, (ii)&nbsp;the Confidentiality Agreement and Clean
Team Agreement shall survive the termination of this Agreement and shall remain in full force and effect in accordance with their respective terms, (iii)&nbsp;the termination of this Agreement shall not relieve any Party from any liability for Fraud
or Willful Breach of this Agreement prior to termination, and (iv)&nbsp;no such termination shall relieve Parent or Merger Sub of their obligations in respect of any amounts payable, or expense reimbursement payable in respect of, any filing fees or
other fees payable to Governmental Bodies pursuant to <U>Section</U><U></U><U>&nbsp;6.2</U>. For purposes of this Agreement, &#147;<U>Willful Breach</U>&#148; means a material breach </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
that is a consequence of an act or omission undertaken by a breaching Party with the knowledge that the taking of, or failure to take, such act would, or would reasonably be expected to, cause or
constitute a material breach of this Agreement, and &#147;<U>Fraud</U>&#148; means actual, intentional and knowing common law fraud (and not constructive fraud or fraud based on negligence or recklessness) under Delaware law with respect to the
making of an express representation or warranty contained in this Agreement with the actual knowledge that such representation or warranty was false as of the date hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.3 Expenses; Termination Fees</B>.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as otherwise expressly set forth herein, including as set forth in <U>Section</U><U></U><U>&nbsp;6.2</U>,
<U>Section</U><U></U><U>&nbsp;8.2</U>, <U>Section</U><U></U><U>&nbsp;9.7</U> and this <U>Section</U><U></U><U>&nbsp;8.3</U>, all fees and expenses incurred in connection with this Agreement and the Transactions shall be paid by the Party incurring
such expenses, whether or not the Merger is consummated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In the event that: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) this Agreement is terminated by the Company pursuant to <U>Section</U><U></U><U>&nbsp;8.1(e)</U>; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) this Agreement is terminated by Parent pursuant to <U>Section</U><U></U><U>&nbsp;8.1(d)</U>; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) (A)&nbsp;this Agreement is terminated (x)&nbsp;by Parent or the Company pursuant to <U>Section</U><U></U><U>&nbsp;8.1(b)</U> (and in
the case of a termination by the Company, only if at such time Parent would not be prohibited from terminating this Agreement pursuant to proviso (y)&nbsp;of <U>Section</U><U></U><U>&nbsp;8.1(b)</U>) or pursuant to
<U>Section</U><U></U><U>&nbsp;8.1(h)</U> or (y)&nbsp;by Parent pursuant to <U>Section</U><U></U><U>&nbsp;8.1(f)</U>, (B)&nbsp;any Person shall have publicly disclosed an Acquisition Proposal or, in the case of termination pursuant to
<U>Section</U><U></U><U>&nbsp;8.1(b)</U> or <U>Section</U><U></U><U>&nbsp;8.1(f)</U>, any Acquisition Proposal has otherwise been communicated to the Board of Directors, in each case, after the date of this Agreement and prior to such termination
(or, in the case of termination pursuant to <U>Section</U><U></U><U>&nbsp;8.1(h)</U>,<I> </I>prior to the Stockholder Meeting) and such Acquisition Proposal has not been withdrawn at least four (4)&nbsp;Business Days prior to the date of such
termination (or, in the case of termination pursuant to <U>Section</U><U></U><U>&nbsp;8.1(h)</U>, at least four (4)&nbsp;Business Days prior to the date of the Stockholder Meeting, or in the case of termination pursuant to
<U>Section</U><U></U><U>&nbsp;8.1(f</U>), at least four (4)&nbsp;Business Days prior to the date of the applicable breach or failure to perform) and (C)&nbsp;within twelve (12)&nbsp;months of such termination the Company shall have entered into a
definitive agreement with respect to an Acquisition Proposal (which Acquisition Proposal is subsequently consummated, whether during or following such twelve (12)&nbsp;month period) or consummated an Acquisition Proposal; <I>provided</I> that for
purposes of this <U>clause (iii)</U>&nbsp;the references to &#147;20%&#148; in the definition of &#147;Acquisition Proposal&#148; shall be deemed to be references to &#147;50%&#148;; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">then, in any such event under <U>clause (i)</U>, <U>(ii)</U> or <U>(iii)</U>&nbsp;of this <U>Section</U><U></U><U>&nbsp;8.3(b)</U>, the Company shall pay or
cause to be paid to Parent or its designee the Termination Fee by wire transfer of same day funds (x)&nbsp;in the case of <U>Section</U><U></U><U>&nbsp;8.3(b)(i)</U>, prior to or concurrently with the execution of the Specified Agreement,
(y)&nbsp;in the case of <U>Section</U><U></U><U>&nbsp;8.3(b)(ii)</U>, within three (3)&nbsp;Business Days after such termination or (z)&nbsp;in the case of this <U>Section</U><U></U><U>&nbsp;8.3(b)(iii)</U>, prior to or concurrently with the
consummation of the Acquisition Proposal referred to in <U>Section</U><U></U><U>&nbsp;8.3(b)(iii)</U>, it being understood that in no event shall the Company be required to pay the Termination Fee on more than one occasion. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) In the event of any termination described in <U>Section</U><U></U><U>&nbsp;8.3(b)</U>,
(i)&nbsp;payment from the Company to Parent or its designee of the Termination Fee pursuant to <U>Section</U><U></U><U>&nbsp;8.3(b)</U> (together with any amounts that become due pursuant to <U>Section</U><U></U><U>&nbsp;8.3(f)</U>) shall be the
sole and exclusive remedy of Parent, Merger Sub and any of their respective Affiliates against the Acquired Corporations and any of their respective former, current or future officers, directors, partners, stockholders, managers, members or
Affiliates (collectively, &#147;<U>Company Related Parties</U>&#148;) arising out of or related to this Agreement or the Transactions and shall constitute liquidated damages for any loss suffered as a result of the failure of the Merger to be
consummated or for a breach or failure to perform hereunder or otherwise, and (ii)&nbsp;upon payment of such amount(s) in accordance with <U>Section</U><U></U><U>&nbsp;8.3(d)</U>, none of the Company Related Parties shall have any further liability
or obligation relating to or arising out of this Agreement or the Transactions and none of Parent, Merger Sub or any of their respective Affiliates shall be entitled to bring or maintain any claim, action or proceeding against any Company Related
Party or any of their respective Affiliates relating to or arising out of this Agreement or the Transactions; <I>provided</I>, that the foregoing shall not relieve the Company from any liability for Fraud or Willful Breach of this Agreement prior to
such termination or any liability under the Confidentiality Agreement and the Clean Team Agreement; <I>provided, further</I>, that Parent may seek specific performance to cause the Company to consummate the Transactions in accordance with
<U>Section</U><U></U><U>&nbsp;9.5(b)</U>, and may elect which remedy to receive if both a grant of specific performance to consummate the Transactions and the payment of the Termination Fee are adjudicated to be available, but in no event shall
Parent be entitled to both such grant of specific performance and the payment of the Termination Fee. Notwithstanding anything to the contrary contained herein, in the case of Willful Breach, in circumstances where the Termination Fee is payable
pursuant to <U>Section</U><U></U><U>&nbsp;8.3(b)</U> and is paid by the Company to Parent pursuant to and in accordance with <U>Section</U><U></U><U>&nbsp;8.3(b)</U>, Parent&#146;s right to receive payment from the Company of the Termination Fee
pursuant to and in accordance with <U>Section</U><U></U><U>&nbsp;8.3(b)</U> (together with any amounts that become due pursuant to <U>Section</U><U></U><U>&nbsp;8.3(f)</U>), shall be the sole and exclusive monetary remedy of Parent and Merger Sub
against the Company Related Parties for any loss or damage suffered as a result of the failure of the Transactions to be consummated or for a breach of, or failure to perform under, this Agreement (including in respect of any Willful Breach), and
upon payment of the Termination Fee (together with any amounts that become due pursuant to <U>Section</U><U></U><U>&nbsp;8.3(f)</U>), none of the Company Related Parties shall have any further liability or obligation relating to or arising out of
this Agreement or the Transactions, whether in equity or at law, in contract, in tort or otherwise, other than any liability under the Confidentiality Agreement or the Clean Team Agreement or liability for Fraud. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) In the event that the Company or Parent terminates this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;8.1(b)</U> or
<U>Section</U><U></U><U>&nbsp;8.1(c)</U> and all conditions to the Closing are satisfied (other than those conditions that by their terms are to be satisfied at the Closing, each of which is capable of being satisfied at the Closing) or waived (to
the extent waivable under applicable Legal Requirements), other than the conditions set forth in (i)<U>&nbsp;Section</U><U></U><U>&nbsp;7.1(b)</U>, but solely to the extent such Legal Requirement, temporary restraining order, preliminary or
permanent injunction, final judgment or other order shall relate to the HSR Act or any other Antitrust Law or (ii)<U>&nbsp;Section</U><U></U><U>&nbsp;7.1(c)</U>, and in either of <U>clause (i)</U>&nbsp;or <U>(ii)</U>, a material breach by the
Company of its obligations under <U>Section</U><U></U><U>&nbsp;6.2</U> is not the principal cause of either the Merger not being consummated by the End Date or the issuance of the applicable final and
<FONT STYLE="white-space:nowrap">non-appealable</FONT> order, decree, ruling or other action, as applicable, then Parent shall promptly pay or cause to be paid to the Company the Parent Termination Fee by wire transfer of same day funds as promptly
as reasonably practicable (and, in any event (x)&nbsp;within two (2) Business Days or (y)&nbsp;concurrently with such a termination by Parent). The parties hereto acknowledge and agree that in no event shall Parent be required to pay the Parent
Termination Fee on more than one occasion. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) In the event of any termination described in <U>Section</U><U></U><U>&nbsp;8.3(d)</U>,
(i)&nbsp;payment from Parent to the Company of the Parent Termination Fee pursuant to <U>Section</U><U></U><U>&nbsp;8.3(d)</U> (together with any amounts that become due pursuant to <U>Section</U><U></U><U>&nbsp;8.3(f)</U> or
<U>Section</U><U></U><U>&nbsp;8.3(g)</U>) shall be the sole and exclusive remedy of the Company and any of its respective Affiliates against Parent, Merger Sub and any of their respective former, current or future officers, directors, partners,
stockholders, managers, members or Affiliates, including Ultimate Parent (collectively, &#147;<U>Parent Related Parties</U>&#148;) arising out of or related to this Agreement or the Transactions and shall constitute liquidated damages for any loss
suffered as a result of the failure of the Merger to be consummated or for a breach or failure to perform hereunder or otherwise, and (ii)&nbsp;upon payment of such amount(s) pursuant to <U>Section</U><U></U><U>&nbsp;8.3(d)</U>, none of the Parent
Related Parties shall have any further liability or obligation relating to or arising out of this Agreement or the Transactions and none of the Company or the other Acquired Corporations or any of their respective Affiliates shall be entitled to
bring or maintain any claim, action or proceeding against any Parent Related Party or any of their respective Affiliates relating to or arising out of this Agreement or the Transactions; <I>provided</I>, that the foregoing shall not relieve Parent
or Merger Sub from any liability for Fraud or Willful Breach of this Agreement prior to such termination or any liability under the Confidentiality Agreement and the Clean Team Agreement; <I>provided, further</I>, that the Company may seek specific
performance to cause Parent and Merger Sub to consummate the Transactions in accordance with <U>Section</U><U></U><U>&nbsp;9.5(b)</U>, and may elect which remedy to receive if both a grant of specific performance to consummate the Transactions and
the payment of the Parent Termination Fee are adjudicated to be available, but in no event shall the Company be entitled to both such grant of specific performance and the payment of the Parent Termination Fee. Notwithstanding anything to the
contrary contained herein, in the case of Willful Breach, in circumstances where the Parent Termination Fee is payable pursuant to <U>Section</U><U></U><U>&nbsp;8.3(d)</U> and is paid by Parent to the Company pursuant to and in accordance with
<U>Section</U><U></U><U>&nbsp;8.3(d)</U>, the Company&#146;s right to receive payment from Parent of the Parent Termination Fee pursuant to and in accordance with <U>Section</U><U></U><U>&nbsp;8.3(d)</U> (together with any amounts that become due
pursuant to <U>Section</U><U></U><U>&nbsp;8.3(f)</U> and <U>Section</U><U></U><U>&nbsp;8.3(g)</U>), shall be the sole and exclusive monetary remedy of the Company against the Parent Related Parties for any loss or damage suffered as a result of the
failure of the Transactions to be consummated or for a breach of, or failure to perform under, this Agreement (including in respect of any Willful Breach), and upon payment of the Parent Termination Fee (together with any amounts that become due
pursuant to <U>Section</U><U></U><U>&nbsp;8.3(f)</U> and <U>Section</U><U></U><U>&nbsp;8.3(g)</U>), none of the Parent Related Parties shall have any further liability or obligation relating to or arising out of this Agreement or the Transactions,
whether in equity or at law, in contract, in tort or otherwise, other than any liability under the Confidentiality Agreement or the Clean Team Agreement or liability for Fraud. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The Parties acknowledge that the agreements contained in this <U>Section</U><U></U><U>&nbsp;8.3</U> are an integral part of the
transactions contemplated by this Agreement and that, without these agreements, the Parties would not enter into this Agreement; accordingly, if the Company fails to timely pay any amount due pursuant to <U>Section</U><U></U><U>&nbsp;8.3(b)</U>, or
Parent fails to timely pay any amount due pursuant to <U>Section</U><U></U><U>&nbsp;8.3(e)</U>, and, in order to obtain the payment, Parent or the Company, as applicable, commences a Legal Proceeding which results in a judgment against the other
Party or the other Party eventually makes such payment, then the <FONT STYLE="white-space:nowrap">non-prevailing</FONT> Party shall pay to the prevailing Party its reasonable and documented costs and expenses (including reasonable and documented
attorneys&#146; fees) in connection with such suit, together with interest on such amount at the prime rate as published in the Wall Street Journal in effect on the date such payment was required to be made through the date such payment was actually
received. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) The Parent Termination Fee is exclusive of Swiss VAT. The payment of, and liability for,
any Swiss VAT imposed with respect to the payment of the Parent Termination Fee shall be the sole responsibility of Parent. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECTION&nbsp;9 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>MISCELLANEOUS PROVISIONS </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.1 Amendment</B>. This Agreement may not be amended except by an instrument in writing signed on behalf of each of the Parties prior to
the Effective Time. Prior to the Effective Time, this Agreement may be amended with the approval of the respective boards of directors of the Company, Parent and Merger Sub at any time, whether before or after the Company Stockholder Approval has
been obtained; <I>provided </I>that after the Company Stockholder Approval has been obtained, no amendment shall be made that by any Legal Requirement requires further approval by the Company&#146;s stockholders without the further approval of such
stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.2 Waiver</B>. No failure on the part of any Party to exercise any power, right, privilege or remedy under this
Agreement, and no delay on the part of any Party in exercising any power, right, privilege or remedy under this Agreement, shall operate as a waiver of such power, right, privilege or remedy; and no single or partial exercise of any such power,
right, privilege or remedy shall preclude any other or further exercise thereof or of any other power, right, privilege or remedy. At any time prior to the Effective Time, Parent and Merger Sub, on the one hand, and the Company, on the other hand,
may, to the extent permissible by applicable Legal Requirements, (i)&nbsp;extend the time for the performance of any of the obligations or other acts of the other, (ii)&nbsp;waive any breach of the representations and warranties of the other
contained herein or in any document delivered pursuant hereto or (iii)&nbsp;waive compliance by the other with any of the agreements or covenants contained herein. Any such extension or waiver shall be valid only if it is expressly set forth in a
written instrument duly executed and delivered on behalf of the Party or Parties to be bound thereby, but such extension or waiver or failure to insist on strict compliance with an obligation, covenant, agreement or condition shall not operate as a
waiver of, or estoppel with respect to, any subsequent or other failure. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.3 No Survival of Representations and Warranties</B>. None
of the representations and warranties contained in this Agreement, the Company Disclosure Schedule or in any certificate or schedule or other document delivered by any Person pursuant to or in connection with this Agreement shall survive the
consummation of the Merger. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.4 Entire Agreement; Counterparts</B>. This Agreement (including its Exhibits) and the Company Disclosure
Schedule, the Confidentiality Agreement, the Clean Team Agreement and that certain letter agreement constitute the entire agreement and supersede all prior agreements and understandings, both written and oral, among or between any of the Parties and
their respective Subsidiaries, with respect to the subject matter hereof and thereof. This Agreement may be executed in one or more counterparts, including by facsimile or by email with .pdf attachments, all of which shall be considered one and the
same agreement, and shall become effective when one or more counterparts have been signed by each of the parties and delivered to the other parties. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.5 Applicable Legal Requirements; Jurisdiction; Specific Performance; Remedies</B>.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) This Agreement, including all matters of construction, validity and performance and any action or proceeding (whether in contract, tort or
otherwise) arising out of this Agreement or any of the Transactions or any other agreements contemplated hereby shall be governed by, and construed in accordance with, the laws of the State of Delaware, including with respect to statutes of
limitations, regardless of the laws that might otherwise govern under applicable principles of conflicts of laws thereof. In any action or proceeding arising out of or relating to this Agreement or any of the Transactions: (i)&nbsp;each of the
Parties irrevocably and unconditionally consents and submits to the exclusive jurisdiction and venue of the Chancery Court of the State of Delaware and any state appellate court therefrom or, if (but only if) such court lacks subject matter
jurisdiction, the United States District Court sitting in New Castle County in the State of Delaware and any appellate court therefrom or, if (but only if) such court lacks subject matter jurisdiction, the Delaware Superior Court and any appellate
court therefrom (collectively, the &#147;<U>Delaware </U><U>Courts</U>&#148;); and (ii)&nbsp;each of the Parties irrevocably consents to service of process by first class certified mail, return receipt requested, postage prepaid, to the address at
which such Party is to receive notice in accordance with <U>Section</U><U></U><U>&nbsp;9.9</U>. Each of the Parties irrevocably and unconditionally (A)&nbsp;agrees not to commence any such action or proceeding except in the Delaware Courts,
(B)&nbsp;agrees that any claim in respect of any such action or proceeding may be heard and determined in the Delaware Courts, (C)&nbsp;waives, to the fullest extent it may legally and effectively do so, any objection that it may now or hereafter
have to the jurisdiction or laying of venue of any such action or proceeding in the Delaware Courts and (D)&nbsp;waives, to the fullest extent permitted by law, the defense of an inconvenient forum to the maintenance of such action or proceeding in
the Delaware Courts. The Parties agree that a final judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by applicable Legal Requirements;
<I>provided</I>,<I> however</I>, that nothing in the foregoing shall restrict any Party&#146;s rights to seek any post-judgment relief regarding, or any appeal from, such final trial court judgment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Parties agree that irreparable damage, for which monetary damages even if available, would not be an adequate remedy, would occur in
the event that the Parties do not perform their obligations under the provisions of this Agreement in accordance with its specified terms or otherwise breach such provisions. Subject to the following sentence, the Parties acknowledge and agree that
(i)&nbsp;the Parties shall be entitled to an injunction or injunctions, specific performance, or other equitable relief, to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof in the courts described in
<U>Section</U><U></U><U>&nbsp;9.5(a)</U> without proof of damages or otherwise, this being in addition to any other remedy to which they are entitled under this Agreement, and (ii)&nbsp;the right of specific performance is an integral part of the
Transactions and without that right, neither the Company, Parent nor Merger Sub would have entered into this Agreement. Each of the Parties agrees that it will not oppose the granting of an injunction, specific performance or other equitable relief
on the basis that the other Parties have an adequate remedy at law or that an award of specific performance is not an appropriate remedy for any reason at law or equity. The Parties acknowledge and agree that any Party seeking an injunction or
injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement in accordance with this <U>Section</U><U></U><U>&nbsp;9.5(b)</U> shall not be required to provide any bond or other security in
connection with any such order or injunction. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">67 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) EACH OF THE PARTIES IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL
PROCEEDING BETWEEN THE PARTIES (WHETHER BASED ON CONTRACT, TORT OR OTHERWISE), INCLUDING ANY COUNTERCLAIM, ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THE ACTIONS OF ANY PARTY HERETO IN THE NEGOTIATION,
ADMINISTRATION, PERFORMANCE AND ENFORCEMENT THEREOF (INCLUDING ANY DISPUTE ARISING OUT OF OR RELATING TO THE FINANCING OR ANY COMMITMENT LETTER OR THE PERFORMANCE OF SERVICES THEREUNDER OR RELATED THERETO). EACH PARTY (I)&nbsp;MAKES THIS WAIVER
VOLUNTARILY AND (II)&nbsp;ACKNOWLEDGES THAT SUCH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS CONTAINED IN THIS <U>SECTION 9.5(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.6 Assignability</B>. This Agreement shall be binding upon, and shall be enforceable by and inure solely to the benefit of, the Parties
and their respective successors and permitted assigns; <I>provided</I>,<I> however</I>, that neither this Agreement nor any of the rights hereunder may be assigned by a Party without the prior written consent of the other Parties, and any attempted
assignment of this Agreement or any of such rights without such consent shall be void and of no effect, except each of Parent and Merger Sub may assign all or any of their rights and obligations under this Agreement to any wholly owned Subsidiary of
Parent that is a tax resident of either the United States or Switzerland without the prior consent of the Company upon prior written notice to the Company; <I>provided</I> that (a)&nbsp;no such assignment shall be permitted without the prior written
consent of the Company if such assignment would, or would reasonably be expected to, prevent, impair or delay Parent or Merger Sub from performing their respective obligations under this Agreement or consummating the Merger and the other
transactions contemplated by this Agreement and (b)&nbsp;no such assignment shall relieve the assigning party of its obligations hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.7 Transfer Tax</B>. Except as otherwise provided in <U>Section</U><U></U><U>&nbsp;1.4(b)</U>, all transfer, documentary, sales, use,
stamp, registration and other similar Taxes imposed with respect to the transfer of Shares pursuant to the Merger shall be borne by the Company and expressly shall not be a liability of holders of Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.8 No Third Party Beneficiaries</B>. Nothing in this Agreement, express or implied, is intended to or shall confer upon any Person (other
than the Parties) any right, benefit or remedy of any nature whatsoever under or by reason of this Agreement, except for: (i)&nbsp;if the Effective Time occurs, (A)&nbsp;the right of the Company&#146;s stockholders to receive the Merger
Consideration pursuant to <U>Section</U><U></U><U>&nbsp;1</U> following the Effective Time in accordance with the terms of this Agreement and (B)&nbsp;the right of the holders of Company Options, Company RSU Awards and Company PSU Awards to receive
the Merger Consideration pursuant to <U>Section</U><U></U><U>&nbsp;1.6</U> following the Effective Time in accordance with the terms of this Agreement; (ii)&nbsp;the provisions set forth in <U>Section</U><U></U><U>&nbsp;6.5</U> of this Agreement
(which are intended for the benefit of each indemnified or insured party (including the Indemnified Persons) contemplated thereby, each of whom will be third party beneficiaries of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">68 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
these provisions); (iii)&nbsp;the limitations on liability of the Company Related Parties set forth in <U>Section</U><U></U><U>&nbsp;8.3(c)</U> and the limitations on liability of the Parent
Related Parties set forth in <U>Section</U><U></U><U>&nbsp;8.3(e)</U>, and (iv)&nbsp;the provisions of <U>Section</U><U></U><U>&nbsp;9.1</U>, <U>Section</U><U></U><U>&nbsp;9.5(c)</U> and this <U>Section</U><U></U><U>&nbsp;9.8</U> (which are intended
for the benefit of the relevant parties identified therein, each of which will be third party beneficiaries of these provisions). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.9
Notices</B>. Any notice or other communication required or permitted to be delivered to any Party under this Agreement shall be in writing and shall be deemed properly delivered, given and received (i)&nbsp;upon receipt when delivered by hand,
(ii)&nbsp;two (2)&nbsp;Business Days after being sent by registered mail or by courier or express delivery service, or (iii)&nbsp;if sent by email prior to 6:00 p.m. recipient&#146;s local time and receipt is confirmed
<FONT STYLE="white-space:nowrap">(e-mail</FONT> sufficing), upon transmission, or (iv)&nbsp;if sent by email after 6:00 p.m. recipient&#146;s local time and receipt is confirmed <FONT STYLE="white-space:nowrap">(e-mail</FONT> sufficing), the day
following the date of transmission; <I>provided </I>that in each case the notice or other communication is sent to the physical address or email address set forth beneath the name of such Party below (or to such other physical address or email
address as such Party shall have specified in a written notice given to the other Parties):<I></I><I>&nbsp;</I> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">if to Parent or Merger Sub
(or following the Effective Time, the Surviving Corporation): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Alcon Research, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">6201 South Freeway </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Fort Worth,
Texas 76134-2099 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attention: General Counsel </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">E-mail:</FONT> royce.bedward@alcon.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">with a copy (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Gibson, Dunn&nbsp;&amp; Crutcher LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">One Embarcadero Center, Suite 2600 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">San Francisco, CA 94111-3715 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attention: &#8194;&#8201;Branden C. Berns; Evan D&#146;Amico; George Sampas </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">E-mail:</FONT> &#8195;&#8194;&#8201;BBerns@gibsondunn.com; EDamico@gibsondunn.com; </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">&#8195;&#8195;&#8201;&#8195;&#8195;&#8194;&#8201;GSampas@gibsondunn.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">if to the Company (prior to the Effective Time): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">STAAR Surgical Company </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">25510
Commercentre Drive </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Lake Forest, California </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attention: &#8194;&#8201;Nathaniel Sisitsky </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Email: &#8195;&#8194;&#8201;&#8201;&#8201;nsisitsky@staar.com </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">69 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">with a copy (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Wachtell, Lipton, Rosen&nbsp;&amp; Katz </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">51 West 52nd Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">New York,
NY 10019 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attention: &#8194;&#8201;Karessa L. Cain </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email: &#8195;&#8194;&#8201;&#8201;&#8201;KLCain@wlrk.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.10 Severability</B>. Any term or provision of this Agreement that is invalid or unenforceable in any situation in any jurisdiction shall
not affect the validity or enforceability of the remaining terms and provisions of this Agreement or the validity or enforceability of the offending term or provision in any other situation or in any other jurisdiction, so long as the economic and
legal substance of the Transactions is not affected in any manner materially adverse to any Party. If a final judgment of a court of competent jurisdiction declares that any term or provision of this Agreement is invalid or unenforceable, the
Parties agree that the court making such determination shall have the power to limit such term or provision, to delete specific words or phrases or to replace such term or provision with a term or provision that is valid and enforceable and that
comes closest to expressing the intention of the invalid or unenforceable term or provision, and this Agreement shall be valid and enforceable as so modified, in each case so long as the economic and legal substance of the Transactions is not
affected in any manner materially adverse to any Party. In the event such court does not exercise the power granted to it in the prior sentence, the Parties agree to replace such invalid or unenforceable term or provision with a valid and
enforceable term or provision that will achieve, to the fullest extent possible, the economic, business and other purposes of such invalid or unenforceable term or provision. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.11 Obligation of Parent</B>. Parent shall ensure that Merger Sub duly performs, satisfies and discharges on a timely basis each of the
covenants, obligations and liabilities applicable to Merger Sub under this Agreement, and Parent shall be jointly and severally liable with Merger Sub for the due and timely performance and satisfaction of each of said covenants, obligations and
liabilities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.12 Construction</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) For purposes of this Agreement, whenever the context requires: the singular number shall include the plural, and vice versa; words
denoting any gender shall include all genders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Parties agree that any rule of construction to the effect that ambiguities are to
be resolved against the drafting Party shall not be applied in the construction or interpretation of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) All references
to days or months shall be deemed references to calendar days or months unless otherwise specified herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) All references to
&#147;$&#148; or dollars shall be deemed references to United States dollars. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">70 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) As used in this Agreement, (i)&nbsp;the words &#147;include&#148; and
&#147;including,&#148; and variations thereof, shall not be deemed to be terms of limitation, but rather shall be deemed to be followed by the words &#147;without limitation&#148; and (ii)&nbsp;the word &#147;or&#148; shall not be exclusive. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The words &#147;hereof,&#148; &#147;herein,&#148; &#147;herewith&#148; and &#147;hereunder&#148; and words of similar import referring to
this Agreement refer to this Agreement as a whole (including the Company Disclosure Schedule and Exhibits hereto and thereto) and not to any particular provision of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Except as otherwise indicated, all references in this Agreement to &#147;Sections&#148; or &#147;Exhibits&#148; are intended to refer to
Sections of this Agreement and Exhibits to this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) With respect to information provided by the Company to Parent, the term
&#147;made available,&#148; &#147;delivered&#148; or such term with similar import used in this Agreement means that the information referred to (i)&nbsp;is included in the Company SEC Documents made publicly available at least three (3)&nbsp;days
prior to the date of this Agreement or (ii)&nbsp;has been posted at least one (1)&nbsp;day prior to the date of this Agreement in the &#147;data room&#148; established by the Company or its Representatives or delivered at least one (1)&nbsp;day
prior to the date of this Agreement in person or electronically by the Company or its Representatives to Parent or its Representatives. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Capitalized terms used in the Company Disclosure Schedule and not otherwise defined therein have the meanings given to them in this
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) The bold-faced headings contained in this Agreement are for convenience of reference only, shall not be deemed to be a
part of this Agreement and shall not be referred to in connection with the construction or interpretation of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k)&nbsp;(i)
Any reference to any Governmental Body includes any successor to that Governmental Body; and (ii)&nbsp;unless the context otherwise requires, any reference to any applicable Legal Requirement refers to such applicable Legal Requirement as amended,
modified, supplemented, or replaced from time to time (and, in the case of statutes, include any rule and regulation promulgated under such statute) and references to any section of any applicable Legal Requirement includes any successor to such
section (<I>provided </I>that, for purposes of any representation and warranty in this Agreement that is made as of a specific date, references to any Legal Requirement shall be deemed to refer to such Legal Requirement, as amended, and to any rule
or regulation promulgated thereunder, in each case, as of such date). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) The information contained in this Agreement and in the
Disclosure Schedules and Exhibits hereto is disclosed solely for purposes of this Agreement, and no information contained herein or therein shall be deemed to be an admission by any party hereto of any matter whatsoever. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature page follows] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">71 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the Parties have caused this Agreement to be executed as of the
date first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>Alcon Research, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David Endicott</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: David Endicott</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Chief Executive Officer and President</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>Rascasse Merger Sub, Inc.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David Endicott</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: David Endicott</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Chief Executive Officer and President</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>STAAR Surgical Company</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Stephen C. Farrell</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Stephen C. Farrell</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Chief Executive Officer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to Agreement and Plan of Merger] </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTAIN DEFINITIONS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For
purposes of the Agreement (including this <B><U>Exhibit A</U></B>): </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Acceptable Confidentiality Agreement</B>. &#147;<U>Acceptable
Confidentiality Agreement</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;5.4</U> of the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Acquired Corporation</B>.
&#147;<U>Acquired Corporation</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;3.1(a)</U> of the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Acquisition
Proposal</B>. &#147;<U>Acquisition Proposal</U>&#148; shall mean any <I>bona fide </I>inquiry, proposal or offer from any Person (other than Parent and its Affiliates) or &#147;group&#148; (other than a &#147;group&#148; that includes Parent or its
Affiliates) within the meaning of Section&nbsp;13(d) of the Exchange Act, relating to, in a single transaction or series of related transactions, any (i)&nbsp;acquisition or exclusive license of assets of any Acquired Corporation equal to more than
20% of the consolidated assets (based on the fair market value thereof) of the Acquired Corporations, taken as a whole, or to which more than 20% of the Acquired Corporations&#146; revenues or earnings on a consolidated basis are attributable,
(ii)&nbsp;issuance or acquisition of more than 20% of the aggregate voting power of the capital stock or equity interests of the Company, (iii)&nbsp;recapitalization, tender offer or exchange offer that if consummated would result in any Person or
group (or the stockholders of any Person) beneficially owning more than 20% of the aggregate voting power of the capital stock or equity interests of the Company (or the surviving entity, or the resulting direct or indirect parent of the Company or
such surviving entity), or (iv)&nbsp;merger, consolidation, amalgamation, share exchange, business combination, recapitalization, liquidation, dissolution or similar transaction involving any Acquired Corporation that if consummated would result in
any Person or group (or the stockholders of any Person) beneficially owning more than 20% of the aggregate voting power of the capital stock or equity interests of the Company (or the surviving entity, or the resulting direct or indirect parent of
the Company or such surviving entity), in each case, other than the Transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Adverse Remedy Impact. </B>&#147;<U>Adverse Remedy
Impact</U>&#148; shall mean a greater than $50&nbsp;million reduction in the aggregate amount of reasonably projected LASIK and ICL sales revenue of Ultimate Parent and its controlled Affiliates, including the Company and its Subsidiaries, taken as
a whole, for the twelve-month period following Closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Affiliate</B>. &#147;<U>Affiliate</U>&#148; shall mean, as to any Person, any
other Person that, directly or indirectly, controls, or is controlled by, or is under common control with, such Person. For this purpose, &#147;control&#148; (including, with its correlative meanings, &#147;controlled by&#148; and &#147;under common
control with&#148;) shall mean the possession, directly or indirectly, of the power to direct or cause the direction of management or policies of a Person, whether through the ownership of securities or partnership or other ownership interests, by
Contract or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Agreement</B>. &#147;<U>Agreement</U>&#148; is defined in the preamble to the Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Anti-Corruption Laws</B>. &#147;<U>Anti-Corruption Laws</U>&#148; shall mean the Foreign
Corrupt Practices Act of 1977, as amended, the UK Bribery Act of 2010, the anti-bribery laws of the People&#146;s Republic of China or any other applicable Legal Requirements pertaining to bribery or corruption. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Anti-Money Laundering Laws</B>. &#147;Anti-Money Laundering Laws&#148; shall mean applicable laws, regulations or rules relating to the
prevention of money laundering or terrorist financing, including financial recordkeeping and reporting requirements, 18 U.S.C. &#167;&#167; 1956 and 1957, the Bank Secrecy Act, as amended by the USA PATRIOT Act, 31 U.S.C. &#167;&#167; 5311 <I>et
seq</I>., and its implementing regulations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Antitrust Laws</B>. &#147;<U>Antitrust Laws</U>&#148; shall mean the Sherman Act, as
amended, the Clayton Act, as amended, the HSR Act, the Federal Trade Commission Act, as amended, all applicable foreign anti-trust laws, and all other applicable Legal Requirements issued by a Governmental Body that are designed or intended to
prohibit, restrict or regulate actions having the purpose or effect of monopolization or restraint of trade or lessening of competition, as well as applicable laws and regulations governing foreign investment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Applicable Third Party</B>. &#147;<U>Applicable Third Party</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;6.2(f)</U> of the
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Awards</B>. &#147;<U>Awards</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;1.6(f)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Board of Directors</B>. &#147;<U>Board of Directors</U>&#148; shall mean the board of directors of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Book-Entry Shares</B>. &#147;<U>Book-Entry Shares</U>&#148; shall mean <FONT STYLE="white-space:nowrap">non-certificated</FONT> Shares
represented by book-entry. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Business Day</B>. &#147;<U>Business Day</U>&#148; shall mean a day except a Saturday, a Sunday or other day
on which banks in the City of New York or Geneva, Switzerland are authorized or required by Legal Requirements to be closed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Capitalization Date</B>. &#147;<U>Capitalization Date</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;3.3(a)</U> of the Agreement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>CDSCO</B>. &#147;<U>CDSCO</U>&#148; shall mean the Central Drugs Standard Control Organization in India. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Certificates</B>. &#147;<U>Certificates</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;1.4(a)</U> of the Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Clean Team Agreement</B>. &#147;<U>Clean Team Agreement</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;5.1</U> of the Agreement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Closing</B>. &#147;<U>Closing</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;1.1</U> of the Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Closing Date</B>. &#147;<U>Closing Date</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;1.1</U> of the Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Code</B>. &#147;<U>Code</U>&#148; shall mean the U.S. Internal Revenue Code of 1986, as amended. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Collective Bargaining Agreement</B>. &#147;<U>Collective Bargaining Agreement</U>&#148;
shall mean any written Contract, memorandum of understanding or other contractual obligation between an Acquired Corporation and any Labor Organization representing employees of an Acquired Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Company</B>. &#147;<U>Company</U>&#148; is defined in the preamble to the Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Company 401(k) Plan</B>. &#147;<U>Company 401(k) Plan</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;6.4</U> of the Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Company Adverse Recommendation Change</B>. &#147;<U>Company Adverse Recommendation Change</U>&#148; is defined in
<U>Section</U><U></U><U>&nbsp;6.1(a)</U> of the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Company Associate</B>. &#147;<U>Company Associate</U>&#148; shall mean each
officer or other employee, or individual who is an independent contractor, consultant or director, of or to the Company or its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Company Board Recommendation</B>. &#147;<U>Company Board Recommendation</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;3.21</U> of
the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Company Cash Awards</B>. &#147;<U>Company Cash Awards</U>&#148; shall mean the long-term cash awards issued pursuant to
the Company Equity Plan or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Company Common Stock</B>. &#147;<U>Company Common Stock</U>&#148; shall mean the common stock,
$0.01 par value per share, of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Company Disclosure Schedule</B>. &#147;<U>Company Disclosure Schedule</U>&#148; shall mean
the disclosure schedule that has been prepared by the Company in accordance with the requirements of the Agreement and that has been delivered by the Company to Parent concurrently with the execution of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Company Equity Plan</B>. &#147;<U>Company Equity Plan</U>&#148; shall mean the STAAR Surgical Company Amended and Restated Omnibus Equity
Incentive Plan, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Company Governmental Authorizations</B>. &#147;<U>Company Governmental Authorizations</U>&#148; is defined
in <U>Section</U><U></U><U>&nbsp;3.15</U> of the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Company IT Systems</B>. &#147;<U>Company IT Systems</U>&#148; shall mean
computers, computer software, firmware, middleware, servers, workstations, routers, hubs, switches, databases, data communications lines, network and telecommunications equipment and all other information technology equipment, infrastructure,
systems and networks, and all associated documentation, owned by, or licensed or leased to, or otherwise used by, any Acquired Corporation (excluding any public networks). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Company Options</B>. &#147;<U>Company Options</U>&#148; shall mean all compensatory options to purchase Shares issued pursuant to the
Company Equity Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Company Owned IP</B>. &#147;<U>Company Owned IP</U>&#148; shall mean all Intellectual Property Rights that are
owned or purported to be owned by any Acquired Corporation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Company PSU Award</B>. &#147;<U>Company PSU Award</U>&#148; shall mean each restricted
stock unit issued under the Company Equity Plan or otherwise granted with respect to Shares, the vesting of which is (or was at the time of grant) subject to performance conditions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Company Related Parties</B>. &#147;<U>Company Related Parties</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;8.3(c)</U> of the
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Company Returns</B>. &#147;<U>Company Returns</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;3.16(a)</U> of the
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Company RSU Award</B>. &#147;<U>Company RSU Award</U>&#148; shall mean each restricted stock unit issued under the Company
Equity Plan or otherwise granted with respect to Shares, excluding Company PSU Awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Company SEC Documents</B>. &#147;<U>Company SEC
Documents</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;3.4(a)</U> of the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Company Securities. </B>&#147;<U>Company
Securities</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;3.3(d)</U> of the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Company Stockholder Approval</B>.
&#147;<U>Company Stockholder Approval</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;3.21</U> of the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Confidentiality
Agreement</B>. &#147;<U>Confidentiality Agreement</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;5.1</U> of the Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Consent</B>. &#147;<U>Consent</U>&#148; shall mean any approval, consent, ratification, permission, waiver or authorization. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Continuing Employee</B>. &#147;<U>Continuing Employee</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;6.3(a)</U> of the Agreement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Contract</B>. &#147;<U>Contract</U>&#148; shall mean any legally binding agreement, contract, subcontract, lease, sublease,
understanding, instrument, bond, debenture, note, option, warrant, license, sublicense, commitment or undertaking. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Copyrights</B>.
&#147;<U>Copyrights</U>&#148; is defined in the definition of Intellectual Property Rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Current D&amp;O Insurance</B>.<B>
</B>&#147;<U>Current D&amp;O Insurance</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;6.5(b)</U> of the Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Customs</B><B></B><B>&nbsp;&amp; Trade Control Laws</B>. &#147;<U>Customs</U><U></U><U>&nbsp;&amp; Trade Control Laws</U>&#148; shall mean
all applicable export, import, customs and trade, and anti-boycott Legal Requirements administered, enacted or enforced by any Governmental Body, including : (a) the U.S. Export Administration Regulations, the U.S. International Traffic in Arms
Regulations, and the import Legal Requirements administered by U.S. Customs and Border Protection; (b)&nbsp;the anti-boycott Legal Requirements administered by the U.S. Departments of Commerce and Treasury; and (c)&nbsp;any other similar export,
import, anti-boycott, or other trade Legal Requirements in any relevant jurisdiction to the extent they are applicable to the Acquired Corporations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Data Privacy Laws</B>. &#147;<U>Data Privacy Laws</U>&#148; shall mean all applicable
Legal Requirements of any applicable jurisdiction relating to: (i)&nbsp;the privacy, protection, receipt, collection, compilation, use, storage, processing, sharing, safeguarding, security (both technical and physical), disposal, destruction,
disclosure or transfer (including cross-border) of Personal Information; and (ii)&nbsp;cybersecurity, including, in the case of <U>clause (i)</U>&nbsp;and <U>(ii)</U>, HIPAA, the General Data Protection Regulation, Regulation 2016/679/EU and the
California Consumer Privacy Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Delaware Courts</B>. &#147;<U>Delaware Courts</U>&#148; is defined in
<U>Section</U><U></U><U>&nbsp;9.5(a)</U> of the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Determination Notice</B>. &#147;<U>Determination Notice</U>&#148; is
defined in <U>Section</U><U></U><U>&nbsp;6.1(b)(i)</U> of the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>DGCL</B>. &#147;<U>DGCL</U>&#148; shall mean the Delaware
General Corporation Law, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Dissenting Shares</B>. &#147;<U>Dissenting Shares</U>&#148; is defined in
<U>Section</U><U></U><U>&nbsp;1.5</U> of the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>DOJ</B>. &#147;<U>DOJ</U>&#148; shall mean the U.S. Department of Justice.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>DPA</B>. &#147;<U>DPA</U>&#148; shall mean Section&nbsp;721 of the U.S. Defense Production Act of 1950, as amended, including all
implementing regulations thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Effective Time</B>. &#147;<U>Effective Time</U>&#148; is defined in
<U>Section</U><U></U><U>&nbsp;1.2(b)</U> of the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Employee Plan</B>. &#147;<U>Employee Plan</U>&#148; shall mean any (a)
&#147;employee benefit plan&#148; as defined in Section&nbsp;3(3) of ERISA (whether or not subject to ERISA), (b)&nbsp;bonus, vacation, deferred compensation, incentive compensation, stock purchase, stock option, other equity or equity-based plan,
severance pay, termination pay, death and disability benefits, hospitalization, medical, life or other insurance benefits (including any self-insured arrangement), medical, dental, vision, prescription or fringe benefits, flexible benefits,
supplemental unemployment benefits, profit-sharing, pension or retirement plan, policy, program, agreement or arrangement, and (c)&nbsp;employment, consulting, separation, severance, change in control, retention, transaction or similar agreement,
and (d)&nbsp;each other employee benefit plan, program or arrangement, in each case of <U>clauses (a)</U>&nbsp;through <U>(d)</U>, (i) that is&nbsp;sponsored, maintained, contributed to or required to be contributed to by any of the Acquired
Corporations for the current or future benefit of any current or former employee, officer or director of any of the Acquired Corporations, (ii)&nbsp;that provides benefits to or compensation to any current or former employee, officer or director of
any of the Acquired Corporations, (iii)&nbsp;with respect to which any Acquired Corporation has any direct or indirect liability (whether current, contingent, or otherwise) or (iv)&nbsp;to which any Acquired Corporation is a party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Encumbrance</B>. &#147;<U>Encumbrance</U>&#148; shall mean any lien, pledge, hypothecation, mortgage, security interest, encumbrance,
option to purchase, easement, claim, right of first refusal or first offer, preemptive right or similar restriction of any nature, in each case other than licenses with respect to Intellectual Property Rights and transfer restrictions under
applicable securities laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>End Date</B>. &#147;<U>End Date</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;8.1(b)</U> of the
Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Entity</B>. &#147;<U>Entity</U>&#148; shall mean any corporation (including any <FONT
STYLE="white-space:nowrap">non-profit</FONT> corporation), general partnership, limited partnership, limited liability partnership, joint venture, estate, trust, company (including any company limited by shares, limited liability company or joint
stock company), firm, society or other enterprise, association, organization or entity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Environmental Law</B>. &#147;<U>Environmental
Law</U>&#148; shall mean any federal, state, local or foreign Legal Requirement relating to pollution or protection of human health, worker health or the protection, preservation or restoration of the environment (including ambient air, surface
water, ground water, land surface or subsurface strata), including any law or regulation relating to emissions, discharges, Releases or threatened Releases of Hazardous Materials, or otherwise relating to the manufacture, processing, distribution,
use, treatment, storage, disposal, transport or handling of Hazardous Materials. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Equity Award Consideration</B>. &#147;<U>Equity Award
Consideration</U>&#148; shall mean the aggregate payments to the holders of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">In-the-Money</FONT></FONT> Company Options Company RSU Awards and Company PSU Awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>ERISA</B>. &#147;<U>ERISA</U>&#148; shall mean the Employee Retirement Income Security Act of 1974, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>European Regulators</B>. &#147;<U>European Regulators</U>&#148; shall mean national competent authorities in each European Union member
state as well as all applicable notified bodies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Exchange Act</B>. &#147;<U>Exchange Act</U>&#148; shall mean the Securities Exchange
Act of 1934, as amended, and the rules and regulations promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Exchange Agent</B>. &#147;<U>Exchange Agent</U>&#148;
is defined in <U>Section</U><U></U><U>&nbsp;1.4(a)</U> of the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Excluded Shares</B>. &#147;<U>Excluded Shares</U>&#148; is
defined in <U>Section</U><U></U><U>&nbsp;1.3(a)(iii)</U> of the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>FDA</B>. &#147;<U>FDA</U>&#148; shall mean the United
States Food and Drug Administration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Fraud</B>. &#147;<U>Fraud</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;8.2</U> of the
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>FTC</B>. &#147;<U>FTC</U>&#148; shall mean the U.S. Federal Trade Commission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>GAAP</B>. &#147;<U>GAAP</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;3.4(b)</U> of the Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>GMP</B>. &#147;<U>GMP</U>&#148; shall mean the applicable good manufacturing practices for medical devices as implemented by a Regulatory
Authority similar to those articulated in ISO 13485, or that has adopted ISO 13485, as in effect at the time of manufacture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Good
Clinical Practices</B>. &#147;<U>Good Clinical Practices</U>&#148; shall mean regulations issued by any Regulatory Authority pertaining to the design, conduct, performance, monitoring, auditing, recording, analysis, human subjects protection,
patient informed consent, and reporting of clinical trials. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Government Funded IP</B>. &#147;<U>Government Funded IP</U>&#148; is defined in
<U>Section</U><U></U><U>&nbsp;3.8(g)</U> of the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Government Official</B>. &#147;<U>Government Official</U>&#148; refers to
(i)&nbsp;any public or elected official, officer, employee (regardless of rank), or person acting on behalf of a national, provincial, or local government, department, agency, instrumentality, state-owned or state-controlled company, public
international organization, or political party and (ii)&nbsp;any candidate for political office. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Governmental Authorization</B>.
&#147;<U>Governmental Authorization</U>&#148; shall mean any approval, permit, license, certificate, franchise, permission, clearance, consent, registration, qualification or authorization issued, granted, given or otherwise made available by or
under the authority of any Governmental Body. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Governmental Body</B>. &#147;<U>Governmental Body</U>&#148; shall mean any:
(a)&nbsp;nation, state, commonwealth, province, territory, county, municipality, district or other jurisdiction of any nature; (b)&nbsp;national, supranational, European Union, federal, state, local, municipal, foreign or other government; or
(c)&nbsp;governmental or quasi-governmental authority of any nature (including European Union and United Kingdom supervisory authorities), including any governmental division, department, agency, commission, instrumentality, organization, unit or
body and any court, arbitrator or other tribunal, including, for the avoidance of doubt, any taxing or similar authority responsible for the imposition, administration or collection of any tax, in each case with competent jurisdiction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Hazardous Materials</B>. &#147;<U>Hazardous Materials</U>&#148; shall mean any waste, material, or substance that is listed, regulated or
defined as hazardous, toxic, a pollutant, a contaminant or words of similar import under any Environmental Law and includes any pollutant, chemical substance, hazardous substance, hazardous waste, special waste, solid waste, asbestos, radioactive
material, polychlorinated biphenyls, <FONT STYLE="white-space:nowrap">per-</FONT> and polyfluoroalkyl substances, petroleum or petroleum-derived substance or waste. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Health Canada</B>. &#147;<U>Health Canada</U>&#148; shall mean the Governmental Body responsible for regulating medical devices in Canada.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>HIPAA</B>. &#147;<U>HIPAA</U>&#148; the U.S. Health Insurance Portability and Accountability Act of 1996, as amended by the U.S.
Health Information Technology for Economic and Clinical Health Act of 2009, including the regulations promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>HSA</B>.
&#147;<U>HSA</U>&#148; shall mean the Health Sciences Authority in Singapore. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>HSR Act</B>. &#147;<U>HSR Act</U>&#148; shall mean the
Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Improvements</B>. &#147;<U>Improvements</U>&#148; shall mean the
buildings, structures and fixtures within or upon the Leased Real Property. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">In-the-Money</FONT></FONT> Company Option</B>. &#147;<U><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">In-the-Money</FONT></FONT> Company Option</U>&#148; is defined in
<U>Section</U><U></U><U>&nbsp;1.6(a)</U> of the Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Indebtedness</B>. &#147;<U>Indebtedness</U>&#148; shall mean (i)&nbsp;any indebtedness
for borrowed money (including the issuance of any debt security) to any Person, (ii)&nbsp;obligations relating to leases classified as capital or financial leases in financial statements in accordance with GAAP, (iii)&nbsp;any obligations evidenced
by notes, bonds, debentures or similar Contracts to any Person other than the Company, (iv)&nbsp;any obligations in respect of letters of credit and bankers&#146; acceptances, (v)&nbsp;all liabilities for any deferred and unpaid purchase price of
assets, property, securities, or services, including all <FONT STYLE="white-space:nowrap">earn-out</FONT> payments, seller notes, and other similar payments (whether contingent or otherwise) calculated as the maximum amount payable under or pursuant
to such obligation, (vi)&nbsp;interest rate swap, forward contract, currency or other hedging arrangements, to the extent payable if terminated, or (vii)&nbsp;any guaranty of any such obligations described in <U>clauses (i)</U>&nbsp;through
<U>(vi)</U> of any Person other than the Acquired Corporations (other than, with respect to each of the foregoing clauses, accounts payable to trade creditors and accrued expenses, in each case, arising in the ordinary course of business). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Indemnified Persons</B>. &#147;<U>Indemnified Persons</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;6.5(a)</U> of the Agreement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Intellectual Property Rights</B>. &#147;<U>Intellectual Property Rights</U>&#148; shall mean any and all intellectual property and
industrial property rights of every kind and description throughout the world, including all U.S. and foreign (i)&nbsp;patents and patent applications, including all provisionals, nonprovisionals, continuations, <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">continuations-in-part,</FONT></FONT> divisionals, reissues, extensions, <FONT STYLE="white-space:nowrap">re-examinations,</FONT> substitutions, and extensions thereof and the equivalents of any of the foregoing in any
jurisdiction (&#147;<U>Patents</U>&#148;), (ii)&nbsp;trademarks, service marks, trade names, logos, slogans, trade dress, design rights, domain names and other similar designations of source or origin, whether or not registered and applications and
registrations for, and all goodwill associated with, the foregoing (&#147;<U>Trademarks</U>&#148;), (iii)&nbsp;copyrights and applications and registrations for the foregoing (&#147;<U>Copyrights</U>&#148;), and (iv)&nbsp;Trade Secrets, including
confidential and proprietary <FONT STYLE="white-space:nowrap">know-how,</FONT> inventions, processes, formulae, models, methodologies, specifications, including manufacturing information and processes, assays, engineering and other manuals and
drawings, standard operating procedures, regulatory, chemical, pharmacological, toxicological, pharmaceutical, physical and analytical, safety, quality assurance, quality control and clinical data and similar data and information, and
(v)&nbsp;rights in software, database rights and industrial property rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Insurance Policies. </B>&#147;<U>Insurance
Policies</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;3.19</U> of the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Intervening Event</B>. &#147;<U>Intervening
Event</U>&#148; shall mean any event, occurrence, circumstance, change or effect that materially affects the business, assets, operations, financial condition or results of operations of the Acquired Corporations, taken as a whole (other than any
event, occurrence, circumstance, change or effect primarily resulting from or arising out of a breach of this Agreement by the Company) occurring or arising after the date of this Agreement that was neither known to the Board of Directors nor
reasonably foreseeable as of the date of this Agreement, which event, occurrence, circumstance, change or effect becomes known to the Board of Directors prior to the Effective Time, other than (i)&nbsp;changes in the Share price, in and of itself,
(ii)&nbsp;the announcement or pendency of this Agreement or the Transactions, (iii)&nbsp;any Acquisition Proposal or (iv)&nbsp;the fact that, in and of itself, the Company exceeds any internal or published projections, estimates or expectations of
the Company&#146;s revenue, earnings or other financial performance or results of operations for any period; <I>provided</I>, however, that the underlying reasons for such events described in <U>clauses (i)</U>&nbsp;and <U>(iv)</U> may constitute an
Intervening Event). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IRS</B>. &#147;<U>IRS</U>&#148; shall mean the U.S. Internal Revenue Service. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Key Employee</B>. &#147;<U>Key Employee</U>&#148; shall mean an employee of any Acquired Corporation at a level of vice president or above.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>knowledge</B>. &#147;<U>knowledge</U>&#148; with respect to an Entity shall mean with respect to any matter in question the actual
knowledge, after reasonable inquiry of their direct reports, of such Entity&#146;s executive officers (or where such Entity is the Company, the executive officers set forth on Section A of the Company Disclosure Schedule). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Labor Organization</B>. &#147;<U>Labor Organization</U>&#148; shall mean any labor or trade union, labor organization, works council or
other employee representative body. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Leased Real Property</B>. &#147;<U>Leased Real Property</U>&#148; is defined in
<U>Section</U><U></U><U>&nbsp;3.7(b)</U> of the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Leases</B>. &#147;<U>Leases</U>&#148; shall mean all leases, subleases,
licenses and occupancy agreements, including all amendments thereto, pursuant to which any of the Acquired Corporations holds or occupies any Leased Real Property. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Legal Proceeding</B>. &#147;<U>Legal Proceeding</U>&#148; shall mean any action, suit, complaint, claim, demand, charge, litigation,
arbitration, audit, proceeding (including any civil, criminal, administrative, investigative or appellate proceeding), hearing, or governmental or regulatory investigation or inquiry, in each case, commenced, brought, conducted or heard by or before
any Governmental Body or any arbitrator. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Legal Requirement</B>. &#147;<U>Legal Requirement</U>&#148; shall mean any national,
supranational, EU, federal, state, local, municipal or foreign law, statute, constitution, resolution, ordinance, common law, injunction, award, code, edict, decree, order, rule, regulation, ruling or requirement issued, enacted, adopted,
promulgated, implemented or otherwise put into effect by or under the authority of any Governmental Body (or under the authority of Nasdaq or another stock exchange) or Regulatory Authority, including all approval, reporting, and GMP standards (or
authoritative similar standards or guidelines) of any Regulatory Authority, as well as Custom&nbsp;&amp; Trade Control Laws, Sanctions, the Foreign Corrupt Practices Act, and other Anti-Corruption Laws, and Antitrust Laws, <I>provided</I>,
<I>however</I>, that with respect to Antitrust Laws, only those related to a Requisite Regulatory Approval. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Material Adverse
Effect</B>. &#147;<U>Material Adverse Effect</U>&#148; shall mean any event, occurrence, circumstance, change or effect which, individually or when taken together with all other events, occurrences, circumstances, changes or effects, has had or
would reasonably be expected to have a material adverse effect on the business, assets, financial condition or results of operations of the Acquired Corporations, taken as a whole; <I>provided</I>,<I> however</I>, that none of the following shall be
deemed to constitute or be taken into account in determining whether there has been, or would reasonably be expected to be, a Material Adverse Effect: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any change in the market price or trading volume of the Company&#146;s stock or change in the Company&#146;s
credit ratings; <I>provided</I> that the underlying causes of any such change may be considered in determining whether a Material Adverse Effect has occurred to the extent not otherwise excluded by another exception herein; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any event, occurrence, circumstance, change or effect resulting from the execution, announcement, pendency or
performance of the Transactions, including the impact thereof on the relationships, contractual or otherwise, of the Company or other Acquired Corporations with any employees, Labor Organization, financing sources, customers, distributors,
suppliers, partners, Governmental Bodies or other business relationships (other than for purposes of any representation or warranty contained in, or the condition in Section&nbsp;7.2(a) to the extent relating to any representation or warranty
contained in, <U>Section</U><U></U><U>&nbsp;3.22</U>, <U>Section</U><U></U><U>&nbsp;3.8(d)</U> or <U>Section</U><U></U><U>&nbsp;3.8(l)</U>); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any event, occurrence, circumstance, change or effect generally affecting the industries in which the Acquired
Corporations operate or in the economy generally or other general business, financial or market conditions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any event, occurrence, circumstance, change or effect arising directly or indirectly from or otherwise relating
to general changes in the financial, credit, banking, securities or capital markets in the United States or any other country or region in the world (including any disruption thereof and any decline in the price of any market index) and including
changes or developments in or relating to currency exchange or interest rates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any event, occurrence, circumstance, change or effect arising directly or indirectly from or otherwise relating
to any political, social or regulatory conditions (or changes in such conditions) in the United States or any other country or region in the world, act of terrorism, cyberterrorism, ransomware or malware, war, national or international calamity,
natural disaster, acts of god, weather or environmental event, epidemic, pandemic, or any other similar event, or any escalation or worsening of any of the foregoing, or any action taken by any Governmental Body in response to any of the foregoing;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(vi)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the failure of the Company to meet internal or analysts&#146; expectations or projections; <I>provided</I> that
the underlying causes of such failure may be considered in determining whether a Material Adverse Effect has occurred to the extent not otherwise excluded by another exception herein; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(vii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any event, occurrence, circumstance, change or effect arising from any action taken by any Acquired Corporation
at the written direction or request of Parent or with Parent&#146;s written consent, or any action required or specifically permitted to be taken by any Acquired Corporation pursuant to this Agreement; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(viii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any event, occurrence, circumstance, change or effect resulting or arising from the identity of, or any facts
or circumstances relating to, Parent, Merger Sub or any of their respective Affiliates, including the impact thereof on the relationships, contractual or otherwise, of the Acquired Corporations with any employees, Labor Organization, financing
sources, customers, distributors, suppliers, partners, Governmental Bodies or other business relationships; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ix)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any event, occurrence, circumstance, change or effect arising directly or indirectly from or otherwise relating
to any change in, or any compliance with or action taken for the purpose of complying with any change in, any Legal Requirement or GAAP (or interpretations or enforcement of any Legal Requirement or GAAP); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(x)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any event, occurrence, circumstance, change or effect resulting or arising from any actual or potential
sequester, stoppage, shutdown, default or similar event or occurrence by or involving any Governmental Body affecting a national or federal government as a whole; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(xi)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any event, occurrence, circumstance, change or effect resulting or arising from changes in anti-dumping
actions, international tariffs, trade policies, sanctions, Legal Requirements, or any &#147;trade wars&#148;; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(xii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any event, occurrence, circumstance, change or effect resulting or arising from any Stockholder Litigation; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(xiii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any event, occurrence, circumstance, change or effect resulting or arising from any breach by Parent or Merger
Sub of this Agreement; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(xiv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any event, occurrence, circumstance, change or effect resulting or arising from any matter disclosed in Section
B of the Company Disclosure Schedule; </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>provided</I> that if any event, occurrence, circumstance, change or effect referred to in the
foregoing <U>clauses (iii)</U>, <U>(iv)</U>, <U>(v)</U>, (<U>ix</U>), <U>(x)</U> and <U>(xi)</U>&nbsp;has had, or would be reasonably expected to have, a disproportionate and adverse effect on the Acquired Corporations, taken as a whole, relative to
other medical device companies in similar geographies in which the Acquired Corporations operate, then the incremental disproportionate adverse effect (and only the incremental disproportionate adverse effect) may be taken into account in
determining whether a Company Material Adverse Effect has occurred. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Material Contract</B>. &#147;<U>Material Contract</U>&#148; is
defined in <U>Section</U><U></U><U>&nbsp;3.9(a)</U> of the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Maximum Amount.</B> &#147;<U>Maximum Amount</U>&#148; is defined
in <U>Section</U><U></U><U>&nbsp;6.5(b)</U> of the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Merger</B>. &#147;<U>Merger</U>&#148; is defined in <U>Recital
(A)</U>&nbsp;to the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Merger Consideration</B>. &#147;<U>Merger Consideration</U>&#148; is defined in <U>Recital
(A)</U>&nbsp;to the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Merger Sub</B>. &#147;<U>Merger Sub</U>&#148; is defined in the preamble to the Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Merger Sub Sole Stockholder Approval</B>. &#147;<U>Merger Sub Sole Stockholder Approval</U>&#148; is defined in <U>Recital (D)</U>&nbsp;to
the Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>MFDS</B>. &#147;<U>MFDS</U>&#148; shall mean the Ministry of Food and Drug Safety in
South Korea. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>MHRA</B>. &#147;<U>MHRA</U>&#148; shall mean the Medicines and Healthcare products Regulatory Agency in the United
Kingdom. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Nasdaq</B>. &#147;<U>Nasdaq</U>&#148; shall mean The Nasdaq Global Market. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>New Plan</B>.<B> </B>&#147;<U>New Plan</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;6.3(b)</U> of the Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>NMPA</B>. &#147;<U>NMPA</U>&#148; shall mean the National Medical Products Administration in China (formerly, China Food and Drug
Administration). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Notice Period</B>. &#147;<U>Notice Period</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;6.1(b)(i)</U> of the
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Old Plan</B>. &#147;<U>Old Plan</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;6.3(b)</U> of the Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Out-of-the-Money</FONT></FONT></FONT>
Company Option</B>. &#147;<U><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Out-of-the-Money</FONT></FONT></FONT> Company Option</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;1.6(b)</U> of
the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Parent</B>. &#147;<U>Parent</U>&#148;<B><I> </I></B>is defined in the preamble to the Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Parent 401(k) Plan</B>. &#147;<U>Parent 401(k) Plan</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;6.4</U> of the Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Parent Material Adverse Effect</B>. &#147;<U>Parent Material Adverse Effect</U>&#148; shall mean any event, occurrence, circumstance,
change or effect which, individually or when taken together with all other events, occurrences, circumstances, changes or effects, has had, or would reasonably be expected to have, a material adverse effect on, or has materially delayed or impaired,
or would reasonably be expected to materially delay or impair, the ability of Parent or Merger Sub to perform their obligations under this Agreement and consummate the Transactions on or before the End Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Parent Related Parties. </B>&#147;<U>Parent Related Parties</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;8.3(e)</U> of the
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Parent Termination Fee</B>. &#147;<U>Parent Termination Fee</U>&#148; shall mean a cash amount equal to $72,375,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Parties</B>. &#147;<U>Parties</U>&#148; shall mean Parent, Merger Sub, and the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Patents</B>. &#147;<U>Patents</U>&#148; is defined in the definition of Intellectual Property Rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Payment Fund</B>. &#147;<U>Payment Fund</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;1.4(a)</U> of the Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Permitted Encumbrance</B>. &#147;<U>Permitted Encumbrance</U>&#148; shall mean (a)&nbsp;(i) any Encumbrance for Taxes that are not due and
payable and (ii)&nbsp;any Encumbrance for Taxes the validity of which is being contested in good faith by appropriate proceedings and for which appropriate reserves have been established in accordance with GAAP, (b)&nbsp;any Encumbrance representing
the rights of customers, suppliers and subcontractors in the ordinary course of business under the terms of any Contracts to which the relevant Party is a party or bound under general principles of commercial
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or government contract law for amounts not yet due and payable or that are being contested in good faith by appropriate proceedings (including mechanics&#146;, materialmen&#146;s, carriers&#146;,
workmen&#146;s, warehouseman&#146;s, repairmen&#146;s, landlords&#146; and similar Encumbrances granted or which arise in the ordinary course of business and under which there is no default by the Acquired Corporations), (c) any interest or title of
a lessor, sublessor or similar Person under leases, subleases or similar arrangements (other than capital leases) entered into by the Company or its Subsidiaries in the ordinary course of business which does not materially interfere with or impair
the value, use (or contemplated use) or utility of such lease, sublease or similar arrangement, (d)&nbsp;in the case of any Contract, Encumbrances that are restrictions against the transfer or assignment thereof that are included in the terms of
such Contract, (e)&nbsp;in the case of real property, Encumbrances incurred or suffered which, individually or in the aggregate, do not and would not materially impair the use (or contemplated use), utility or value of the applicable real property
or otherwise materially impair the present or contemplated business operations at such location, or zoning, entitlement, building and other land use regulations imposed by Governmental Bodies having jurisdiction over such real property which are not
violated by the current use or occupancy of the Leased Real Property in any material respect, (f)&nbsp;Encumbrances to secure obligations arising under workers&#146; compensation, unemployment insurance and social security Legal Requirements,
(g)&nbsp;Encumbrances reflected in the Company SEC Documents securing indebtedness or liabilities that are reflected in the Company SEC Documents and (h)&nbsp;Encumbrances that do not, individually or in the aggregate, materially impair the existing
use of the assets or property of the Person affected by such Encumbrance or otherwise materially impair business operations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Person</B>. &#147;<U>Person</U>&#148; shall mean any individual, Entity or Governmental Body. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Personal Information</B>. &#147;<U>Personal Information</U>&#148; shall mean (a)&nbsp;any information or data that constitutes
&#147;personal data,&#148; &#147;personal information,&#148; &#147;personally identifiable information,&#148; or any comparable term under any Data Privacy Laws and (b)&nbsp;any information that can identify, relate to, describe, be associated with,
or be reasonably capable of being associated with a particular individual. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>PMDA</B>. &#147;<U>PMDA</U>&#148; shall mean the
Pharmaceuticals and Medical Devices Agency in Japan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period</B>. &#147;<U><FONT
STYLE="white-space:nowrap">Pre-Closing</FONT> Period</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;5.1</U> of the Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Privacy Requirements</B>. &#147;<U>Privacy Requirements</U>&#148; shall mean all (i)&nbsp;Data Privacy Laws, (ii)&nbsp;internal and
external privacy policies, programs and procedures, (iii)&nbsp;contractual obligations and (iv)&nbsp;applicable industry or nongovernmental regulatory body rules, regulations and standards, in each case of the foregoing <U>clauses</U>
<U>(i)</U><I></I>&nbsp;through <U>(iv)</U>, to the extent relating to (x)&nbsp;data privacy, cybersecurity or the privacy of individuals or (y)&nbsp;the Processing of any Personal Information or other sensitive, regulated or confidential data by or
on behalf of any Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Processing</B>. &#147;<U>Processing</U>&#148; shall mean, in addition to any comparable term under any Data
Privacy Laws, any operation or set of operations which is performed on Personal Information or on sets of Personal Information, whether or not by automated means, such as collection, recording, organization, structuring, storage, adaptation or
alteration, retrieval, consultation, use, disclosure by transmission, dissemination or otherwise making available, alignment or combination, restriction, erasure or destruction. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Proxy Statement</B>. &#147;<U>Proxy Statement</U>&#148; is defined in
<U>Section</U><U></U><U>&nbsp;3.4(g)</U> of the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Qualified Bidder</B>. &#147;<U>Qualified Bidder</U>&#148; means a Person or
group of Persons that has made an Acquisition Proposal after the date hereof (<I>provided</I> that such Acquisition Proposal did not result from a breach of <U>Section</U><U></U><U>&nbsp;5.4</U>) that, prior to the Window Shop End Time, the Board of
Directors has concluded in good faith (after consultation with its outside legal counsel and its financial advisor) either constitutes or could reasonably be expected to lead to or result in a Superior Offer and has notified Parent in writing of
such determination; <I>provided</I>,<I> however</I>, that any such Person (or group of Persons) shall immediately cease to be a Qualified Bidder (and all provisions of this Agreement that apply to Qualified Bidders in their capacity as such shall
cease to apply with respect to such Person (or group of Persons)) immediately upon the expiration in accordance with its terms, or withdrawal, of any Acquisition Proposal submitted by such Person (or group of Persons). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Registered IP</B>. &#147;<U>Registered IP</U>&#148; shall mean all Patents, Trademarks and Copyrights that are registered or issued under
the authority of any Governmental Body, and all applications for any of the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Regulatory Authority</B>. &#147;<U>Regulatory
Authority</U>&#148; shall mean the FDA, NMPA, PMDA, European Regulators, Health Canada, MHRA, MFDA, CDSCO, MFDS, and HSA, and all other Governmental Bodies with jurisdiction over the clearance, approval, licensure, registration, importation,
distribution, marketing, or sale of medical devices. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Release</B>. &#147;<U>Release</U>&#148; shall mean any presence, emission, spill,
seepage, leak, escape, leaching, discharge, injection, pumping, pouring, emptying, dumping, disposal, migration, or release of Hazardous Materials from any source into or upon the environment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Remedy Action.</B> &#147;<U>Remedy Action</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;6.2(b)</U> of the Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Representatives</B>. &#147;<U>Representatives</U>&#148; shall mean officers, directors, employees, attorneys, accountants, investment
bankers, consultants, agents, financial advisors, other advisors and other representatives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Requisite Regulatory Approvals</B>.
&#147;<U>Requisite Regulatory Approvals</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;7.1(c)</U> of the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Restricted
Person</B>. &#147;<U>Restricted Person</U>&#148; shall mean any person or entity identified on the U.S. Department of Commerce&#146;s Denied Persons List, Unverified List or Entity List or the U.S. Department of State&#146;s Debarred List. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Rights Share</B>. &#147;<U>Rights Share</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;1.3(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Sanctioned Person</B>. &#147;<U>Sanctioned Person</U>&#148; shall mean any Person that is the target of Sanctions, including, (a)&nbsp;any
Person listed in any Sanctions-related list of designated Persons maintained by the Office of Foreign Assets Control of the U.S. Department of the Treasury or the U.S. Department of State, the United Nations Security Council, the European Union, any
EU member state or His Majesty&#146;s Treasury of the United Kingdom, (b)&nbsp;any Person located, organized or resident in a Sanctioned Territory or (c)&nbsp;any Person, directly or indirectly, owned or controlled by any such Person or Persons
described in the foregoing clauses (a)&nbsp;and (b) so as to subject the person to Sanctions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Sanctioned Territory. </B>&#147;<U>Sanctioned Territory</U>&#148; shall mean, at any
time, a country or territory which in the last five (5)&nbsp;years is or has been itself the subject or target of any country-wide or territory-wide Sanctions (at the time of this Agreement, Cuba, Iran, North Korea, the Crimea, <FONT
STYLE="white-space:nowrap">so-called</FONT> Donetsk People&#146;s Republic, <FONT STYLE="white-space:nowrap">so-called</FONT> Luhansk People&#146;s Republic regions of Ukraine, and the <FONT STYLE="white-space:nowrap">non-government</FONT>
controlled areas of the Kherson and Zaporizhzhia oblasts of Ukraine). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Sanctions</B>. &#147;<U>Sanctions</U>&#148; shall mean economic
or financial sanctions or trade embargoes imposed, administered or enforced from time to time by the U.S. government (including through the Office of Foreign Assets Control of the U.S. Department of the Treasury or the U.S. Department of State), the
United Nations Security Council, the European Union, any EU member state, His Majesty&#146;s Treasury of the United Kingdom, or any other relevant Governmental Body with regulatory authority over a jurisdiction in which the Acquired Corporations
operate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Sarbanes-Oxley Act</B>. &#147;<U>Sarbanes-Oxley Act</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;3.4(a)</U> of the
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SEC</B>. &#147;<U>SEC</U>&#148; shall mean the United States Securities and Exchange Commission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SEC Clearance Date</B>. &#147;<U>SEC Clearance Date</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;5.3(a)</U> of the Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Securities Act</B>. &#147;<U>Securities Act</U>&#148; shall mean the Securities Act of 1933, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Shares</B>. &#147;<U>Shares</U>&#148; is defined in <U>Recital (A)</U>&nbsp;to the Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Specified Agreement</B>. &#147;<U>Specified Agreement</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;8.1(e)</U> of the Agreement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Specified Governmental Body.</B> &#147;<U>Specified Governmental Body</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;7.1(b)</U>
of the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Stockholder Litigation</B>. &#147;<U>Stockholder Litigation</U>&#148; shall mean any Legal Proceeding asserted,
threatened or commenced against the Company or any of its directors or officers in such individual&#146;s capacity as such by any stockholder of the Company (in its capacity as such or through a derivative action) relating to this Agreement or the
Transactions. For the avoidance of doubt, any Legal Proceeding asserted, threatened or commenced by Parent, Merger Sub or their Affiliates shall not constitute Stockholder Litigation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Stockholder Meeting</B>. &#147;<U>Stockholder Meeting</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;5.3(a)</U> of the Agreement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Subsidiary</B>. An Entity shall be deemed to be a &#147;<U>Subsidiary</U>&#148; of another Person if such Person directly or
indirectly owns (a)&nbsp;an amount of voting securities or other interests in such Entity that is sufficient to enable such Person to elect at least a majority of the members of such Entity&#146;s board of directors or other governing body, or
(b)&nbsp;at least 50% of the outstanding equity, partnership or other similar ownership interests of such Entity. For purposes hereof, a Person or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Persons shall be deemed to have a majority ownership interest in a partnership, association, limited liability company or other business entity if such Person or Persons are allocated a majority
of partnership, association, limited liability company or other business entity gains or losses or otherwise control the managing director, managing member, general partner or other managing Person of such partnership, association, limited liability
company or other business entity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Superior Offer</B>. &#147;<U>Superior Offer</U>&#148; shall mean a <I>bona fide</I> written
Acquisition Proposal received after the date of this Agreement that the Board of Directors determines, in its good faith judgment, after consultation with outside legal counsel and its financial advisors, is reasonably likely to be consummated in
accordance with its terms, taking into account all legal, regulatory and financing aspects (including certainty of closing) of the proposal and the Person making the proposal and other aspects of the Acquisition Proposal that the Board of Directors
deems relevant, and if consummated, would result in a transaction more favorable to the Company&#146;s stockholders (solely in their capacity as such) from a financial point of view than the Transactions (including after giving effect to proposals,
if any, made by Parent pursuant to <U>Section</U><U></U><U>&nbsp;6.1(b)(i)</U>); <I>provided</I> that for purposes of the definition of &#147;Superior Offer&#148; in all cases, the references to &#147;20%&#148; in the definition of Acquisition
Proposal shall be deemed to be references to &#147;50%&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Surviving Corporation</B>. &#147;<U>Surviving Corporation</U>&#148; is
defined in <U>Recital (A)</U>&nbsp;to the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Swiss VAT. </B>&#147;<U>Swiss VAT</U>&#148; shall mean the Swiss Federal Value
Added Tax (<I>Mehrwertsteuer</I>). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Takeover Laws</B>. &#147;<U>Takeover Laws</U>&#148; shall mean any &#147;moratorium,&#148;
&#147;control share acquisition,&#148; &#147;fair price,&#148; &#147;supermajority,&#148; &#147;affiliate transactions,&#148; or &#147;business combination statute or regulation&#148; or other similar state anti-takeover laws and regulations
(including, for the avoidance of doubt, Section&nbsp;203 of the DGCL). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Tax</B>. &#147;<U>Tax</U>&#148; shall mean any U.S. federal,
state, or local, or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> tax (including any net income tax, gross income tax, franchise tax, capital gains tax, capital stock tax, gross receipts tax, gross profits tax, branch profits tax, value-added
tax, surtax, estimated tax, premium tax, windfall profit tax, environmental tax, license tax, occupation tax, employment tax, unemployment tax, national health insurance tax, social security tax, disability tax, excise tax, estimated tax,
alternative or minimum tax, ad valorem tax, transfer tax, registration tax, stamp tax, sales tax, use tax, service tax, property tax, business tax, withholding tax, payroll tax, Swiss Federal Withholding Tax (<I>Verrechnungssteuer</I>) or Swiss
Federal Value Added Tax (<I>Mehrwertsteuer</I>)), <FONT STYLE="white-space:nowrap">add-on</FONT> minimum tax, custom, impost, tariff, duty, levy, assessment, or other tax or charge in the nature of a tax, imposed, assessed or collected by or under
the authority of any Governmental Body, together with any interest, penalties, surcharges or additions to tax with respect thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Tax Return</B>. &#147;<U>Tax Return</U>&#148; shall mean any return (including any information return), report, statement, declaration,
estimate, schedule, form, election, certificate, claim, refund or other document or information filed or required to be filed with any Governmental Body in connection with the determination, assessment, collection or payment of any Tax and any
attachments thereto or amendments thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Termination Fee</B>. &#147;<U>Termination Fee</U>&#148; shall mean a cash amount equal to
$43,425,000; <I>provided</I> that in the event the Termination Fee becomes payable as a result of the termination of this Agreement (x)&nbsp;by the Company pursuant to <U>Section</U><U></U><U>&nbsp;8.1(e)</U> with respect to a Superior Offer from a
Qualified Bidder or (y)&nbsp;by Parent pursuant to <U>Section</U><U></U><U>&nbsp;8.1(d)</U> in response to a Company Adverse Recommendation Change with respect to a Superior Offer from a Qualified Bidder, then in the case of either of the
immediately preceding clauses (x)&nbsp;or (y), the Termination Fee shall be $14,475,000. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Top Distributor.</B> &#147;<U>Top
Distributor</U>&#148; shall mean a top ten (10)&nbsp;distributor of the Acquired Corporations, taken as a whole, based on revenues during the fiscal year ended December&nbsp;27, 2024. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Top Supplier.</B> &#147;<U>Top Supplier</U>&#148; shall mean a top ten (10)&nbsp;supplier of raw materials, inventory or manufacturing
services to the Acquired Corporations, taken as a whole, based on expenditures during the fiscal year ended December&nbsp;27, 2024. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Trade Secret</B>. &#147;<U>Trade Secret</U>&#148; shall mean any confidential and proprietary information that constitutes a trade secret
under any applicable Legal Requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Trademarks</B>. &#147;<U>Trademarks</U>&#148; is defined in the definition of Intellectual
Property Rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Transactions</B>. &#147;<U>Transactions</U>&#148; shall mean (a)&nbsp;the execution and delivery of the Agreement and
(b)&nbsp;all of the transactions contemplated by the Agreement, including the Merger. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Transfer Regulations. </B>&#147;<U>Transfer
Regulations</U>&#148; shall mean (a)&nbsp;any regulation implementing the Acquired Rights Directive 2001/23/EC, (b)&nbsp;the United Kingdom Transfer of Undertaking (Protection of Employment) Regulations 2006 (as amended) and (c)&nbsp;any equivalent
automatic transfer regulations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Ultimate Parent</B>. &#147;<U>Ultimate Parent</U>&#148; means Alcon Inc., a corporation
(soci&eacute;t&eacute; anonyme) organized under the laws of Switzerland. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Voting Company Debt</B>. &#147;<U>Voting Company
Debt</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;3.3(b)</U> of the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WARN</B>. &#147;<U>WARN</U>&#148; is defined
in <U>Section</U><U></U><U>&nbsp;3.17(n)</U> of the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Willful Breach</B>. &#147;<U>Willful Breach</U>&#148; is defined in
<U>Section</U><U></U><U>&nbsp;8.2</U> of the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Window Shop End Time</B>. &#147;<U>Window Shop End Time</U>&#148; means 11:59
p.m. (New York time) on September&nbsp;19, 2025. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g54875dsp05.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Alcon Agrees to Acquire STAAR Surgical </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><B>&#149;</B></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>STAAR Surgical is a leader in refractive surgery using Implantable Collamer Lenses, offering solutions for
moderate to high myopes </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><B>&#149;</B></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Acquisition of STAAR is complementary to Alcon&#146;s laser vision correction business and is expected to be
accretive in year two </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><B>&#149;</B></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Alcon to purchase all outstanding shares of STAAR for $28 per share in cash, valuing STAAR at approximately
$1.5&nbsp;billion in equity value </B></P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Ad Hoc Announcement Pursuant to Art. 53 LR </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>GENEVA and LAKE FOREST, CA, Aug 5, 2025 &#150; </B>Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and
STAAR Surgical Company (NASDAQ: STAA), the manufacturer of the Implantable Collamer<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Lens (ICL), today announced the companies have entered into a definitive merger agreement through which
Alcon intends to acquire STAAR. The acquisition includes the EVO family of lenses (EVO ICL<SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP>) for vision correction for patients with moderate to high myopia (nearsightedness), with or without
astigmatism. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the terms of the agreement, Alcon will purchase all outstanding shares of STAAR common stock for $28 per share in cash, which
represents approximately a 59% premium to STAAR&#146;s <FONT STYLE="white-space:nowrap">90-day</FONT> Volume Weighted Average Price (VWAP) and a 51% premium to the closing price of STAAR common stock on August&nbsp;4, 2025. The transaction
represents a total equity value of approximately $1.5&nbsp;billion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;With the number of high myopes rising globally, the acquisition of STAAR
enhances our ability to offer a leading surgical vision correction solution for those who are not ideal candidates for other refractive surgeries such as LASIK,&#148; said David Endicott, CEO of Alcon. &#147;This transaction will allow us to provide
treatment options across the full spectrum of myopia&#151;from contact lenses to surgical interventions&#151;reinforcing our commitment to addressing the most significant needs in eye care.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An estimated 50% of the world will be myopic by 2050 and today nearly 500&nbsp;million people are considered high myopes.<SUP
STYLE="font-size:75%; vertical-align:top">1</SUP> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With its innovative design, the EVO family of ICLs are implantable lenses that address a wide range of
vision correction needs, including myopia with and without astigmatism, through a minimally invasive procedure that is reversible. The EVO family of ICLs are implanted between the iris (the colored part of the eye) and the natural crystalline lens
during a procedure that does not remove corneal tissue. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We believe the transaction with Alcon represents the best path forward and provides the
greatest value for STAAR shareholders,&#148; said Stephen Farrell, CEO of STAAR. &#147;As we&#146;ve shared, fluctuating demand in China over the past two years has continued to create significant headwinds for STAAR as a standalone company.
I&#146;m proud of our team&#146;s efforts to address recent challenges, but there is more work to do. As a significantly larger company, Alcon has the capabilities and scale to accelerate EVO ICL adoption and bring our innovative technology to more
surgeons and patients worldwide.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Elizabeth Yeu, Chair of the STAAR Board of Directors, said, &#147;The STAAR Board is committed to
maximizing value for shareholders. We have determined that this carefully negotiated transaction is in the best interest of STAAR shareholders as it delivers immediate and certain value at a significant premium, value that exceeds what we believe
could be achieved under STAAR&#146;s standalone strategy.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The transaction is not subject to a financing condition. Alcon intends to finance the
transaction through the issuance of short- and long-term credit facilities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The transaction is anticipated to close in approximately six to 12 months,
subject to customary closing conditions, including regulatory approval and approval by STAAR&#146;s shareholders. The transaction is expected to be accretive to earnings in year two. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Boards of Directors of Alcon and STAAR have each unanimously approved the transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Morgan Stanley&nbsp;&amp; Co. LLC is serving as financial advisor to Alcon, and Gibson, Dunn&nbsp;&amp; Crutcher LLP is serving as legal advisor to Alcon.
Citi is serving as the exclusive financial advisor to STAAR, and Wachtell, Lipton, Rosen&nbsp;&amp; Katz is serving as legal advisor to STAAR. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As
previously announced, STAAR will release financial results for its second quarter that ended June&nbsp;27, 2025, on Wednesday, August&nbsp;6, 2025, after the market close. Given the pending acquisition by Alcon, STAAR will not host a conference call
in conjunction with earnings. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Forward-looking Statements </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release contains &#147;forward-looking statements&#148; within the meaning of the Private Securities Litigation Reform Act of 1995. All statements
contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding the potential transaction between Alcon and STAAR and the expected
timing, impacts and benefits thereof, Alcon&#146;s and STAAR&#146;s business strategies, performance, market adoption and estimates of market size. In some cases, you can identify forward-looking statements by terms such as &#147;aim,&#148;
&#147;anticipate,&#148; &#147;approach,&#148; &#147;believe,&#148; &#147;contemplate,&#148; &#147;could,&#148; &#147;estimate,&#148; &#147;expect,&#148; &#147;goal,&#148; &#147;intend,&#148; &#147;look,&#148; &#147;may,&#148; &#147;mission,&#148;
&#147;plan,&#148; &#147;possible,&#148; &#147;potential,&#148; &#147;predict,&#148; &#147;project,&#148; &#147;pursue,&#148; &#147;should,&#148; &#147;target,&#148; &#147;will,&#148; &#147;would,&#148; or the negative thereof and similar words and
expressions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forward-looking statements are based on Alcon&#146;s and STAAR&#146;s management&#146;s current expectations, beliefs and assumptions and on
information currently available to us. Such statements are subject to a number of known and unknown risks, uncertainties and assumptions. The following factors could cause actual results and future events to differ materially from those set forth or
contemplated in the forward-looking statements: (i)&nbsp;the proposed merger may not be completed in a timely manner or at all, including the risk that any required regulatory approvals are not obtained, are delayed or are subject to unanticipated
conditions that could adversely affect STAAR or the expected benefits of the proposed merger or that the approval of STAAR&#146;s stockholders is not obtained; (ii)&nbsp;the failure to realize the anticipated benefits of the proposed merger;
(iii)&nbsp;the possibility that competing offers or acquisition proposals for STAAR will be made; (iv)&nbsp;risks that third parties and/or STAAR stockholders may oppose consummation of the proposed merger on the proposed terms or at all;
(v)&nbsp;the possibility that any or all of the various conditions to the consummation of the merger may not be satisfied or waived (vi)&nbsp;the occurrence of any event, change or other circumstance that could give rise to the termination of the
merger, including in circumstances which would require either party to pay a termination fee; (vii)&nbsp;the effect of the announcement or pendency of the merger on STAAR&#146;s ability to retain and hire key personnel, STAAR&#146;s ability to
retain key customers, suppliers or distributors or its operating results and business generally, (viii)&nbsp;there may be liabilities related to the merger that are not known, probable or estimable at this time or unexpected costs, charges or
expenses; (ix)&nbsp;the merger may result in the diversion of management&#146;s time and attention to issues relating to the merger; (x)&nbsp;there may be significant transaction costs in connection with the merger; (xi)&nbsp;legal proceedings may
be instituted against STAAR following the announcement of the merger, which may have an unfavorable outcome; and (xii)&nbsp;STAAR&#146;s stock price may decline significantly if the merger is not consummated. In addition, a number of other important
factors could cause actual future results and other future circumstances to differ materially from those expressed in any forward-looking statements, including but not limited to those important factors discussed under the heading &#147;Risk
Factors&#148; contained in Alcon&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">20-F</FONT> for the fiscal year ended December&nbsp;31, 2024 and in STAAR&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for
the fiscal year ended December&nbsp;27, 2024, each as filed with the Securities and Exchange Commission (&#147;SEC&#148;), as such factors may be updated from time to time in such company&#146;s other filings with the SEC, accessible on the
SEC&#146;s website at www.sec.gov and the Investor Relations section of STAAR&#146;s website at investors.staar.com and Alcon&#146;s website at investor.alcon.com. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All forward-looking statements are expressly qualified in their entirety by such factors. Except as required by law, neither Alcon nor STAAR undertake any
obligation to publicly update or review any forward-looking statement, whether because of new information, future developments or otherwise. These forward-looking statements should not be relied upon as representing Alcon&#146;s or STAAR&#146;s
views as of any date subsequent to the date of this press release. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>About Alcon </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to
enhance sight and improve people&#146;s lives. Our Surgical and Vision Care products touch the lives of more than 260&nbsp;million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and
refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at www.alcon.com. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>About STAAR Surgical </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">STAAR Surgical (NASDAQ:
STAA) is the global leader in implantable phakic intraocular lenses, a vision correction solution that reduces or eliminates the need for glasses or contact lenses. Since 1982, STAAR has been dedicated solely to ophthalmic surgery, and for 30 years,
STAAR has been designing, developing, manufacturing, and marketing advanced Implantable Collamer<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> Lenses (ICLs), using its proprietary biocompatible Collamer material. STAAR ICL&#146;s are
clinically-proven to deliver safe long-term vision correction without removing corneal tissue or the eye&#146;s natural crystalline lens. Its EVO ICL<SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP> product line provides visual freedom
through a quick, minimally invasive procedure. STAAR has sold more than 3&nbsp;million ICLs in over 75 countries. Headquartered in Lake Forest, California, the company operates research, development, manufacturing, and packaging facilities in
California and Switzerland. For more information about ICL, visit www.EVOICL.com. To learn more about STAAR, visit www.staar.com. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Important Safety
Information for the EVO Family of ICLs </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The EVO Visian ICL Lens is intended for the correction of moderate to high nearsightedness. EVO Visian ICL
and EVO Visian TICL surgery is intended to safely and effectively correct nearsightedness between <FONT STYLE="white-space:nowrap">-3.0</FONT> D to <FONT STYLE="white-space:nowrap">-15.0</FONT> D, the reduction in nearsightedness up to <FONT
STYLE="white-space:nowrap">-20.0</FONT> D and treatment of astigmatism from 1.0 D to 4.0 D. If patients have nearsightedness within these ranges, EVO Visian ICL surgery may improve distance vision without eyeglasses or contact lenses. Because the
EVO Visian ICL corrects for distance vision, it does not eliminate the need for reading glasses, patients may require them at some point, even if they have never worn them before. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Implantation of the EVO Visian ICL is a surgical procedure, and as such, carries potentially serious risks. Patients should discuss the risks with their eye
care professional. Complications, although rare, may include need for additional surgical procedures, inflammation, loss of cells from the back surface of the cornea, increase in eye pressure, and cataracts.<B> </B>For additional information with
potential benefits, risks and complications please visit DiscoverICL.com. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Additional Information </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release may be deemed solicitation material in respect of the proposed acquisition of STAAR. A special stockholder meeting will be announced soon to
obtain stockholder approval in connection with the proposed merger. STAAR expects to file with the SEC a proxy statement and other relevant documents in connection with the proposed merger. Investors of STAAR are urged to read the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
definitive proxy statement and other relevant materials carefully and in their entirety when they become available because they will contain important information about the Company and the
proposed merger. Investors may obtain a free copy of these materials (when they are available) and other documents filed by STAAR with the SEC at the SEC&#146;s website at <U>www.sec.gov</U> and at STAAR&#146;s website at investors.staar.com. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>No Offer or Solicitation </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This communication is
for informational purposes only and is not intended to and does not constitute, or form part of, an offer, invitation or the solicitation of an offer or invitation to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any
securities, or the solicitation of any vote or approval in any jurisdiction, pursuant to the proposed transaction or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Participants in the Solicitation </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Alcon,
STAAR and certain of their respective directors, executive officers and other members of management and employees may be deemed to be participants in soliciting proxies from its stockholders in connection with the proposed merger. Information
regarding Alcon&#146;s directors and executive officers is contained in Alcon&#146;s annual report on Form <FONT STYLE="white-space:nowrap">20-F</FONT> for its fiscal year ended December&nbsp;31, 2024, which was filed with the SEC on
February&nbsp;25, 2025. Information regarding the persons who may, under the rules of the SEC, be considered to be participants in the solicitation of STAAR&#146;s stockholders in connection with the proposed merger will be set forth in STAAR&#146;s
definitive proxy statement for its special stockholder meeting. Additional information regarding these individuals and any direct or indirect interests they may have in the proposed merger will be set forth in the definitive proxy statement when and
if it is filed with the SEC in connection with the proposed merger. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>References </U></B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Brien A Holden at al.
Ophthalmology. 2016 <FONT STYLE="white-space:nowrap">May;123(5):1036-42.</FONT> </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10.5pt; font-family:Times New Roman"><B>Connect with us on &#8195;


<IMG SRC="g54875g0805095346770.jpg" ALT="LOGO">
 &#8195;


<IMG SRC="g54875g0805095347199.jpg" ALT="LOGO">
 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Alcon Investor Relations </U></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Daniel Cravens, Allen Trang </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">+ 41 589 112 110 (Geneva) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">+ 1 817 615 2789 (Fort Worth) </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">investor.relations@alcon.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Alcon Media Relations </U></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Steven Smith </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">+ 41 589 112 111 (Geneva) </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">+ 1 817 551 8057 (Fort Worth) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">globalmedia.relations@alcon.com </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>STAAR Investor&nbsp;&amp; Media Relations </U></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Niko Liu, CFA </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">United States: <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">626-303-7902</FONT></FONT> ext 3023 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Hong Kong: <FONT STYLE="white-space:nowrap">+852-6092-5076</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">nliu@staar.com </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">investorrelations@staar.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Connie Johnson </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">+1 626 303 7902
<FONT STYLE="white-space:nowrap">(x-2207)</FONT> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">cjohnson@staar.com </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g54875dsp05.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g54875dsp05.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 B17AI9@  34T *@    @  0$2  ,
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MKX/@_,88#,UAXS4H5$D_6W](][.,.ZM#VS6L?Q/7O^#:K</^">$Q;_H:[_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@!,8-(1@TZB@!M&-M.HH -M)VI:* $/'_UJ04ZB@ HZT44 )GFC&:6
MB@!O^?K0!@TZB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **,T4 %%% .30 449H% !10#F@<T %%&:* "BBB@
M HH)P*#TH **,\?A10 44$X%&: "BC/-% !111CB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK5HC?9?$6F3,1PKVKIGMQR?K^%9RPLD[G3'CG)I?\OU]S_R/G]B$/1O;WH/
MKVNZ_8,\;0AC#<:+<!1@YE=/YK5"[_8M\?P*RFQT^3;@92\'.?J!2]E/L=E/
MBS**GPUX_BOS1Y&:*](O?V1?B#8J6_X1^291WBGC?_V:L/6?@7XP\/INNO#>
ML(N ?D@\W_T#-0XM.S.ZGG.!J:PJQ?S.3HJU?:)>Z6Q%U97EJ1U$T#1D?@<5
M36:-NDB<=<G&*1VPKTY*\9(=12;L@'YBI/51N_E3MN3\OS?3D_I0:W3T$HI2
MNVD!S^- [!10>O'/X4'K0(**.E!XH"Z"B@G!I-W2@.MA:*** "BBB@ HHHH
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MA7HZ 1?#[PF^T_\ +?3UF_\ 0LUPU/%3 1=X49?.R_4]"EX%9S+6KB(?B_\
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M!^#[B(M9ZIKEN_;$J2+^3+G]:Y75/^">TY=C8^*(2O99[/D?BKG^5?HSK?\
MP3+^,.D_=T73;[WMM4MAG_OME_E7GWBO]E_XB^"9634O!NO0A>"\5J;B/\&C
MW*?SKT\/G64UM*>(C]Z.6>,XRP>E6G4_[>BW^A\#:O\ L$^+K5&>UU#P[=!>
M=AN)(W;Z?NROYFN*\2?LU>.O#!/VCPQJ5PBC_66FVY4_39S^E?>T]M-93[)(
M9H9.059=K#UX/-1K"(9_W:JS=_+93S[X)_6O4IQI5/@DFA4_$3.*'NXF"?JK
M/\6C\X]3\,WVB*PO=-U.R?NMS:R1[?S4?SK.4[A\HX'I7Z5[7@W+M96;K@@$
M?48[US^O?"GPOXF.=0\-Z%?%LEGELTW\XYW!<_J.E5+ R6I[.%\5J=O]HH/U
MC8_/4J<>WK0OS?3UZU]N^(/V0?AWK:-MT*2PD;^.TNI(<?AD@?B#]*X[5_\
M@GUH-R'-CX@U>UD_A\^**Y"?CA,_C6+PLSW\)XD936TG>/JCY2'5N^/2C/\
MG->\^(OV ?$]I)_Q+]:T/5(U/RF9I+69OJF&4'V!Q7$^(_V4?B!X4MI)IO#M
MQ=0QYWO8NESM'NJG<._4=CZ5G[.2/H\+Q/E>(TIUX_?;\SSW- -2WFFW%C.8
MYX)H9%(S')&RR GMM(W9]L<YJ-T\M-S?(H/._P"0_D:GD9[M.4:BYH.Z\A**
M$_>/A<-WX.<4F>:D8M%'>C/- !11GFC.30 44$T4 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11VHS_DT
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M]% #3"":!#CN:=10%AIB!IOV9??\ZDHH ;Y?'6CRO>G446 :$QCGI3AP***
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MH_A71;7R1Q)]G5I&/J20<FN]@A$;?*JJJ\  8Q7Q6/\ %:K)_P"QT;?XG?\
M(_0<L\"5=2S'$7\HK3[V?G?\-_\ @D?XJUZTAF\0ZWI^C^8!NMXE,T@]?FX&
M?:O;/AW_ ,$F_A[X;B']N7&K>(9MV29)?)C(]-J?XU]2Q0, G'\6:LA*^)QG
M&>;XEOFK-+LM#])RSPQX>P=I*@I2766IYSX%_97^'_PYMUCT?PGH]IM.=QB$
MC$^NYLFNZAT^&VA6.*-8XU&%51@ 5=VT;.:^=K8FM5?-5DY/S;?YGVF%R["X
M96P].,%Y)+\BL8UW<'\J=Y?. OY5,4S2A=M8G8,CB^7FG"/!IU% "8YI0,"B
MB@!,<TN.***  #% XHHH * ,444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH ,4WRN>M.HH 88<GK08!3Z*32>X#/)S_$:##D?>I]
M%,"C=V7FR[6^967!W5YW\2OV3OA_\67:XUSPGI-U=E=HN1 (YE'IO7#?K7J&
M#FF,C8^Z/RK:CB*M&7-2DXOR=CCQ67X?$P<,1!23[I,^'?BY_P $@;&^NYKK
MP7X@;2UD+'[)J4;3Q \8Q("&"]>H;].?GCXE?\$__BI\,9I-WAN;6K-" +C2
M&^U*WKA!^\XZG*<]LU^LWDL?X?SI/L:L/F7=GJ,]:^RRWQ S;"I0<E-=I+]3
M\USKP>R#'7E3BZ<N\7I]SN?AK>026-S);S136]Q$Q5HI4994(X(9<<?B<^U,
M(62/:ZJRMU!S_*OV@^)'P'\*?%2R:#7O#NE:HLOREIH%:1!CJK?>!]P:^7_B
MC_P1YT/6&N)_"?B/4M'DD)9;>_Q=P*>RJ1M=5_%C7W^5^)V#JOEQL'"_5:H_
M*<Z\%<UPK]K@)JHNRTE]VQ^8?C?]F7P3X\,\EYHL5K=3#FYL3]GD!]3M&&_X
M$#7B/CS]@?6-/EDFT'5K745C&?L]V/L\P&,C#<KT[G]*_17XI_\ !/3XJ?">
MSFN+C0UUFS3/[[1YOMB@>ICP)!_WR1[UXQ/9RZ;/Y%PLD,Z-ADE4QL#C^Z><
MU]W@<RR[&PYL-4C)>3U^X^.69\1\/R]EB8RC;I)-W7K^MS\\/&OPM\1?#A$.
MN:)J.FK)G9))'NAE [K(N4(_&N>1M\:LK*V[I@C^A-?I888[B)H9562-^7C*
MY1_]X="/8UYC\2_V2?!WQ*=IEL3X?O.1]HTR../=GNT)&QS[\'ISTQU?5;:(
M^PRGQ1I2DJ>-IV\T[K[CXC/!_O<4$XKV[QK^PKXI\/2-)HUQ9Z]:XW!01!<+
M[;'.T_17_.O'_$/A75/"NHR6VJ:?=Z=<*VPI<1&/)_$8_(D>]<KIR6Z9^AY?
MG>!QJOAJBE\_T*-%!5@/7'!QVHSQFIW=CV.5]@HH&/>B@DW/!'PR\0?$BZ\G
M1-(O=0(/S-'&=B?5C\HZ^O%>V_#O]@.\NQ#<>)-8AL5R#):62F1_7#/D 'W&
M:^G;.PAL+18888;>'@+'%&J)& !P  !5BTM)M5N%M[>&2XF<[5CB0LV3V '-
M>A[&E&*E-ZGX)F7B-F.*;I86/(GMU?Y'+^ _@[X7^&VS^Q=%L[6>,!3=%-]P
MY]3(>?RQ73%?-&YF^;KDG^?&?UKV[X-?\$^/B5\6XEG_ +*70+%BH\_4<QM(
M#W5/O&OK#X-_\$I_!?@E[>\\137GB6_C(9XF/E6N?]T<G\37RN;<>95@$XQE
MSS[1_P Q93X>\1YY5YZZ<8/[4]/PO<_/GP/\,_$7Q3U..S\/Z'J>J3,N\^1$
M75!ZDCL/7I7TM\)O^"3GC#Q7##=>)-6TWPW$V!Y2*;JX4''IA0?;=U%?H5X<
M\*Z?X3T];73;"TL;=!A8[>%(E'X**U!&H ^5<^N*_,,T\3,?B&Z>%C[./WO[
MV?LF1^">5X>U3,).K+M\*_!ZGB/PF_X)^_#7X46T)30+/6M0CZW>J#[4[GUV
MM\@_!1BO9XK6.U"K&B1K&N J<<>U6T3<:=(@"'@5\!BL9B,3+GQ$W)^;N?K>
M RG!X*/)A*<8+R5B(KNZ\^F>U/1!Y>.E1M(J#+,H],TUIE1N6 ]\URGHEC'O
M0W)%0E]WW6IN['\7.?7_ #ZT[JUQ<W0LXYI>U5%G4C_6#<.HS3Q<9&=W:GJ%
MTRP30<U7,RG^(<T&8*!N8*>V32Z7"Y8HJ,/A 0WXU'-,%?K3&3EO2@FJ_GK\
MWS+[G/2D\W ^]P>OM03S6+/.?Y4IJNMRN[&]=P[9Z42R -M+4%;DXS2\[O:J
MXD4-C<..V>:&GVCKMSV-&I/,BQWI <FJZ3!N0P8=.O>FF7G&[V'-+F0<R6Y;
M[TG.:K)(",[OE^M/W[C][\C1?L5?H3YHJ.%P ?K3O,7UI^H>@[O03@TW?EN*
MA,BES\W?% $X/-'.:K,_S9Z?C2>>H7[P/'8T 63D#_ZU.!JKYR_WNO/6E$NU
M?O?G4\W85^Y9S35+5"959?O?E],_UIIG&W.[]:=QEDGBE[U76;RQ][]>E)YZ
M@?>7KZT]=B5)%GFFDD5%YO/7CUI#*K?QCTSGO1<HG!R*3YL57$@4D;N5Z@F@
M2C=][Z<T 6 W/-'S>U5QT^9N_K0'!.=WX9I7%%W5V6NU-9B /U-5_. ."PW?
M6E\S*Y+<FAZ.PRQS0:KK-D#YNP/6G++G^+/TI<R$3]J.HJKYXWE2P#=QFG"=
M0WWAT]:8N8G.<4I/'\JK/+O^ZV:5YA]W>!CI_*CF11.<T G%0&90F=Z]>,FA
MYU X=?FZ'-%P)SGVI#FJ_GJH^\OKDFE#9 PWZT:@6.<T9-5_-##[W/3.:0R;
M3][]::U"Z6Y:-':JIF]&7CKS3_.7;][GTI+45UNB;-+59I1G;N&?<T?:%V_?
M7CCK3>@7)\GVI1UJL9E&,MCOR:FBD#(.1CUH&244UC@4;OEH =2<YIDCAE'-
M1K(H/W^>XS4Z] TZE@YHS55;@.>&SVH$JKSO'YT[@6>?:E-57G6/[S;1T.30
M9-W\7&?6F+F70L?-3L\U5+_[7'UH%RA'#CIW- <R+0YI.:K"8!L%N0.1FA;E
M69OF' Z9HZV'S)EGYL]J #58SJ!][M1YX/\ $.GK2] N602:7G%55E 7);]:
M!*,?>_6F*^ERR,YH''6H!*,8W=Z3S5S][\C0,L@YI.2:ABDP.3]ZFB5?[WZT
M!=%@')I,D57,J\YDZ>]"N&)^;V'-'J!:'2D48JL9?+ W2>PR:4SYXW?2E+3<
M/0G"X'Z<T!*@$H)/S?K2^>JX&[V%'6P$S1[JC9<@_E3?. 8Y;D=>:!(NS.[C
M-,".2S4KU8KCN:XOXD_L[>#?B] W_"2>'=*U:1EV>;+!MF1/[JNN' [XW8SS
M7?[!BDV#TJJ-2=&7-2DXORT9RXK!T,3#V>(@I1[-)K\3X;^,_P#P2 M;R>2Z
M\$Z\EB')9=.OXV:)3U^61<D?BOU)XQ\N?%[]D#XB_!>29]8\/7EQ9P$XO;0^
M?#M]<K]WOP<&OV"GA7:ORKUYXJ":TCN4821I(I&&5ONGUXK[G*?$/-<':-27
MM(]GO]^Y^7Y]X.Y'CKSPR]C/^[M]U['X<([%MNW:=O/\.,U3UWP[8>*M,-GJ
MMC:ZC;C[L5U&)4_ 'I^&#[U^M_QQ_86^'_QR@62\TI=*U!1A+O346"3/N ,-
M^-?)_P 9O^"3_BSPD9KKPGJ%OXALU&X0R_N;H#T Y5C7Z7E'B)EF,CRXF].7
MG=K[S\8SKPFS[*Y.I@FZD5K>+M+YJY^;?Q._89T'Q7/]I\/W'_"-SD<P,C7%
MJQ]@6+)^9KPCQ]^RYXR^'\=Q/-I<E]8P9/VNRS-&1ZX W+]"*^_?''PX\0_#
M[4OLNO:-J6CS9Y6YA,8;'IV_*LB%>/O9/3K7VN']A6A[2E-/TU/%P/&V=9;-
M4L7%RMNI:?CN?FM@_P 2,K>AP"/SHK]$-9^%GA?Q%?->:AX?TF^NI1\TKVZA
MC]2.I]SSS16_U5=SZ^/BMAK+FHNY]M?!G_@DIKFO1PWGC75H]'C< M96F)9L
M#G!;IR/3I7UU\&_V,_ /P1:&XT318/MR*!]LGS).W'J?\]J]02S&T_+\J\*/
M058C3$:^N*_E_-N*LTS&3>(JOE[*Z7YG[QD' .2Y5%>PHIS7VI6<OOL0P66Q
MBV03],5-Y'RCIFG[>*4C(KYW?5GV48I:(B%OCO3EBQW[T_'%&*"MM@QQ391N
MC;Z4ZFR'$;?2@#Q?]N7XD:U\(/V=-6USP_>?8=4MYH$CF*!]@9P#P:XG]B[]
MIC5O&'P1\67GC:[^U:QX0EE>[<QA6,/E^8G [8X!]36M_P %-GQ^R#KQ])[<
MC)Q_RT%?.O[1-MJG@#XDP:+X>6../XS>&]/L&:/^&4%%>7C@MCK[9KZ3+\/0
MJ8)4II*3DW?K96NON;/D\RQ6(HX[F@WR*-K>;3L_OL=W^P[^U5XX^-/[3=UI
MGB#4?,T6[T:YU*SM5155%\V 1GC_ &)#^=<K^SK\=/B7\=+'6YKGXKZ+X372
M[D0HFHQQ+YRG/W<D=,8KK?@+X*L_A?\ \%++[P[8LBPZ3X'BMU08R0B62DX_
M4GWKYM_9OUWX-Z.FN0?%33[Z^NI+M5M!"I*QIAMX.&'\6.N:]3V.'J2J2P\%
MK"+223UO9Z/K;<\EUJ\*=.%:;TE)-MM=.Z\SZC_:3^)OQ"\*?$[X0^#M \70
MVMUXHT^&VOM16U62.ZN2\:&XP>QW,0/?VJ]!\9OB1^S9\=/#?AGXB:MI?B;0
M?%T@M[;5(;<V\EM)D+@J.N"5_ GTKSW]K[XM>'?"?QU^ /BI9&M?#L.GPZK$
MNP>:+??"Z@)D<A&48]:U_''Q"_X;X^.W@%?">DZS%X2\+WOVZ^U>Y@$49.4)
M53R,@ C&3DL..*Y</A8RHTW*"]GR3<I:7NF[:[]M.IV5,0U7G:3YU*%E=VM9
M7/3O#OQE\1R_M]:IX+GOMWAVUTD74=MM'ROM)SGKUK@/VV?VI_''A[XJZAH_
M@:^&G0^$-+%_J\C0"57+NH4<],;A^M7;37[31?\ @IMXEO+J:.*.T\-F=]S8
MPJQDFO/_ ("_#3XG?M'R>.O&V@:UX?TK3?&=W-8SIJ%B+HW,2D@!20=J@$41
MPN%IR5:7+94XZ/5.4GK]RN14Q6*E3=&#DY.<MM[+U^1]H_!GXCP_%'X2:#XA
M@9675;.*<@'[K$#(_ UX!^VC\;/'/A?]H_P#X+\)^(%T.+Q3$D,CM )0LCRN
MH<@\X 6C_@FCXIDT;1O%/PVU*93JW@O4WPH.%,3L?N@_P[PY [#%<C_P4"\+
M6GCC]M3X4Z'?-(MKK"1V<IBE,<@1[F0$HPY5NGS#IFN7"82C2S*=*=G%*375
M;:.W7T/4Q6*K5LMA4A=2;2:V>ZN=Y^S'\9?&LW[2/BKX:^+]6TWQ,VBV/VV'
M4K2 0D,#"#&X!])AD'^)&KSWP-\7/B-\5/B/X^LX_BGH?A"'PYKUSIUM%?QQ
MYEC$LH4KN(^Z% -:'[*4=C^R7^U!XG^'/B+[)'>:[,MSH6LRK_I&I0.Q*6S2
M,?F. ,#^^DG9EKQ/PIXG^#>D_&+XF+\3K&\O;B3Q3>OIWV89VQ?:)@0<.O7C
MUKL^KT7.M*E%-<L6FDM=KM+IZ=#R)5JT:=&,Y-.[NFWHO,^F/V@_C?XL^&/Q
M7^#^@V&N175OX@*QZI/%$A6_(**64]@22>*]H_:5\4:EX&^!_B?6M)G%OJ&F
MV+RP2;0VUAC!P:^3_P!N#XAZ!X:^(GP/\10^9;Z!96XNHU"C>EO^[*#&?O;<
M<9ZBO1_B!^VMX)_:1^!GQ"TOPW-J#W5CHSW$@N;<1+M)"C!W')S7FSP4N2C5
MC'1WOIYZ7/3IY@H^VA*>ME;7R_S.?_9<\7_$;XJZ5X7\0:C\8-!AAO;B.2ZT
M22",7$JA_FB^]G+?3O79_MO_ !F\5:#XA\'^"O UP+?Q-XD>>[DF"[FCMH(V
M8C'OAS[F,#O7SW^QIXZ^!.DR^"X=4TW4&^(!O8HH[D)F$7#L40DE\8Y'.*Z/
MPU-XZ_:Q_:W\7>,/ ^LZ5I(\%A='L+B^M_M,8B+2I\H.1N;9(Q/HX]:]"I@Z
M4<9*I424()M722;V2TW/.HXNJ\'&G3;<YV6C;:[[['N_P._:@N?&?[%/_">R
MQKJ6L:-I=U-J$48 \RYMU.>.GS *_'9Q7E7[.?CWXT?M'Z#;^)M,^(?AOY+P
M?:=&-D";>'=R3_P'D=C7*_LL>.+W]D?XS_%+P!XFA;6GAL_[5CL=.M_EOY$C
M25_(AYX>&9?EQ_!CM7*^(O%/@SQ!\3M!U+X&VGBC1_%]U?(;W3X+<PVJH6^8
M2(&(4>N/E(Y]JN&7TE5JTTE:5I1E:\>5J]GV]0J9A4E&FY2:<;J4;VDVM%TL
MSUKXU?'/QQ<_MBW'@72/&]AX2TA;&.=;B]1/*1MA))+8^\>V:^A_V<K;6K;P
M3)_;GC#3?&MXTS;+ZQ15B"C^'Y21D5\5?M8ZOX)TO_@H!?2>/K>XO/#*V">=
M##RY8QG80,KQGWKZW_8K\0_#_P 0_"9O^%;V=UI_A^"[DC:*X3:QEX+'[QX_
M&N#-\-"EA:+IQLG%/9;]==_D>AE-:4\75<Y7:;ZO\CUXW8C+;OEXW?XUQOAC
M]I/P/XR\;3>&],\3:5>ZY",O:1R$OZ\'&UOH":Z+Q;H3>(_#&I:<LKV\E_:2
MVPF3[T1=&7<#ZC(-?#WP0_X)C^// 'QX\/Z_J.K:/'I>AZC%?22VUU(TLZ1L
M&VK&4 7=T/S'C=ZUY^7X7#5:525>KRN*O%=WV/6QV*Q-*I3C0I<R;LWV\_D?
M>T4V0?T_.OF_]JW]H#Q18?%K0?AKX#^RV_B;7D^TRWEPFY+6$L1D#U^5S]%K
MZ+LPR;MX^;.<#\*^/?VO[?4/@3^V/X3^+TNEWVJ>&K>U_L_4/LB;WM"HF4,1
M[K*",\96GD]%5,0XS2>CLN[MH9YQ4J0H*46UJKVZ+J>J?"/PW\6/A[KUY=^.
M/%^C^(]!M]/DG)@M/)E61>=O^[@$_A7E?PX^(_QH_:YEUKQ!X6\0:5X+\-PW
M;6FFQ36GGM<E>I)_+\Z]0^%O[7/A/]JB?5/#OAFWU[=)I\IDN;JS$4$>Y2FW
M<&/S<].*\,_9Q_:@L_V*/"=]X ^(&BZUI]Y8ZA,^GS06P>.Z5CD$$E<\CJ,Y
MS7?AZ=9PJ7I1]M[MHM+1=7;[CS<1*GS4X^UE[+6\KO5]%<]1_97_ &F/$OC=
MO''@_P 91PIXN\%12-)<P*%CNP PW8'0AES[@BN+_8+_ &OO%7C[XEKX=\;Z
ME]L_X2*TDNM&D:,+\T$LZR)\OJ(7//3R_>I/V1/">N>-?B!\5?BAJ6FS:+I?
MBBVECTZ&X0QR3#YWWD'MC;WY.:\3\"P7'PN_9_\ AS\7K%/M7_"'^)+VUNT!
MVM);2SDMS_#DB503P/-]Z[OJN%E*O3<5S2Y4NRE9W7WGEK&8N"HU4W9.3?G%
M,]2^,G[7GCBW_:V_L_P_JC6O@V#Q+9>&W3R%83W("?:N3S_%M^@S3OVF/VN/
M''PJ_:XOM+T_4!)X7T,64]UIOE*/-ADV"3#]1R_X5PVM>!+CP7\.O@!J&K2!
MM6\6>+3K]ZV>&>Y>!D)]S$B$^AW5U/QA^'D/QC_;Y^('AOS(U:]\,-&C@_-#
M)]F!1ACH0V#SVKLH4\!%IS@FHTVGYM22O^9E.MC^27O.\IIKR33=OEH>K?M\
M_M+ZQ\*/!OA^W\&WJV^M:^QNHW$8=A:HF]GP>,<J/QKF_BE^T;XRT']COX<>
M*+'5O*UKQ%=VPO+GR5)F5V.X8[<<<5XM\)[W6/CMX9\9>*]>V[? O@V30X/F
M!VS#*''_   <^I KTGXC>"-5\9?\$WOAS=:'9R:E-H:VNH200(9)&17;=MQU
MQQD>E<\<#A*,*5"HDVIVD^]U>WIL=,L7BJ[J5XMVY=%Z.W^9[#^WE\6O$7PC
M_9BCU[P[?'3]8:]M8EGV!L!T;=D'CTKS?]LW]H/XA>!O#_PPC\*ZK]EU+Q39
M22W'[I7-Q*$A90 1CDLX^K"N*_:>_:PTW]K_ ."FG> _!NC^(+[Q5->6\LEN
MUD56 HC*=S G #-U( P*[3]K#2&\/?&[]F;3;IE\ZSU**WDP>"5EM5;\.#^%
M887#4:/LEB(*]YMI]E'3\=C;&8JM653V$WRV@DUW;LS>\8_M=:AXW_8"U#QU
MX=OH=-\3VBVUO<A '-I=?:XXY>#U4[G*^H/M3/VA?V@O&'@W6_@?#INI?98_
M%HB.J!8E/VG(@)Y[#YVX'K7A7[9WP[OOV5?$WBO3M/CA3P'\3O+EAC'R"QN(
MKB.<KMZ  Y"@_P $F!]VO0OVL)EAUC]F@R,JG;;C<2 #\EK3^I81*G-6M4E)
M^BY59?)W^XS>.Q4N>";4H**?F[N[^X]!_:'^/_C35?VA--^%/P]>ST_5IK<7
M5WJ%ROF+;QX)X7V S6/=_&'XH?LO?&?PSH_C[5--\5^'O%DRVD5]!;_9W@E)
M QCVR/P-97[0=UJ'[-/[<5G\4KS3-0U3P?J&GBRO9K2+S&LWVLO([=0>2,]*
MP_B;\=+7]NOXW^ ]%\%:;J,FF^&;]=3U&]NX1'Y(!!Z GLN.N2348?"IP@XP
M7L^1N3ML_7?3H56Q4XRE^\?M.=**Z-7/5;#XT^)9_P#@HS?^"?[0SX;CT,7B
M6@1>)?*A;<&Z_P 3?G47COXW^)='_P""B/@GP+'?%?#.J:=)=7-H$'[R5;:\
MDW;NH^:)>.G%<)\=/$,O[,O[?\?Q*US3]1N/"6K:0MD;NSA\Q;9A&B$.20%.
MY!QGD-2?#'7_ /AK+_@H)H?Q!\-V>H1^%O"VEM'+>W4!B2>1H)XMJ=CS<9P"
M<;3ZUE+"TY05:$?<5+5Z6YO\[G4LPJ*I[%M^T]IM_=[_ '#M3^,WC[QY^U+\
M0O"MK\2-+\&:9X=N=MH;Z%-CJ=@VJ6(R06S7U%\%EU*S^&VEQZQKUGXGU1(V
M,^IVJA8;O+L590"1@+M''I7P'XX\3_#+0_VU/BM_PM"PNM1T]KT"S2W3+)+B
M,DGYU_AXK[F_9Y\1^%]:^!VA:AX.CDL_#+6["R2==ABC1W0AN3C#*QZ]JQSK
M#QC"FH1LFH]%:]M[K4Z,EJ2E.I*H]G+JWI?[CRG]LSXS>,M/^)N@^"? -]'8
M:Q=V5QJMY.\88""-"0G/J1D>M=)\'_COJ/Q'_8VN?%P?R-<L=*N?M#%1E+J)
M6R2#[@'\:\%\#V'Q _:8_:4\?>/? ^O:+IL.E7/]B02ZA9BYQ  00H.0.A/_
M  .M#]D_3M2\#:[\8/@SJVH6\VMW=G-=V9CPMO.\J$.8US\H)8'':NBIA<-&
M@H)QYX\K??5^]^:.*&+Q4L3.HU)0?,DO1:?C<]H_8A^+/B#XI?LDQ^(]>OS?
M:PSW^;GRPF?+D<)P..  /PKSGX#_ !.^)W[07['OBG5M+\02?\)GI.JRQV+^
M2FVZ2..-_((QCY@[ '^]BN(_9O\ VM=*_9;^!%Y\./%VD>(+/Q19R7HAMUL2
M5G$I=TP203DG&0"#D8ZUTW[/WC*X_8E_8;U+6O$4 L-;UR^GO-*TNX!6>25P
MB1(RXW?P;F]%%/$8&-*=248K6:Y.S6O_  +A1QWM%3CS.R@W*U[IZ6(+O]N?
M7/C/\/\ P3X9\$;K?XE^(+E;74&:+*:8(2XFD8$8^;:S$=@&]J^O-%T2;1_#
MD-O<WDM[<0P@2W,@ :Y<* 9"!P"<9P.!FO@?2?A;XK_8LMO!_P :=16*]_M2
M>23Q'9&/#6<5W)N&T] VQE4_W7 'W37WKX9\7V'CKPG:ZQIES'=:=J%OY\$R
M'*LC D'/;TQ[&N/.*-"$XK"?!KKY]O1=#MR.I7E&7UIOGMMY='ZL^.OV6_VO
M?&OB+]I/^Q_%.L"\\/ZM?WVF6B^4J^5-&Y\L''J.*N_MB_M?>*_"WQOC\/\
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CTX\TV8X7\:=6A84444 %!YHHH 3;1MXI:*  # HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g54875g0805095346770.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g54875g0805095346770.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  E "4# 2(  A$! Q$!_\0
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0L1B*D*CC%Z%TJ<'!-H__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g54875g0805095347199.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g54875g0805095347199.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  H "D# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#-M+35/%.M
M>5$6N;R8EV=VZ#N2>PI-<T#4/#UZMKJ$:J[+N1E.58>QJ_X*U>[T;Q"MQ9V;
M7;/&R/"GWF7@G'TP*O>.-7U'Q%K-I%)IDUJ50K! XR[[CR?T_2OI7.HJRBDN
M6Q\@J=.6'<VWSW./HK0?0]5CGB@?3[A99L^6A0Y;'7'YU+J'AO6=+@\^]T^:
M*+NY&0/KCI6WM(WM<P]E.S=GH=!\+[J>+Q?%;I*ZPRQOYB \-A21Q]17N%>$
M_#/_ )'>U_W)/_0#7NU>)F2_?+T/HLH;^KOU_P CPOX8?\CQ;_\ 7&3^5=5X
MP_Y*GX9^D?\ Z,:N5^&'_(\6_P#UQD_E75>,/^2I^&?I'_Z,:NJO_O7_ &Z_
MU./#?[FO\2_0Z;QCXCM_#%C#?-;+/=.QBA!XQGEN?3@5+H>J0>,?"QGE@")<
M!XI8SR >AKDOC%_QX:5_UVD_]!%:_P +/^1+3_KXD_G7$Z45A546]ST%6G+&
M2HOX;' ?#5=GCJV3^ZLH_P#'6KW2O#?AS_R/T/\ VU_]!:O<JO,OXJ]/\S/*
M/X#]7^A\VVUSJ?AC6&DBW6U[#E#O4$C/!X-27GB?5K_5;74[FY#W=KCRGV ;
M<'(X^IHHKV8QC)*;6MCY^4YP;A%NR8:SXFU;7XXDU*Y$RQ$L@"!<$]>E2Z5X
MOUO1;(6=A=B* ,6V^6IY/7K113]E#EY;*PO;5.;GYG?N;7PQMKB?QA'=+$S1
>1HYDD X7*D=?J:]OHHKP\Q=ZUO(^CRJ-L/?NV?_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
